info@cpisra.org

Email: info@cpisra.org
Home » Anti-Doping

Anti-Doping

World Anti-Doping Agency

https://www.wada-ama.org/


CPISRA Anti-Doping Documents



Latest Anti-Doping News


17/06/21 – WADA ANNOUNCES FURTHER RISE IN GLOBAL TESTING FIGURES IN LEAD-UP TO TOKYO 2020

Montreal, 16 June  2021 – The World Anti-Doping Agency (WADA) announced today that global testing figures are continuing to rise as activities of a growing number of Anti-Doping Organizations (ADOs) worldwide are returning to normal.
 
As announced in May, the overall number of samples collected by ADOs around the world is quickly going up despite the ongoing COVID-19 pandemic. The latest figures, released today, show that 24,430 samples were collected in May 2021 by 152 ADOs, which is the highest number of samples collected since the pandemic started in March 2020.
 
Despite restrictions that are still in place throughout parts of the world, out-of-competition testing is now at a level greater than for the same period in 2019. Specifically, in April 2021, 14,560 out-of-competition tests were carried out compared to 12,713 in April 2019. In May, the number went up to 16,149, compared to 13,691 for the same month in 2019 and was the highest number of out-of-competition samples collected over the past 29 months. In-competition testing figures for May 2021 were also the highest in the past 15 months with 8,281 samples collected from events and competitions.
 
WADA Director General Olivier Niggli said: “The rise of testing numbers around the world represents a significant effort on the part of Anti-Doping Organizations in light of the ongoing pandemic. WADA thanks them for their commitment, flexibility and determination to deliver a quality testing program in challenging circumstances. With just over a month to go before the start of the Olympic Games, Anti-Doping Organizations are in the final phase of delivering on their strategic testing plans. WADA urges them all to continue to make the most of this time to ensure that all athletes bound for Tokyo have been properly tested and to implement the testing recommendations they have received from the Pre-Games Expert Group led by the International Testing Agency (ITA).”
 
This Pre-Games Expert Group has issued test recommendations to all the Summer Olympic International Federations (IFs) and National and Regional Anti-Doping Organizations (NADOs and RADOs) for athletes likely to participate in the Olympic Games Tokyo 2020, as part of a program to ensure they are subject to a suitable level of testing in the lead-up to the event.
 
WADA’s Director General added: “I would also like to remind all Anti-Doping Organizations that the International Olympic Committee (IOC)-funded pre-Olympic long-term storage program delivered by the ITA is available to them, at no cost, so they can securely put samples away in a long-term storage facility for possible further analysis in the months and years to come. As detection methods are constantly being improved and updated, retaining samples for up to 10 years means that those who have taken a prohibited substance cannot rest easy for a full decade after they have been tested. The storage and further analysis of samples has yielded considerable success in previous years and it is a requirement under the 2021 International Standard for Testing and Investigations that Anti-Doping Organizations must have a written strategy for storage and further analysis as part of their testing programs.
 
“The further analysis of samples collected during Beijing 2008 and London 2012 Olympic Games by the IOC has so far produced more than 130 Anti-Doping Rule Violations, which clearly highlights the effectiveness of such a program to provide more effective detection. I am confident that this program will continue to have further impact in the years to come.”
 
In addition, WADA is working to ensure that the WADA-accredited laboratory in Tokyo will be ready for the challenge of the Games. WADA will also have an Independent Observer (IO) team present in Tokyo to monitor the anti-doping activities at the Olympic Games and work in partnership with the IOC, the ITA and the organizing committee to ensure the most effective anti-doping program is delivered. Similarly, WADA will have an IO team monitoring the anti-doping activities of the Paralympic Games in partnership with the International Paralympic Committee.

Number of samples collected (blood, urine and Athlete Biological Passport)
2019-2021 Comparison
 

Month202120202019
January14,28020,28817,539
February17,73125,25923,819
March23,01711,20726,933
April22,09957825,219
May24,4302,62527,146
June 7,70626,904
July 11,08128,084
August 14,61929,360
September 18,69926,638
October 21,09426,897
November 19,63626,469
December 15,46420,873
Total 168,256305,881

















Number of samples collected out of competition
2019-2021 Comparison

 

Month202120202019
January10,15212,5469,988
February11,93713,62212,379
March15,2926,86813,139
April14,56056912,713
May16,1492,51213,691
June 6,73413,377
July 8,91614,933
August 9,87115,443
September 11,92015,015
October 13,09715,112
November 13,96315,265
December 10,88012,012
Total  68,090111,498163,067

15/06/21 –WADA ISSUES REVISED INTERNATIONAL STANDARD FOR RESULTS MANAGEMENT WITH MINOR AMENDMENTS

Montreal, 14 June 2021 

Dear Colleagues,

The World Anti-Doping Agency (WADA) issues a revised International Standard for Results management (ISRM), which was approved by WADA’s Executive Committee (ExCo) on 20 May 2021 with immediate effect.

This new version has minor amendments, which are summarized below and available on WADA’s website, that were made to ensure the ISRM’s alignment with various WADA Technical Documents and the latest version of the International Standard for Laboratories (ISL).
 

  1. Article 3.6

At the time the ISRM was drafted, the definition of “Adaptive Model” was a defined term from the 2019 International Standard for Laboratories (ISL). In the 2021 version of the ISL, which was adopted at the November 2020 Executive Committee Meeting, the term “Adaptive Model” was removed as the ISL articles no longer referred to this term. However, the term “Adaptive Model” is used 18 times in the ISRM, specifically, Annex C – Results Management Requirements and Procedures for the Athlete Biological Passport.

In addition, the definition of “Athlete Passport Management Unit Report” is currently a defined term in one Technical Document, namely the WADA Technical Document related to the Athlete Passport Management Unit Requirements and Procedures (TDAPMU). However, this defined term is used seven times in the ISRM, specifically, Annex C – Results Management Requirements and Procedures for the Athlete Biological Passport.

Therefore, these two definitions concerning the Athlete Biological Passport (ABP), namely “Adaptative Model” and “Athlete Passport Management Unit Report”, were moved from the ISL and the TDAPMU respectively to the ISRM, where both definitions are better suited.
 

  1. Article 5.1.2.3

The Comment to article 5.1.2.3 of the ISRM referred to article 5.3.4.5.4.8.5 of the 2019 ISL and reflected the three-month deadline for the “B” Sample confirmation to be performed. Since the adoption of the 2021 version of the ISL in November 2019, article 5.3.4.5.4.8.5 of the 2019 ISL has become article 5.3.6.2.3 in the 2021 ISL and its relevant part was amended as follows:
 

If the “B” Confirmation Procedure is to be performed, either upon the request of the Athlete or the Testing Authority or Results Management Authority, it should be performed as soon as possible after the Testing Authority or Results Management Authority, as applicable, has provided such notice to the Laboratory.

The Comment to article 5.1.2.3 of the ISRM was amended accordingly.

  1. Comment to Article 8.6

The last sentence of the World Anti-Doping Code (Code) definition of “Operational Independence” was missing in the Comment to Article 8.6 of the ISRM.

For reasons of consistency between the Code and the ISRM, the missing sentence was added to the Comment to Article 8.6 of the ISRM.
 

  1. Articles C.2.1.6 and C.2.1.6.1

The “Suspicious Steroid Profile” (SSP) system was conceived in 2014 in part to deal with (i) unmatched samples due to the lack or delayed entry of Doping Control Forms (DCFs) at the time, (ii) the fact that some athletes may have had existing steroid data prior to 2014 indicating an elevated T/E not requiring Isotope Ratio Mass Spectrometry (IRMS), and (iii) the heterogeneous use of external Athlete Passport Management Units (APMUs). With the mandatory entry of DCFs, the collection of six years of ABP data, and the mandatory use of WADA-approved APMUs, revisions to the SSP system were needed.

The ISRM was amended accordingly in order to provide flexibility to make changes to the SSP notification system of the steroid module in the Technical Document related to the Measurement and Reporting of Endogenous Anabolic Androgenic Steroids (EAAS) Markers of the Urinary Steroid Profile (TDEAAS) and the TDAPMU without contradicting the ISRM.

The purpose of the ISRM is to set out the core responsibilities of Anti-Doping Organizations with respect to Results Management. In addition to describing certain general principles of Results Management, the Standard also sets out the core obligations applicable to the various phases of Results Management from the initial review and notification of potential Anti-Doping Rule Violations (ADRVs), through Provisional Suspensions, the assertion of ADRVs and proposal of Consequences, the Hearing Process until the issuance, and notification of the decision and appeal.

Should you have questions or comments on the revised ISRM, please feel free to contact WADA’s Results Management Unit at: rm@wada-ama.org.

Best regards,

World Anti-Doping Agency


13/06/21 – WADA STRENGTHENS GLOBAL ANTI-DOPING SYSTEM THROUGH RE-BUILD OF ITS ANTI-DOPING ADMINISTRATION AND
MANAGEMENT SYSTEM

In this latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency (WADA) team and its partners, we look at WADA’s Anti-Doping Administration Management System (ADAMS), and how it is making athletes’ lives easier and the work of the anti-doping community more effective. Previous ‘Spotlight’ features are available on WADA’s website.

For many elite athletes and anti-doping professionals around the world, one of the most regular types of interaction they have with WADA is through ADAMS. Launched in 2005, ADAMS is a secure and cost-free, web-based system that centralizes doping control-related data such as: athlete whereabouts, testing history, laboratory results, the Athlete Biological Passport (ABP), Therapeutic Use Exemptions (TUEs) and Anti-Doping Rule Violations. Available in 24 languages, ADAMS facilitates the sharing of information among relevant organizations and promotes efficiency, transparency and effectiveness in all anti-doping activities.

ADAMS allows data entry and storage, enabling data-sharing and reporting in a highly secure environment and is subject to strict data protection and personal privacy regulations. Under the World Anti-Doping Code, all Anti-Doping Organizations (ADOs) must use ADAMS for specific aspects of their anti-doping program. Among the users are around 3,000 ADO staff from National and Regional Anti-Doping Organizations, International Federations, Major Event Organizations, and delegated third parties, such as the International Testing Agency; roughly 160 personnel from WADA-accredited laboratories; and 150 experts from Athlete Biological Passport Units – all with specific access to the system limited to their needs. But far and away the most numerous of ADAMS’ stakeholders are the 30,000 or so athletes who rely on the system to enable them to update their whereabouts information, review their personal data and generally keep up-to-date on anti-doping matters.

As with all technology-based systems, ADAMS needs to be constantly reviewed and updated to ensure it remains current. As a result, in 2017, WADA initiated significant upgrades to ADAMS’ underlying infrastructure that laid the foundation for a complete rebuild of ADAMS aimed at optimizing support to the global anti-doping program and better serving athletes and anti-doping stakeholders. Referred to as ‘Next Gen’ ADAMS, the rebuild launched a number of modules over the past two years, which prioritize mobility, enhanced connectivity, reliability, performance and general usability. And, like all ‘Next Gen’ features, the new modules were designed with privacy, information security and transparency for end users as absolute priorities.

Specifically

1. In November 2019, WADA launched an all-new whereabouts application for athletes, known as Athlete Central. Available for free download and use from the Apple Store and Google Play, this multi-lingual app features location-based address recommendations and integrated user support. It was designed for athletes – based on extensive consultation that included more than 2,000 athlete submissions – in order to address the challenges they have faced with earlier whereabouts solutions.

2. In January 2020, WADA launched the new Testing Center module, which was developed with planning and monitoring functionalities, effectively reinventing the way that data on doping control programs are presented to ADOs in real time. The new module provides ADOs with a test distribution planning and monitoring tool, as well as a dashboard view of compliance with the Technical Document for Sport Specific Analysis. Together, this equips ADOs with the means to assess their progress more efficiently and act on the information more quickly, and improves WADA’s means to monitor testing activity

3. In May 2021, WADA launched DCO Central, a new doping control sample collection app for tablets that is also available for free from the Apple Store and Google Play. ‘DCO Central’ provides Doping Control Officers from ADOs and Sample Collection Agencies with an online and offline solution for secure and fast data collection as part of doping control sample collection, which is now entirely paperless and, most importantly, connected to ADAMS to reduce manual data entry, while improving data accuracy and the speed and security of data exchange.

WADA Deputy Chief Operating Officer, Stuart Kemp, said: “WADA is proud of what has been achieved with ‘Next Gen’ ADAMS in a relatively short space of time by a committed team of ADAMS and IT experts within WADA. We are particularly grateful to the athletes and stakeholders worldwide that we consulted to ensure that ‘Athlete Central’, the ‘Testing Center’ and ‘DCO Central’ would meet their needs. ADAMS is a critical component of the global anti-doping system and will continue evolving in line with the available technology and the changing needs of athletes and others within the anti-doping community.

“’Next Gen’ ADAMS is also a key initiative of WADA’s 2020-2024 Strategic Plan, which requires the Agency to ensure that its digital tools and services are intuitive, modern, functional and accessible. We want to ensure that athletes receive as much support as possible when it comes to fulfilling their commitment to compete clean and delivering a system that fits in with their preferences and lifestyles is a priority for us.”

WADA ADAMS Team Lead and Senior Manager, Ndiate Chaya Ndiaye, said: “The roll-out of ‘Next Gen’ is being carried out in a strategic, sustainable way, one carefully constructed and tested one module at a time. This affords us the opportunity to showcase the module and invite a focus group of users to experience it and provide feedback for further tweaking, ensuring we get it right before we move on to the next module. It also ensures that there is less risk of a negative impact on daily users by newly introduced bugs, while also offering an opportunity to integrate user metrics to measure the performance of new design with less pressure on training and support teams.”

The improvements will not stop here. More are on the way with better graphics and improved recommendations coming for the ABP module, more user-friendly dashboards and an upgraded submission process for TUEs, as well as a host of intuitive enhancements for the laboratory reporting module.

Ndiate Chaya Ndiaye added: “The history of ADAMS has been characterized by constant improvement and agile evolution much like the anti-doping system itself. The future of ’Next Gen’ ADAMS is going to be no different as we make sure it remains cutting edge and accessible for a brand-new generation of users.”


09/06/21 – WADA SIGNS MEMORANDUM OF UNDERSTANDING WITH THE CENTRAL EUROPEAN ANTI-DOPING ORGANIZATION TO COLLABORATE ON ANTI-DOPING PROGRAM DEVELOPMENT

Montreal, 9 June  2021 – The World Anti-Doping Agency (WADA) has signed a memorandum of understanding (MOU) with the Central European Anti-Doping Organization (CEADO) to collaborate on specific anti-doping program development activities, beginning with a project involving the Eastern Europe Regional Anti-Doping Organization (EERADO).

CEADO is a partnership of eight National Anti-Doping Organizations (NADOs) from Austria, Croatia, Czech Republic, Hungary, Poland, Serbia, Slovakia and Slovenia that work together with the main goal of supporting and strengthening the anti-doping system in the region.

The MOU, which has been signed by WADA Director General Olivier Niggli and CEADO Chairman Michael Cepic, requires the two organizations to meet regularly and, as necessary, discuss areas of collaboration that are of a mutual interest. The EERADO project is of particular importance this year as this Regional Anti-Doping Organization is set to disband at the end of 2021 after 13 years of good work. The closure of EERADO comes as its member countries’ NADOs are now in a position to operate independently, allowing WADA to redirect resources to other regions of the world where there is a greater need. This project will enable EERADO members to benefit from ongoing guidance and support as they further develop their national anti-doping programs.

WADA Director General, Olivier Niggli, said: “The global anti-doping system relies on collaboration between various stakeholders, and this MOU between WADA and the Central European Anti-Doping Organization will boost the anti-doping work being carried out between National Anti-Doping Organizations in Europe. The first project with CEADO will provide a comprehensive training and development program for a range of Eastern European countries, helping them to operate effectively outside the Regional Anti-Doping Organization network. Through projects such as this, WADA is assisting the development of innovative anti-doping strategies for those countries that need it most so that the global system is strengthened overall. I thank the leadership of CEADO for their readiness to cooperate in this way, ultimately delivering more effective programs for the protection of clean sport.”

CEADO Chairman, Michael Cepic, said: “The Central European Ant-Doping Organization was founded with the intention of collaborating and sharing experience between its eight members and to work on common projects in various anti-doping areas for the benefit of athletes. We appreciate WADA´s invitation to support Eastern European countries in their common goal to establish independent and World Anti-Doping Code-compliant Anti-Doping Organizations.”

EERADO Director General, Temur Ukleba, said: “This project enables anti-doping managers to get acquainted with the structural development and good governance of Anti-Doping Organizations within this region. It will also offer advice and guidance in relation to legislative and other regulations, effective implementation of the World Anti-Doping Code, guidelines, technical documents and educational platforms, as well as challenges faced by each country. We think this model is an excellent example of successful cooperation on anti-doping issues between countries with different capabilities.”

WADA created the RADO Program in 2004 to build or strengthen anti-doping capacity in parts of the world most at need. The program supports less resourced NADOs and National Olympic Committees acting as NADOs with funding, training and ongoing anti-doping assistance. It currently assists 15 RADOs that include 131 countries across the world.


08/06/21 – WADA AND SHIONOGI PHARMACEUTICAL COMPANY SIGN MOU FORMALIZING COLLABORATION TO PROTECT CLEAN SPORT

Montreal, 4 June  2021 – The World Anti-Doping Agency (WADA) has signed a memorandum of understanding (MOU) with the major Japanese pharmaceutical company, Shionogi & Co. Ltd., which will ensure that the Agency is notified immediately of any new Shionogi compounds or substances in development that have the potential for sports-related doping abuse.

The MOU, which has been signed by WADA President Witold Bańka and President and CEO of Shionogi & Co., Ltd., Dr. Isao Teshirogi, is the latest commitment from the pharmaceutical industry to assist WADA in its efforts to protect clean sport. Under the terms of the MOU, Shionogi will share information with WADA in relation to compounds in its portfolio that could be used to gain an unfair advantage in the sporting arena.

Following the signing, Mr. Bańka said: “This is another step forward for anti-doping. Through partnerships such as this, the anti-doping community can better anticipate possible doping trends. For the past 10 years, WADA has been working closely with the pharmaceutical industry to identify new compounds that might have a performance-enhancing effect in sport and allow us to develop detection methods at a much faster rate, either before the products have come to market or at the first signs of abuse. I thank our colleagues at Shionogi for their vision and willingness to collaborate in this important aspect of anti-doping.”

President and CEO of Shionogi & Co., Ltd., Dr. Isao Teshirogi, said: “Shionogi is committed to discovering and developing pharmaceutical products as well as to ensuring their correct use in society. Our policy is to supply the best possible medicine to protect the health and wellbeing of the patients we serve. Shionogi supports WADA’s efforts to prevent the abuse of medicines for doping in sport and we are delighted to have signed this MOU. Shionogi hopes that athletes will maintain their health and play sports under fair conditions and we intend to fulfill our social responsibilities as a pharmaceutical company by sharing with WADA all relevant information on compounds under development in our portfolio.”

Since 2011, WADA has been forging alliances with a number of companies within the pharmaceutical sector in order to keep up to date with the ever-shifting drug research and development landscape. These agreements have included some of the biggest and most influential pharmaceutical companies in the world, including Japan, such as GlaxoSmithKline, AstraZeneca, Astellas, Kyowa Kirin, Pfizer and Roche, as well as the International Federation of Pharmaceutical Manufacturers and Associations


08/06/21 – WADA PUBLISHES 2020 MONITORING PROGRAM FIGURES

Montreal, 3 June 2021 

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) is distributing the 2020 Monitoring Program Figures to stakeholders, as per the World Anti-Doping Code (Code).

The document – which is being shared with you on a confidential basis – provides data for substances, by sport, which were not on the 2020 List of Prohibited Substances and Methods (Prohibited List) but that were monitored during 2020 in order to detect patterns of misuse in sport; and, potential inclusion on the List.

Article 4.5 of the 2015 Code (in effect for the 2020 monitoring data) states that “WADA, in consultation with signatories [of the Code] and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport. […] WADA shall make available to International Federations and National Anti-Doping Organizations, on at least an annual basis, aggregate statistical information by sport regarding the additional substances.”

Should you have any questions, please contact statistics@wada-ama.org.

Best regards,

World Anti-Doping Agency


08/06/21 – WADA INVITES STAKEHOLDERS TO NOMINATE CANDIDATES FOR 2022 STANDING COMMITTEE MEMBER VACANCIES

Montreal, 31 May 2021 – The World Anti-Doping Agency (WADA) invites its stakeholders to nominate candidates for vacant positions on WADA’s 2022 Standing Committees.
 
The following Standing Committees, which report to WADA’s Executive Committee (ExCo), play a key advisory role in policy and priority development for the Agency. The successful candidates will be approved by WADA’s ExCo on 20 November 2021 and take office on 1 January 2022 for three-year terms. This call for nominations is in accordance with WADA’s Governance Regulations which require the Agency, on an annual basis, to announce its call for nominations six months prior to when the decision will be taken by the ExCo.
 
Aside from outlining the vacancies, WADA is pleased to provide links to the current Terms of Reference (TOR) that outline the scope of work and functioning for each Standing Committee.
 

Committees [Terms of Reference (TOR)]Vacant positionsDeadline
Athlete Committee [TOR]
Five positions
 
[Two seats are filled by Athletes who also sit on WADA’s Foundation Board]
 
Friday, 1 October 2021
Compliance Review Committee [TOR]
 

One independent compliance expert position 

As stated in WADA’s Governance Regulations, WADA’s Nominations Committee shall be responsible for recruiting, reviewing and vetting the candidates for the positions of independent members of the CRC. Applicants who meet the stricter independence criteria required for independent members of the CRC, may however apply in order to expand the candidate pool from which the Nominations Committee can consider.
 
Friday, 3 September 2021
 
[Earlier deadline because of the involvement of the Nominations Committee in the process.]
Education Committee [TOR]Four positionsFriday, 1 October 2021
Finance and Administration Committee [TOR]Four positionsFriday, 1 October 2021
Health, Medical and Research Committee [TOR]Four positionsFriday, 1 October 2021


WADA President Witold Bańka said: “WADA benefits greatly from its diverse and committed Committee members. Their expertise and advice to WADA’s Executive Committee and Management is crucial to advancing the Agency’s mission for doping-free sport. We encourage all stakeholders to consider their respective regions and organizations and to nominate suitable candidates for the vacant positions on WADA’s 2022 Standing Committees.”
 
How to submit nominations
 
To be considered, all applications must include the following:

  1. an updated curriculum vitae(1), which fully outlines the candidate’s experience and expertise; and
  2. a letter of endorsement from one of WADA’s current Foundation Board members or a recognized WADA stakeholder group. [It should be noted that this is not required of the independent compliance expert position.]

Applicants submitting their file to be considered by WADA’s Nominations Committee for the vacancy of independent compliance expert will need to include confirmation that they meet the required stricter independence criteria.

Applications are to be forwarded by Friday, 1 October 2021 (or Friday, 3 September 2021 as it relates to the CRC vacancy) to Mr. Olivier Niggli, WADA Director General (c/o marjorie.chinnarassen@wada-ama.org).

Any questions should also be directed to Mr. Niggli, c/o Ms. Chinnarassen.

Note:
(1) For purposes of review, evaluation and approval, candidates consent to the sharing of their curriculum vitae and candidate file (and personal information contained therein) with the WADA Director General, the Chair of the relevant Standing Committee, the Nominations Committee where applicable, and the Executive Committee and Foundation Board, in accordance with Article VI, By-Laws on Standing Committees, and IX. Candidate Privacy Policy, of WADA’s Governance Regulations. Candidates are asked to review the Candidate Privacy Policy for details about how their personal information will be processed by WADA. By submitting their application, candidates confirm that they have read and understood the policy and accept its terms.


08/06/21 – WADA PUBLISHES REVISED TECHNICAL DOCUMENTS AND NEW TECHNICAL LETTERS

Montreal, 31 May 2021

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes revised versions of five Technical Documents (TDs) (along with their Summaries of Modifications); as well as, two new Technical Letters (TLs), which were approved by WADA’s Executive Committee on 20 May 2021.
 
REVISED TECHNICAL DOCUMENTS

Under the International Standard for Laboratories (ISL), WADA’s TDs are issued to provide direction to WADA-accredited Laboratories, WADA-approved Laboratories and other stakeholders on specific technical or procedural issues. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code, TDs undergo periodic revisions to address scientific and technological advances in the performance of anti-doping tests and the reporting of test results, as well as to reflect feedback received from WADA-accredited Laboratories and other WADA stakeholders.

The revised TDs, along with their Summaries of Modifications, are listed below and are available and indexed on WADA’s website:

  1. TD2021BAR Analytical Requirements for the Hematological Module of the Athlete Biological Passport, along with the Summary of Modifications.

    In this revised version of the TD2021BAR, in Article 6.1, the reference to International Standard for Testing and Investigations (ISTI) Annex K, Article K.2.4 was replaced by ISTI Annex I, Article I.2.7.
  2. TD2021EPO Harmonization of Analysis and Reporting of Erythropoietin (EPO) and other Erythropoietin-Receptor Agonists (ERAs) by Polyacrylamide Gel Electrophoretic (PAGE) Analytical Methods, along with the Summary of Modifications.

    In this revised version of the TD2021EPO, the implementation date of the TD was postponed to 1 September 2021. This modification, which was requested by the WADA EPO Working Group, was triggered by the difficulties faced by certain laboratories in becoming compliant with the new requirements of the TD2021EPO under the existing COVID-19 pandemic restrictions.
  3. TD2021IRMS Detection of Synthetic Forms of Prohibited Substances by GC/C/IRMS, along with the Summary of Modifications.

    In this revised version of the TD2021IRMS, the following points were modified:
  • Article 1.0: Clarification that the general technical recommendations and method validation requirements described in this TD shall also be applied to the analysis of 19-norandrosterone (19-NA) and 19-noretiocholanolone (19-NE), notwithstanding that these two substances are subject of a separate TD (TDNA).
  • Article 1.1.3: Clarification that the same endogenous reference compounds (ERCs) and target compounds (TCs) that led to the “A” sample Adverse Analytical Finding shall be measured in the “B” sample.
  • Article 2.1.1: Clarification that sample volume adjustment may allow the analysis of TCs and ERCs present in the sample at a concentration lower than the respective limit of quantification (LOQ) as long as the signal is within the validated linearity range of the IRMS instrument for that particular analyte.
  • Article 2.1.2: The reference to the monitoring of the precision of the 45/44 and 46/44 ratios as a check for the stability of CO2 pulses has been removed.
  • Article 2.1.2: Equation 3 for the mass balance adjustment of measured δ13C values of acetylated compounds has been reviewed. The term “C” in Eq. 3 had been misquoted as representing the concentration and therefore has been removed.
  • Article 2.3.2: Clarification under criterion iv. that the criterion for the ERC-A and ERC-Etio pairs may be applied only if no other criterion based on the measurement of T, 5α-Adiol and/or 5β-Adiol can be used.
  • Article 2.4.2: Clarification that the laboratory shall explain, in the comments section of the Test Report in ADAMS, the reason(s) why pregnanediol (PD) could not be used as the ERC1.
  1. TD2021NA Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone, along with the Summary of Modifications.

    In this revised version of the TD, the unnecessary requirement to inject a blank urine sample before the sample under confirmation was removed from Article 3.2.3. It is considered that the potential of any contamination shall be addressed by the laboratory during method validation, and that the use of negative quality control (NQC) and positive quality control (PQC) samples is sufficient to monitor any issues during routine analysis. 
  2. TD2021EAAS Measuring and Reporting of Endogenous Anabolic Androgenic Steroid (EAAS) Markers of the Urinary Steroid Profile, along with the Summary of Modifications.

    In this revised version of the TD, the misquotation of some article numbers, which erroneously referenced articles that no longer exist in the TD2021IRMS, was corrected in Articles 3.3.1 and 3.3.2. Therefore, those specific TDIRMS article numbers have been removed and replaced by a general reference to the TDIRMS. 

    In addition, it was clarified in Article 3.3.2 that the Laboratory shall also report the measured specific gravity of the “B” Sample.

DEADLINES FOR IMPLEMENTING THE REVISED TDs

All WADA-accredited Laboratories are required to implement these TDs in their procedures by the following deadlines (WADA-approved Laboratories are only expected to implement TD2021BAR):

1 June 2021:

  • TD2021BAR
  • TD2021NA
  • TD2021EAAS
  • TD2021IRMS

1 September 2021:

  • TD2021EPO

NEW TECHNICAL LETTERS

Under the ISL, WADA’s TLs are issued in letter format on an ad-hoc basis in order to provide direction to the WADA-accredited and WADA-approved Laboratories and other stakeholders on particular issues related to the analysis, interpretation and reporting of results for specific Prohibited Substance(s) and/or Prohibited Method(s) or to the application of specific laboratory procedures.

The TLs below were developed as a result of the recommendations made by the WADA Working Group on Contaminants and are available and indexed on WADA’s website:

  • TL23 – Minimum Reporting Level for Certain Substances known to be Potential Meat Contaminants

    This new TL includes clarification regarding the reporting and results management of findings for certain substances (clenbuterol, ractopamine, zeranol and zilpaterol) which may be used as growth promoters for livestock in some countries and therefore may be associated with findings resulting from the consumption of contaminated meat.
  • TL24 – Minimum Reporting Level for Certain Diuretics that are known Contaminants of Pharmaceutical Products

    This new TL includes clarification regarding the reporting and results management of findings for certain diuretics (acetazolamide, bumetanide, furosemide, hydrochlorothiazide, torsemide and triamterene) which are known to be found as contaminants of some pharmaceutical products.

DEADLINE FOR IMPLEMENTING THE NEW TECHNICAL LETTERS

All WADA-accredited and WADA-approved Laboratories are required to implement these new TLs in their procedures by 1 June 2021.

Should you have any questions or comments regarding these revised Technical Documents and new Technical Letters, please contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


28/05/21 – WADA EXTENDS DEADLINE TO RESPOND TO SOCIAL SCIENCE RESEARCH SURVEY TO 16 JUNE

Montreal, 27 May 2021

Dear Colleagues,

Following our communication of 27 April regarding the Social Science Research (SSR) Collaboration Platform, the World Anti-Doping Agency (WADA) informs stakeholders that the deadline to respond to the social science research survey that accompanied the communication has been extended from 31 May to 16 June 2021.

The survey is designed to gather stakeholder feedback in the area of social science research as it relates to sport integrity; and, since it was launched, WADA has received responses from over 220 organizations and researchers. We would like to thank all stakeholders who took the time to respond and encourage others to complete the survey to ensure as many contributions as possible.

Stakeholders are kindly asked to provide feedback on their experience with social science research to help participating organizations learn the needs of the sporting community; and, improve their support and promotion of social science research in sport in the future.

The Social Science Research Collaboration Platform is an informal “community of practice” for international organizations that fund or support social science research in sport integrity matters. Its focus is to share best practices and raise the visibility of the research to increase its usability and, ultimately, its impact on the sporting system. The organizations involved engage to share experiences using their collective insights to improve the benefits of social science research – including reducing duplication and importantly, improving the way in which it is disseminated, understood and adopted by stakeholders in the field of sport.

Other member organizations participating in the Platform include; the Council of Europe, the European Commission, the International Olympic Committee (IOC), the Partnership for Clean Competition (PCC) and the United Nations Educational, Scientific and Cultural Organization (UNESCO).

Should you have any questions regarding the Social Science Research Collaboration Platform, or any of the information outlined above, please contact Ani Meliksetyan, Coordinator, Research and Policy (Education), at: ssr@wada-ama.org.

Thank you and best regards,

World Anti-Doping Agency


27/05/21 – WADA ANNOUNCES INDEPENDENT OBSERVER TEAMS FOR TOKYO GAMES

Montreal, 26 May 2021 – The World Anti-Doping Agency (WADA) is pleased to announce its planned Independent Observer (IO) program for the Olympic and Paralympic Games in Tokyo, Japan, which will run from 23 July to 8 August, and from 24 August to 5 September 2021, respectively.  

WADA’s IO program, which complements WADA’s compliance monitoring of Major Events Organizations, is intended to provide oversight and instill confidence in both athletes and the public as to the quality, effectiveness, and reliability of anti-doping programs during major events such as the Olympic and Paralympic Games and other international, multisport events.
 
WADA Director General Olivier Niggli said: “Since it was launched at the 2000 Olympic Games in Sydney, WADA’s Independent Observer program has provided important oversight of anti-doping programs at the Olympic Games, Paralympic Games and other major international sporting events. Working in collaboration with event organizers, the impartial and multi-skilled Independent Observer teams have helped to strengthen anti-doping delivery for more than 50 major events. Whether in real-time during the events or via the reports that are delivered afterwards, thanks to this program, important improvements have been made to how anti-doping is delivered during major events – all aimed at providing robust protections for athletes.”
 
For the Tokyo Games, the teams will once again be composed of international experts across the full range of anti-doping disciplines – a mix of WADA and other Anti-Doping Organizations’ specialists – and will observe all aspects of the programs, including:

  • Test distribution planning;
  • Selection of competitors for testing;
  • Notification of doping control;
  • Therapeutic Use Exemption (TUE) procedures;
  • Chain of custody; and
  • Sample analysis and results management.

The teams, outlined below, will provide daily feedback as to possible improvements that could be made to the program, which is being operated by the International Testing Agency (ITA), on behalf of the International Olympic Committee (IOC), and by the International Paralympic Committee (IPC), respectively. The IO teams will then issue post-Games reports that will formalize recommendations for the IOC, the IPC, the WADA-accredited laboratory in Tokyo, the organizing committees, and WADA – all designed to enhance anti-doping activities at future events.
 
Independent Observer Team – Tokyo 2020 Olympic Games

  • Dr. Francesca Rossi (Italy), Director of Testing, National Anti-Doping Agency of France (Chair);
  • George Tsamis (Greece), Senior Manager, Standards and Harmonization, WADA (Vice-Chair);
  • Dr. Osquel Barroso (Cuba), Senior Deputy Director, Laboratories, WADA;
  • Gina Gill Herrera (Colombia), Manager, Athlete Biological Passport and TUEs, National Anti-Doping Agency of Colombia;
  • Kenny Lee (Republic of Korea), Manager, Asia and Oceania Office, WADA;
  • Greg McKenna (UK), Head of Biathlon Integrity Unit, International Biathlon Union;
  • Aya Nakitanda (Uganda), Medical Doctor and President, National Anti-Doping Agency of Uganda (former athlete); and
  • Marissa Sunio (USA), Senior Manager, Legal Affairs, WADA.

Independent Observer Team – Tokyo 2020 Paralympic Games

  • Jenny Schulze (Sweden), Manager, Testing and Science, National Anti-Doping Agency of Sweden (Chair);
  • Ieva Lukosiute-Stanikuniene (Lithuania), Senior Manager, NADO/RADO Relations and Development, WADA (Vice-Chair);
  • Thomas Delaye-Fortin (Canada), Head of Legal and Governance; Badminton World Federation;
  • Yoko Dozono (Japan), Medical Consultant (TUEs), WADA; and
  • Jeongmin Lee (Republic of Korea), Member, Asian Paralympic Committee Athletes’ Council (former athlete).           

WADA’s Outreach Program, which has been a long-standing fixture during the Games to raise anti-doping awareness among athletes and others, will not be present in Tokyo in its usual format due to the COVID-19 restrictions. While these important face-to-face interactions will not be possible on this occasion, the program is still planning static imagery and other ways to promote clean sport inside the Athlete Village and will distribute Play True promotional items to athletes being tested in the Village.


25/05/21 – WADA TO HOLD MORE REGIONAL ‘LIVE’ WEBINARS
IN JUNE

Montreal, 24 May 2021 

Today, the World Anti-Doping Agency (WADA) publishes the Agency’s ‘live’ webinar schedule for June, which encompasses all webinars being offered; in particular, as part of WADA’s:

Unless otherwise noted, the webinars are being hosted in English only.
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
1 June
07:00 EDT/
11:00 GMT
 
Webinar for Athletes participating in the 2020 Tokyo Olympic Games
 
(in French)
Amadou Dia Ba, Former Olympic Silver Medalist from Senegal and Chair of the Athletes’ Commission of the Association of National Olympic Committees of Africa

Sameh Elray, Manager, Africa Office, WADA (Moderator)
 
Kadidiatou Kanouté Tounkara,
Former Olympic Basketball Player from Mali, Chair of WADA Education Committee and Member of WADA Athlete Committee
Africa Series

For Athletes, Athlete Support Personnel,
National Olympic Committees (NOCs) and Athlete Commissions from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible
17 June
04:00 EDT/ 09:00 CET
 
Anti-doping regional workshop for National Anti-Doping Organizations (NADOs) and Law EnforcementMathieu Holz, Senior Investigator, Intelligence and Investigations, WADA


Sébastien Gaillard, Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from Central European countries
Registration via invitation only
22 June
22:30 EDT/
23 June
11:30 Tokyo Time
Results Management under the 2021 International Standard for Results ManagementKenny Lee, Manager, Asia/Oceania Office, WADA (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
CISP Series / Asia-Oceania Series

For Anti-Doping Organizations (ADOs) and members of Disciplinary/ Appeal Panels from Asia/Oceania countries
Register here
 
Please first create an ADEL account before registering via the link above.
29 June
22:30 EDT/
30 June
11:30 Tokyo Time
Applicable Sanctions in Results Management Kenny Lee, Manager, Asia/Oceania Office, WADA (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
CISP Series / Asia-Oceania Series

For ADOs and members of Disciplinary/ Appeal Panels from Asia/Oceania countries
Register here
 
Please first create an ADEL account before registering via the link above.


We also take the opportunity to remind stakeholders of the remaining webinars to be held in May:
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
27 May
04:00 EDT/ 09:00 CET
Anti-doping regional workshop for NADOs and Law EnforcementMathieu Holz, Senior Investigator, Intelligence and Investigations, WADA


Sébastien Gaillard, Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from Central European countries
Registration via invitation only
31 May
07:00 EDT/
11:00 GMT
Webinar for Athletes participating in the 2020 Tokyo Olympic GamesDr. Aya Nakitanda, Olympian swimmer (Uganda) & Chair of the Africa Zone V Regional Anti-Doping Organization Education Committee
 
Rodney Swigelaar,
Director, Africa Office, WADA (Moderator)
Africa Series

For Athletes,
Athlete Support Personnel,
NOCs and Athlete Commissions from African countries
To register, please send your information
(name, country,
job title) to sameh.elray@wada-ama.org
as soon as possible

To register, please simply view the registration instructions in the ‘To register’ sections of the above table.

Please note that on an ongoing basis, WADA will communicate its evolving live webinar schedule and prompt stakeholders to register and participate.

Should you have any questions regarding the above, please contact Ms. Selva Balasingam, WADA Communications Coordinator, at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


18/05/21 – WADA STATEMENT ON THE U.S. OFFICE OF NATIONAL DRUG CONTROL POLICY REPORT TO CONGRESS

Montreal, 17 May 2021 – The World Anti-Doping Agency (WADA) acknowledges today’s report submitted by the United States Office of National Drug Control Policy (ONDCP) to the U.S. Congress regarding the ongoing governance reform taking place within WADA.

In the report, the ONDCP highlights some of the meaningful reforms that WADA has implemented since 2018 as well as some further enhancements it would like to see. Thanks to the reforms that have been carried out already, one-third of the 14-member Executive Committee (ExCo) and 38-member Foundation Board (Board) is now made up of active or former elite athletes while there are four independent members of the ExCo, including the President and Vice-President. Further reforms are being considered, including the introduction of a Code of Ethics and the formation of an independent Ethics Board to ensure compliance with the standards of conduct required for good governance.

WADA President Witold Bańka said: “WADA takes note that the ONDCP recognizes the hard work and considerable progress achieved by the Agency during the past year.

“Enhancing our governance model, increasing our independence and ensuring that athletes remain at the forefront of everything WADA does continues to be a key priority of my Presidency. On that front, I am proud of WADA’s accomplishments to date. There is more work to be done in this area and, in collaboration with all of our diverse stakeholders, including the U.S. Government, we will continue to make meaningful improvements, following a democratic and consultative process, on how the Agency is governed to ensure it evolves together with our role and with the global fight against doping in sport in general.

“The long-standing partnership between WADA and the U.S. Government is important for the protection of clean sport around the world. As a founding member of WADA, the U.S. Government has historically played a significant and constructive leadership role. We anticipate that the Biden-Harris Administration will work with us to maintain that position. To that end, I look forward to welcoming the Acting Director of the ONDCP, Regina LaBelle, to her first meeting of the Foundation Board later this week. Indeed, I have personally invited Acting Director LaBelle to play a leading role in WADA’s development of a Code of Ethics and formation of an independent Ethics Board.

“In addition, WADA continues to offer its support to the U.S. Government, the ONDCP and the United States Anti-Doping Agency in their efforts to strengthen the fight against doping in their country. Currently, approximately 90% of American athletes do not compete under the terms of the World Anti-Doping Code, with the main professional leagues and college sports so far operating outside that protection.

“WADA was formed 22 years ago on a foundation of international cooperation and collaboration between Public Authorities and the Sports Movement, with the U.S. Government very much to the fore. We are focused on moving forward and meeting today’s challenges together in a spirit of partnership.


13/05/21 – WADA LAUNCHES STAKEHOLDER CONSULTATION FOR THE 2022 PROHIBITED LIST

Montreal, 12 May 2021

Dear Colleagues,

Annually, the World Anti-Doping Agency (WADA) consults its stakeholders to review the content and structural changes being proposed to the following year’s List of Prohibited Substances and Methods (Prohibited List), which is an International Standard under Article 4.1 of the World Anti-Doping Code (Code).
 
As part of the consultation process, stakeholder feedback is collected throughout the year. Then, in January and April of every year, WADA’s List Expert Group meets to discuss the feedback, evidence and proposed content and/or structural changes; and, to formulate the draft Prohibited List for the following year.
 
On 26-27 April and 7 May, the List Expert Group met virtually to prepare the following documents, which we are confidentially giving you access to today for Stakeholder Consultation purposes via WADAConnect, the Agency’s online stakeholder consultation platform:

  1. Draft 2022 Prohibited List
  2. Draft 2022 Monitoring Program
  3. Summary of Major Modifications and Explanatory Notes, which are intended to facilitate your review

As is customary, WADA kindly asks that someone within your organization, with the relevant professional experience and expertise in anti-doping, be given the opportunity to carefully review the draft 2022 Prohibited List and provide comments concerning the proposed content (additions, deletions or other modifications) and/or structural changes. We would ask that, whenever possible, comments be supported by relevant reference(s) to medical or scientific evidence; pharmacological effect; and/or, personal experience concerning the substances or methods in question.

As it relates to the change in S9: Glucocorticoids, you may recall that when WADA’s Executive Committee (ExCo) considered the draft 2021 List at its September 2020 meeting, it approved prohibiting all injectable routes of administration of glucocorticoids in-competition; and, asked WADA Management to implement the prohibition on 1 January 2022 (vs. 2021). This was to allow enough time for: broad communication and education of athletes, their entourage and medical personnel; WADA-accredited laboratories to update their procedures; and, medical and support personnel to address the safe use of glucocorticoids for clinical purposes within anti-doping. Nevertheless, if you have suggestions on how to refine this change, we invite you to do so.

As usual, the WADAConnect platform will encourage respondents, separately, to propose further additions, deletions or other modifications under ‘Comments for future consideration’; which, will be evaluated and considered carefully over the course of the year but are unlikely to be incorporated within the 2022 Prohibited List. 
 
We believe that conducting this Stakeholder Consultation helps ensure that the Prohibited List evolves in step with the highest possible scientific standards; and, reflects the needs of the anti-doping community.
 
In keeping with the annual process, the 2022 Prohibited List will not be made public until after it is approved by WADA’s ExCo at its September meeting. Therefore, we ask you to ensure that the draft is kept confidential in order to preserve the integrity of the Stakeholder Consultation process. As we know, earlier publication would compromise the process and lead to confusion in the minds of athletes and other stakeholders worldwide.
 
To provide comments

  1. Simply connect to WADAConnect. If you do not currently have access, please consult the short guide on how to create a user account that is available on the platform.
  2. Once you have a user account, please inform Ms. Hai-Yen Huynh at WADA’s Science & Medical Department at hai-yen.huynh@wada-ama.org and ask to be added to the private List Consultation Group. This is necessary in order to provide comments.  
  3. Please input your comments by 16 July 2021

Should you have any questions or concerns, please contact hai-yen.huynh@wada-ama.org.

Thank you in advance for your organization’s feedback.

Best regards,

World Anti-Doping Agency


06/05/21 – WADA IMPOSES ANALYTICAL TESTING RESTRICTION ON THE BUCHAREST LABORATORY

Montreal, 5 May 2021 – Effective 1 May 2021 and for a period of up to six months, the World Anti-Doping Agency (WADA) has imposed an analytical testing restriction (ATR) on the Romanian Doping Control Laboratory in Bucharest (Bucharest Laboratory) as it relates to the Gas Chromatography / Combustion / Isotope Ratio Mass Spectrometry (GC/C/IRMS) analytical method.

In April 2021, the Bucharest Laboratory voluntarily informed WADA that it would be unable to update its GC/C/IRMS method by the time WADA’s updated Technical Document on IRMS (TD2021IRMS) came into effect on 1 May 2021. As such, in keeping with the International Standard for Laboratories (ISL), the ATR is not being imposed due to any underperformance or specific non-conformity resulting from the application of its GC/C/IRMS procedure. Rather, it is being imposed so the Laboratory can focus its efforts on improving its GC/C/IRMS method in compliance with the new TD2021IRMS requirements.

During the ATR, the Bucharest Laboratory can continue carrying out its regular anti-doping activities, as per the ISL. However, all routine samples that require GC/C/IRMS analysis shall be securely transported with a demonstrable chain of custody for GC/C/IRMS analysis to another WADA-accredited laboratory.

According to the ISL, WADA is responsible for accrediting and re-accrediting anti-doping laboratories, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in conjunction with International Organization for Standardization (ISO) assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC) and signatories to the ILAC Mutual Recognition Arrangement (ILAC MRA). 


04/05/21 – WADA SCIENTIFIC RESEARCH: DRIVING ANTI-DOPING FORWARD

In this latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency (WADA) team and its partners, we look at scientific research and the crucial role it continues to play in the protection of clean sport. Previous ‘Spotlight’ features are available on 
WADA’s website

The importance of science to the protection of sport’s integrity cannot be overstated, which is why it is at the very heart of WADA’s mission for doping-free sport. To keep it there, it is vital that scientific knowledge continues to evolve and mature, which makes research the key to driving advances in anti-doping.

Since 2001, WADA has helped researchers around the world develop breakthroughs in anti-doping science. The Agency’s scientific research grants are critical because they increase the volume of research dedicated to developing new and improved detection methods for performance-enhancing substances and methods as well as attract researchers with fresh ways of thinking.

Cutting-edge research helps the anti-doping community in a range of ways, providing the tools needed to protect sport. These objectives include:

  • Improving existing detection methods;
  • Developing new tests;
  • Detecting new substances (both directly and indirectly through markers);
  • Integrating new technologies into the system; and
  • Anticipating new trends in doping.

In a nutshell, this is what research is trying to find out and why it is so important to sport’s integrity.

WADA Senior Executive Director, Science and International Partnerships, Dr. Olivier Rabin, said: “Scientific research is a cornerstone of anti-doping. Understanding what certain substances do to enhance performance and then devising robust ways to detect those substances through testing and sample analysis is, in large part, how we catch those who cheat and deter others who might be tempted. It is absolutely vital for the system that we stay up to date on the very latest developments and to do that we work with some of the most brilliant and innovative scientists in the world.”

Major breakthroughs

In the 20 years of WADA-funded research, almost USD 83 million has been invested in more than 500 projects, all which have benefited WADA and other anti-doping authorities that are striving to keep sport clean. Some of the breakthroughs that science has enabled include:

  • Developing and constantly improving tests to detect erythropoietin (EPO), human growth hormone, gene doping and many other prohibited substances and methods (often before they are available on the market);
  • Devising the first consolidated List of Prohibited Substances and Methods, which came into force in 2004, and strengthening it every year since;
  • Harmonizing and improving analytical capabilities in anti-doping laboratories;
  • Developing exciting new innovations, such as dried blood spot analysis and artificial intelligence for future applications in anti-doping.

Dr. Rabin said: “As outlined within WADA’s 2020-2024 Strategic Plan, WADA wants to do more impactful research based on key priorities and outcomes in order to lead some future global changes in the anti-doping community and also be more athlete centered by bringing scientific and medical results closer to the daily preoccupation of athletes. One way we will do that is through the integration of new, innovative technologies to benefit collection procedures, the security of samples and the processing of data associated to sample analysis, as well as making information on prohibited substances and methods more readily accessible and visible to the athletes and their entourage.

“It is encouraging to see that, after a few years of WADA’s anti-doping research budget being diverted to other areas of high priority for the Agency, the funding is coming back. With continued financial support in this area, I am confident that we can make even more breakthroughs in collaboration with our partners to further protect clean sport for athletes.”

WADA’s annual budget is sourced equally from governments of the world and the International Olympic Committee (IOC). Some of the additional investment has come about thanks to an IOC initiative announced in November 2019. Specifically, the IOC President pledged to match any contributions from governments in support of the Agency’s research and/or investigations activities. With matching funding by the IOC, the initiative has raised more than USD 7 million for these core activities – more than USD 4.7 million of which will be allocated to research.

Dr. Rabin: added: “WADA is very grateful to the IOC and to the many governments that have responded to the IOC’s call so far. We appeal to other governments to take advantage of this wonderful opportunity as much as possible.”

Range of rewarding collaborations

This financial boost will give WADA-funded researchers greater scope to forge ahead with their ground-breaking collaborations. WADA Deputy Director, Science and Medicine, Dr. Marcia MacDonald, said: “Our research – like so much in science – is collaborative. We recognize the value of partnerships. We work with a range or organizations, such as the United Nations (through agencies such as the UN Office on Drugs and Crime, UNESCO and the World Health Organization), the European Union, the Council of Europe, the Partnership for Clean Competition, the International Testing Agency, Anti-Doping Organizations, the pharmaceutical industry, universities and other research bodies, and many provincial and national governments of the world.

“Even outside our formal calls for proposals, we are always open to scientists from around the world who want to make a difference in this space. If anyone has an idea that could have a beneficial application in anti-doping, then they are encouraged to let us know. We want to hear from them.”

As a scientist with a background in biochemistry and genetics, Dr. MacDonald believes that the area of anti-doping research is one of the most rewarding fields she could be in. She said: “One of the things that excites me about working with WADA is the relative ease of the implementation of research results into anti-doping practice. In addition to that and the very collaborative and inclusive community of anti-doping scientists, I like the way this work combines many diverse scientific topics with policy. There are so many aspects of the World Anti-Doping Code and other harmonizing documents that are connected to anti-doping science in some way, so there is always something challenging to work on.”

Pushing the boundary of anti-doping knowledge is one of WADA’s vital functions, work that is overseen by the Agency’s Health, Medical and Research Committee (HMRC) chaired by Prof. Lars Engebretsen from Norway. This Standing Committee monitors scientific developments in sport with the aim of safeguarding doping-free sport practice. With this aim, it oversees the following WADA Expert Advisory Groups: Prohibited List, Therapeutic Use Exemptions (TUEs), Laboratory and Gene and Cell Doping. The HRMC is also involved in the selection of WADA-funded scientific research grant projects and assesses the latest trends to ensure these projects remain relevant.

Annual call for exciting and innovative projects

On a yearly basis, WADA promotes and funds scientific research projects in such areas as the optimization of analytical tools for the detection of doping substances or methods, the enhancement of the Athlete Biological Passport (ABP), as well as the pharmacology of prohibited substances and of drug combinations. With this objective, WADA gives high priority to projects with direct and imminent applicability in the fight against doping in sport. More specifically, applicants are encouraged to propose translational research beyond the discovery stage, and the proposed projects should always aim to attain concrete deliverables by the end of the funding period.

For 2021, WADA received 66 proposals, which are currently being reviewed by external independent reviewers and an additional panel of experts. The final ranking and recommendation to WADA’s Executive Committee will be established by the HMRC.

Dr. Rabin added: “Receiving and assessing these grant applications is one of the highlights of the year. We get to hear about exciting projects from a range of talented and ambitious scientists, and work out how they might best fit in to our overall vision for clean sport. It is always inspiring and is an annual reminder of just how many people care deeply about protecting athletes and the integrity of sport. This is what WADA is all about.”


03/05/21 – WADA COLLABORATES WITH INTERNATIONAL ORGANIZATIONS TO RAISE THE VISIBILITY OF SOCIAL SCIENCE RESEARCH IN SPORT

Stakeholders interested in improving social science research regarding sport integrity are invited to respond to a short survey by 31 May

Montreal, 27 April 2021

Dear Colleagues,
 
The World Anti-Doping Agency (WADA) is pleased to announce the launch of a Social Science Research (SSR) Collaboration Platform established by WADA in partnership with the Council of Europe, the European Commission, the International Olympic Committee (IOC), the Partnership for Clean Competition (PCC) and the United Nations Educational, Scientific and Cultural Organization (UNESCO) to raise the visibility of social science research in Sport.
 
The Social Science Research Collaboration Platform is an informal “community of practice” for international organizations that fund or support social science research in sport integrity matters. Its focus is to share best practices and raise the visibility of social science research to increase its usability and, ultimately, its impact on the sporting system. The organizations involved engage to share experiences using their collective insights to improve the benefits of social science research, including reducing duplication of research and importantly, improving the way in which social science research is disseminated, understood and adopted by stakeholders in the field of sport.
 
In order to promote this unique partnership, the Social Science Research Collaboration Platform is pleased to publish jointly today:

  1. A Communiqué that highlights the social science research opportunities available for stakeholders; and
  2. A Survey designed to gather stakeholder feedback in the area of social science research as it relates to sport integrity. Stakeholders are kindly asked to provide feedback by 31 May on their experience with social science research to help participating organizations learn the needs of the sporting community; and, improve their support and promotion of social science research in sport in the future.

As outlined in the Communiqué, while each of the organizations involved in the Social Science Research Collaboration Platform has its own specific research priorities, the overarching research themes that capture all of the organizations’ common interests are:

  • Athlete welfare/wellbeing
  • Sport integrity
  • Values-based education
  • Sport governance
  • Effectiveness of education
  • Equality and inclusion in sport
  • Athlete environment/influences on behavior
  • Impact of technology on sport integrity

WADA and its partners are confident that the Social Science Research Collaboration Platform will have a positive impact on the sporting system and welcomes requests to join the Platform from other international and regional organizations that have a role in funding or supporting social science research in sport (including private organizations).

Should you have any questions regarding the new Social Science Research Collaboration Platform, or any of the information outlined above, please contact Ani Meliksetyan, Coordinator, Research and Policy (Education), at: ssr@wada-ama.org.

Best regards,

World Anti-Doping Agency


24/04/21 – WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR MAY

Montreal, 23 April 2021 

Today, the World Anti-Doping Agency (WADA) publishes the Agency’s ‘live’ webinar schedule for May, which encompasses all webinars being offered; in particular, as part of WADA’s:

Unless otherwise noted, the webinars are being hosted in English only.
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
5 May
10:00 EDT

5 de mayo
10:00 ET
 
Results Management under the 2021 International Standard for Results Management (in Spanish)

Gestión de resultados de acuerdo al Estándar Internacional de Gestión de Resultados 2021
 
María José Pesce, Director, Latin America Office, WADA (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA

María José Pesce, Directora, América Latina, AMA (Moderadora)

Tharinda Puth, Gerente, Asuntos legales, AMA
Latin America Series

For Anti-Doping Organizations (ADOs) and members of Disciplinary / Appeal Panels from Latin American countries

Serie CISP- América Latina 

Para organizaciones antidopaje y miembros de los paneles de primera instancia y de apelación de países latinoamericanos 
Registration via invitation only.
For more information please contact edna.serra@wada-ama.org

Invitación solamente.
Para más información contactar a edna.serra@wada-ama.org
12 May
10:00 EDT

12 de mayo
10:00 ET
 
Applicable Sanctions in Results Management (in Spanish)

Las sanciones apropiadas en la gestión de resultados
María José Pesce, Director, Latin America Office, WADA (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA

María José Pesce, Directora, América Latina, AMA (Moderadora)

Tharinda Puth, Gerente, Asuntos legales, AMA
Latin America Series

For ADOs and members of Disciplinary / Appeal Panels from Latin American countries

Serie CISP- América Latina 

Para organizaciones antidopaje y miembros de los paneles de primera instancia y de apelación de países latinoamericanos 
Registration via invitation only.
For more information please contact edna.serra@wada-ama.org

Invitación solamente.
Para más información contactar a edna.serra@wada-ama.org
27 May
04:00 EDT/ 09:00 CET
Anti-doping regional workshop for National Anti-Doping Organizations (NADOs) and Law EnforcementMathieu Holz, Senior Investigator, Intelligence and Investigations, WADA


Sébastien Gaillard, Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from Central European countries
Registration via invitation only
31 May
07:00 EDT/
11:00 GMT
Webinar for Athletes participating in the 2020 Tokyo Olympic Games
 
Please note that the French version of this webinar will be offered on 1 June.
TBDAfrica Series

Athletes,
Athlete Support Personnel,
National Olympic Committees (NOC) and Athlete Commissions from African countries
To register, please send your information
(name, country,
job title) to sameh.elray@wada-ama.org
as soon as possible


We also take the opportunity to remind stakeholders of the remaining webinars to be held in April:
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
29 Apr
04:00 EDT/ 09:00 CET
Anti-doping regional workshop for NADOs and Law EnforcementMathieu Holz, Senior Investigator, Intelligence and Investigations, WADA
 
Sébastien Gaillard,
Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from Eastern European countries
Registration via invitation only
30 Apr
11:00 EDT

30 de abril
11:00 ET
Introduction to WADA and anti-doping for athletes (in Spanish)

Introducción a la Agencia Mundial Antidopaje (AMA) y el antidopaje para deportistas
Adriana Escobar, Member, WADA Athlete Committee

Francisco Leon, Senior Manager, Program Development and NADO/RADO relations, WADA

María José Pesce, Director, Latin America Office. WADA

Adriana Escobar, miembro del Comité de Atletas de la AMA

María José Pesce, Directora, América Latina, AMA

Francisco Leon, Gerente Senior, Desarrollo de Programas y Relaciones NADO / RADO, AMA
Athlete Series

For Spanish-speaking athletes

Serie para deportistas

Para deportistas hispanos
Register here /
Inscribirse

To register, please simply view the registration instructions in the ‘To register’ sections of the above table.

Please note that on an ongoing basis, WADA will communicate its evolving live webinar schedule and prompt stakeholders to register and participate.

Should you have any questions regarding the above, please contact Ms. Selva Balasingam, WADA Communications Coordinator, at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


24/04/21 – WADA LAUNCHES SURVEY TO EXPLORE ATHLETE VULNERABILITY FACTORS ASSOCIATED WITH
POTENTIAL DOPING

Please complete the survey by 23 May 2021

Montreal, 22 April 2021

Dear Colleagues,
[International Federations]
 
As you may know, one of the key initiatives outlined in the World Anti-Doping Agency’s (WADA’s) Five-Year Strategic Plan is to ‘ Focus on impactful research based on key priorities and outcomes’. In keeping with this initiative, in October 2020, WADA commissioned a Social Science Research project – in partnership with Canada’s Université de Sherbrooke Research Chair on Anti-Doping in Sport – to examine the concept of ‘athlete vulnerability factors associated with potential doping’ in different sports.
 
Today, WADA is pleased to launch the next phase in this Social Science Research project by publishing the Vulnerability Sport Profile Survey – which aims to explore the key athlete vulnerability factors associated with potential doping in different sports.
 
The survey, which takes less than 15 minutes to complete, welcomes both International and National level sport perspectives and seeks to explore:

  • the vulnerability factors that exist or are prevalent in different sports
  • the most influential athlete support personnel at different stages of an athlete’s career for different sports
  • the risk of inadvertent doping in different sports
  • the stages of an athlete’s career or their experiences that may increase their vulnerability to dope

It is important to note that the survey is anonymous as no private information will be collected or shared and the analyses will focus on aggregated data at either a sport, national or regional level. 

The objective of the research project, which will incorporate the insight gathered via this survey, is to increase our understanding of the factors that may make athletes more vulnerable to inadvertent or intentional doping – and to identify what interventions can be implemented to enhance our collective efforts to protect athletes and clean sport. The outcomes of the research, which will incorporate the insight gathered via this survey, will be shared with you and the clean sport community.

The survey is an initial scoping survey of International Federation (IF) and National Federation (NF) personnel familiar with the culture and structure of their sport – as well as any other individuals who can provide an informed perspective on the vulnerability of athletes in their sport.

If the response from this initial survey is sufficient, each sport and/or country will be better informed about the groups and types of athletes who may be more vulnerable to doping and, therefore, allow the federations to be more proactive in protecting these athletes. The results will also help WADA to identify specific areas for additional and/or more robust research.

The deadline to complete the survey is 23 May 2021. Where possible, WADA kindly requests that the personnel responding from both IFs and NFs be technical, medical, sport or coaching staff with a good knowledge of the structure and culture of their sport. We understand that one individual may not be able to provide feedback on all questions. The Agency therefore kindly asks all IFs to forward the survey to as many relevant staff, volunteers and respective NFs as possible in order to gather as much input as possible about the sport at both the international and national levels.

Should you have any questions regarding the survey, please contact WADA’s Social Science Research team at: ssr@wada-ama.org.

We thank you in advance for your cooperation on this important project and for your contribution to the protection of clean sport.

Best regards,

World Anti-Doping Agency


20/04/21 UPDATE ON THE APPROACH TO MONITORING CODE COMPLIANCE BY SIGNATORIES

Montreal, 19 April 2021

Dear Colleagues,
[World Anti-Doping Code Signatories]

We are writing to provide you with an important update on the World Anti-Doping Agency’s (WADA) monitoring of World Anti-Doping Code (Code) Signatories’ compliance following the latest meeting of WADA’s independent Compliance Review Committee (CRC), which was held virtually on 14 and 15 April 2021.

With immediate effect, the full compliance procedures detailed in the International Standard for Code Compliance by Signatories (ISCCS) and described here on WADA’s website are back in force in their entirety. This means that where a Code Signatory is currently in a compliance procedure* and the subsequent three-month deadline provided by WADA’s internal Compliance Taskforce under the ISCCS has expired, the CRC will review the case and, where it deems it necessary, will make a recommendation of non-compliance of the Signatory to the WADA Executive Committee. However, in order to recognize the persistent negative impact of the COVID-19 pandemic on some Signatories’ anti-doping programs, the CRC decided to postpone any recommendation of non-compliance until its next meeting in August 2021. The exception to this will be cases where serious non-conformities may not have been resolved by a Signatory that is in a position to do so, and where the CRC may be invited by WADA Management to make a recommendation of non-compliance to the WADA Executive Committee following a “fast track” compliance procedure outlined in Article 9.5 of the ISCCS.

This CRC decision was based in particular on the presentation by WADA Management of data on testing activity since the previous meeting of the CRC in February 2021, which demonstrated an increase in the number of testing authorities worldwide collecting samples and a return to “near-to-normal levels” of global testing activity. This decision follows one full year of various levels of freezing of compliance procedures due to the pandemic.

Since COVID-19 started, WADA and the CRC have regularly reviewed and analyzed the situation affecting Signatories’ ability to deliver their anti-doping activities and, since freezing all procedures in April 2020, have gradually re-opened those procedures in a staggered approach. At its October 2020 meeting, the CRC decided to re-open the issuing of Corrective Action Reports (CARs) and Mandatory Information Requests (MIRs). Then, in February 2021, the CRC decided to re-open the possibility for the Agency to initiate compliance procedures. The final step of the procedure that remained frozen was recommendations by the CRC of cases of non-compliance to the WADA Executive Committee, which has now been reinstated.

During its meeting of 14 and 15 April 2021, the CRC also discussed in depth various elements related to the implementation of the consequences of the Court of Arbitration for Sport (CAS) award in the non-compliance case of the Russian Anti-Doping Agency (RUSADA). These include in particular the monitoring process applied by WADA to ensure that all Code Signatories comply with the CAS decision and that RUSADA’s operational independence is respected as per the CAS award. The CRC has received frequent updates from WADA Management since the issuance of the CAS decision and has expressed satisfaction for the work conducted by WADA so far. The CRC members will continue to follow all developments closely.

Lastly, WADA wishes to take this opportunity to remind all Signatories that have not yet adopted anti-doping rules in line with the 2021 World Anti-Doping Code and International Standards to do so as soon as possible. This is a critical compliance requirement that may lead to a recommendation of non-compliance, and WADA remains available to assist these Signatories.  

We thank you for your continued commitment to clean sport and remain available to support you in meeting your compliance obligations. Should you have any questions regarding this communication or Code compliance in general, we invite you to contact us at compliance@wada-ama.org.  

Sincerely,

World Anti-Doping Agency

*A compliance procedure is opened by WADA’s internal Compliance Taskforce when a Signatory does not resolve a non-conformity contained in a Corrective Action Report by a given deadline. As a result, the Signatory is generally given a further three months to resolve the outstanding non-conformity to the satisfaction of WADA prior to it being referred to the CRC


20/04/21 REMINDER: WADA TO VIRTUALLY HOST THERAPEUTIC USE EXEMPTION SYMPOSIUM ON 22-23 APRIL

Montreal, 15 April 2021

Dear Colleagues,
 
The World Anti-Doping Agency (WADA) wishes to remind stakeholders that it will virtually host a Therapeutic Use Exemption (TUE) Symposium, via two, two-hour sessions, on 22 and 23 April 2021.
 
The primary objective of the virtual TUE Symposium is to further harmonize the approach to TUEs, which ensure that athletes with legitimate medical conditions may participate in sport despite their need for a prohibited substance or method. As you can see from the Program, the virtual TUE Symposium will discuss elements of the 2021 International Standard for Therapeutic Use Exemptions that entered into effect on 1 January 2021; and, include interactive discussions on medical cases; medico-legal issues; retroactive TUEs; and the challenges regarding global harmonization of practices. There will also be dedicated question-and-answer sessions.
 
Stakeholders are encouraged to attend both days of the virtual TUE Symposium and are invited to register:

  • here for part 1 of the Program on 22 April from 00:00 to 02:10 (EDT).
  • here for part 2 of the Program on 23 April from 00:00 to 02:10 (EDT).

A recording of the Symposium presentations will be made available on WADA’s Anti-Doping Education and Learning Platform (ADEL) for a period of three months after the event. 

Should you have any questions regarding the virtual TUE Symposium, please contact WADA’s Medical Unit at medical@wada-ama.org.

We look forward to seeing you virtually during the webinar.

Best regards,

World Anti-Doping Agency


16/04/21 – WADA RELEASES UPDATED GUIDELINES FOR EFFECTIVE TESTING AND INTELLIGENCE SHARING

Montreal, 15 April 2021

Dear Colleagues, 
 
Today, the World Anti-Doping Agency (WADA) publishes the following two updated Guidelines to support Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Testing and Investigations (ISTI), which came into force on 1 January 2021. 

  1. Guidelines for Implementing an Effective Testing Program 
  2. Guidelines for Gathering Information and Sharing Intelligence 

These Guidelines are additional to the Guidelines for Sample Collection Personnel and Guidelines for Sample Collection that were published on 9 February 2021.

The four Guideline documents have been updated to align with the 2021 ISTI requirements; and also, to offer more practical examples for ADOs implementing effective testing and intelligence programs. While the four documents are currently available in English only, the French versions will follow in the coming weeks.
 
The Guidelines can be found on WADA’s website and on the Agency’s Anti-Doping Education and Learning platform (ADEL) as part of the Code Implementation Support Program (CISP). The Guidelines are accompanied by a number of operational templates and checklists for ADOs to use, which are also available on ADEL, including:

  • Checklist: Risk Assessment
  • Template: International Federation (and Major Event Organization) Risk Assessment & Test Distribution Plan (TDP)
  • Template: National Anti-Doping Organization (NADO) Risk Assessment & TDP
  • Template: Policy for Sample Retention and Further Analysis Strategy
  • Template: Registered Testing Pool (RTP) Inclusion Notice
  • Template: RTP Inclusion Notice – Whereabouts to Other ADO
  • Template: Testing Pool (TP) Inclusion Notice
  • Template: RTP or TP Removal Notice
  • Checklist: Planning an Effective Testing Program
  • Template: Policy for Gathering Anti-Doping Intelligence
  • Checklist: How to Comply with Article 11 of the ISTI (Intelligence)

In addition to the above templates and checklists, we encourage all stakeholders to visit ADEL for many other useful resources such as webinars, presentations, guides and more.

WADA Guidelines provide Code Signatories with recommended practices for several aspects of anti-doping programs. While they are not mandatory, they offer technical guidance to ADOs in the implementation of their anti-doping programs. As with all Guidelines under the World Anti-Doping Program, these documents are subject to ongoing review. 

Should you have any questions or feedback regarding the Guidelines or other resources related to the 2021 ISTI, please contact WADA’s Standards and Harmonization Department at: SandH@wada-ama.org

Thank you and best regards, 

World Anti-Doping Agency 


06/04/21 – REMINDER: WADA INVITES STAKEHOLDERS TO CELEBRATE PLAY TRUE DAY 2021

Play True Day 2021 will take place on 9 April

Montreal, 1 April 2021

Dear Colleagues,

Further to the World Anti-Doping Agency’s (WADA’s) media release of 26 March 2021, WADA wishes to remind stakeholders that Play True Day 2021 will be celebrated on 9 April 2021.

Since 2014, in April of every year, WADA and the anti-doping community worldwide have celebrated Play True Day — a day that is dedicated to Clean Sport and is intended to raise awareness among athletes, the sporting public and others about the importance of protecting Clean Sport.

This year’s theme is “What does Play True mean to you?”. Therefore, we invite athletes, National and Regional Anti-Doping Organizations, Sports Federations, Governments, Major Event Organizers and other anti-doping stakeholders from around the world to join the Agency’s social media campaign on 9 April 2021.

Like previous years, to engage as many stakeholders as possible, WADA has created a number of branded visuals (available in English, French and Spanish) for participants to incorporate and share their own Play True Day 2021 photos and videos. These include:

  • Branded frames that can be layered onto photo or video messages;
  • A Play True Pledge that can be either printed and personalized or personalized digitally for various social media platforms; and

Various GIFs that will be created for the day to be used on Instagram.

[Click here for examples and detailed instructions on how to use the above visuals

Participants are also encouraged to:

  • innovate by creating personalized What does Play True mean to you? visuals based on their specific country, language and/or sport;
  • use hashtags #PlayTrue and #PlayTrueDay both in the lead-up to and on the day to extend the reach and impact of the campaign on social media; and
  • follow the campaign in real time via our dedicated Play True Day social media wall on WADA’s website.

Should you have any queries or if you would like to inform WADA of your planned Play True Day social media efforts, please contact Patrick Handfield, Digital Communications Consultant/Webmaster at: patrick.handfield@wada-ama.org.

Finally, as an anti-doping community stakeholder, we would kindly ask you to ensure that this message is conveyed on to the relevant persons within your organization so they too can participate in the campaign.

Thank you and we look forward to you joining in the celebration of Play True Day 2021.

Best regards,

World Anti-Doping Agency


01/04/21 – WADA LAUNCHES ‘SPEAK UP!’ IN SPANISH AND ENCOURAGES CONFIDENTIAL SOURCES TO REPORT DOPING MISCONDUCT

Montreal, 31 March 2021 – In another boost for athletes and others with information on doping misconduct in sport, the World Anti-Doping Agency (WADA) announces that its secure, digital whistleblower platform ‘Speak Up!is now available in Spanish, in addition to English and French. ‘Rompe el Silencio!’ is intended for potential Spanish-speaking informants and whistleblowers (confidential sources) to report possible Anti-Doping Rule Violations (ADRVs) under the World Anti-Doping Code (Code), non-compliance violations under the Code, or any act or omission that could undermine the fight against doping in sport. ‘Rompe el silencio!’ – which includes a secure app for iPhone and Android devices – is now available on the App Store and Google Play.

WADA Director, Intelligence and Investigations, Gunter Younger said: “WADA is pleased to launch ‘Rompe el Silencio!’ to cater to Spanish-speaking athletes and other potential informants or whistleblowers who wish to report suspicious activity to WADA. Confidential sources are the lifeblood of investigations. Since the launch of WADA’s ‘Speak Up!’ Program and platform in March 2017, WADA’s Intelligence & Investigations Department has triggered hundreds of cases stemming directly from intelligence received from confidential sources. These cases range from allegations against individual athletes or support personnel, to complex cases involving systemic anti-doping mismanagement, non-compliance and/or corruption.

“The success of the ‘Speak Up!’ Program not only highlights the increasing importance of investigations in delivering justice, but also the vital role of informants and whistleblowers to the global anti-doping system. These individuals, whose identities will never be revealed publicly by WADA, are directly responsible for hundreds of intelligence disclosures that have been actioned by the Agency’s Confidential Information Unit and each have contributed to protecting the integrity of sport worldwide. Before they come forward, confidential sources need to feel comfortable, secure and reassured. One way of ensuring that happens is being able to interact with them in their own language, which is why WADA has now added Spanish, in addition to English and French.”

Anyone who detects, identifies, witnesses, knows or has reasonable grounds to suspect that doping-related misconduct has occurred, is encouraged to ‘Speak Up!’. It is, however, important to note the distinction between an informant and a whistleblower as these statuses do trigger different rights and responsibilities. Any person reporting misconduct to WADA will be considered an informant. The informant may decide not to pursue further cooperation with the Agency once they have provided information. An informant can become a whistleblower if both WADA and the informant agree to cooperate further. In this case, WADA and the informant will enter into a formal whistleblower agreement, which offers additional rights as outlined within WADA’s current Whistleblower Program Policy.

WADA’s Whistleblower Program Policy was first approved by WADA’s Foundation Board in November 2016. It formalizes the legal framework and outlines what the Agency will provide in terms of support, confidentiality, protection, and other elements, as well as, the way to go about raising concerns and how they would be investigated by WADA. It is re-evaluated on a continual basis to ensure that it meets international best practice and appropriately addresses the needs of confidential sources.

For more information about ‘Rompe el Silencio!’ and ‘Speak Up!’, please visit the Speak Up! website, which can be accessed via WADA’s website


30/03/21 – WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR APRIL

Montreal, 29 March 2021

Today, the World Anti-Doping Agency (WADA) publishes the Agency’s ‘live’ webinar schedule for April, which encompasses all webinars being offered; in particular, as part of WADA’s:

Unless otherwise noted, the webinars are being hosted in English only.
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
1 Apr
09:00 EDT/ 13:00 GMT
Results Management under the 2021 International Standard for Results Management

(in French)
 
Sameh Elray,
Manager, WADA Africa Office (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
African Series

For Anti-Doping Organizations (ADOs) and members of Disciplinary/ Appeal Panels from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible.
13 Apr
09:00 EDT/ 13:00 GMT
Applicable Sanctions in Results ManagementSameh Elray,
Manager, WADA Africa Office (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
African Series

For ADOs and members of Disciplinary/ Appeal Panels from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible.
15 Apr
09:00 EDT/ 13:00 GMT
Applicable Sanctions in Results Management

(in French)
Sameh Elray,
Manager, WADA Africa Office (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
African Series

For ADOs and members of Disciplinary/ Appeal Panels from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible.
22 Apr
00:00 EDT
WADA 2021 Therapeutic Use Exemption (TUE) Virtual Symposium: Part I

Note: Please see WADA communication of 24 March for Program information
Katia Alloun, TUE Manager, WADA (Moderator)

Yoko Dozono, Medical Manager, WADA (Moderator)
 
Prof. David Gerrard, WADA TUE Expert Advisory Group Chair

Dr. Peter Harcourt, Medical Director, Australian Football League
 
Dr. James Kissick, Sports Medicine Physician, Canadian Medical Protective Association

Dr. Katja Mjøsund, Specialist in Sports and Exercise Medicine, Paavo Nurmi Centre, Sports & Exercise Medicine, University of Turku, Finland 

Dr. Alan Vernec, Medical Director, WADA
N/A

For TUE physicians and ADO managers
Register here
23 Apr
00:00 EDT
WADA 2021 Therapeutic Use Exemption (TUE) Virtual Symposium: Part II

Note: Please see WADA communication of 24 March for Program information
Katia Alloun, TUE Manager, WADA (Moderator)

Yoko Dozono, Medical Manager, WADA (Moderator)

Dr. Simon Kemp, Sports Physician, Parkside Hospital, United Kingdom
 
Prof. David Gerrard, WADA TUE Expert Advisory Group Chair

Liz Riley, General Counsel, International Paralympic Committee

Dr. Ola Rønsen, Chief Medical Officer & Head of Global Health Aker Solutions, Aker Solutions, Norway
 
Dr. Susan White, Sports and Exercise Physician, Australian Sports Drug Medical Advisory Committee

Dr. Alan Vernec, Medical Director, WADA
N/A

For TUE physicians and ADO managers
Register here
29 Apr
04:00 EDT/ 09:00 CET
Anti-doping regional workshop for National Anti-Doping Organizations (NADOs) and Law EnforcementMathieu Holz, Senior Investigator, Intelligence and Investigations, WADA
 
Sébastien Gaillard,
Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from Eastern European countries
Registration via invitation only
30 Apr
11:00 EDT
Introduction to WADA and anti-doping for athletes

(in Spanish)
Adriana Escobar, Member, WADA Athlete Committee

Francisco Leon, Senior Manager, Program Development and NADO/RADO relations, WADA

María José Pesce, Director, Latin America Office. WADA
Athlete Series

For Spanish-speaking athletes
Register here
30 de abril
11:00 ET
Introducción a la Agencia Mundial Antidopaje (AMA) y el antidopaje para deportistasAdriana Escobar, miembro del Comité de Atletas de la AMA

María José Pesce, Directora, América Latina, AMA

Francisco Leon, Gerente Senior, Desarrollo de Programas y Relaciones NADO / RADO, AMA
Serie para deportistas

Para deportistas hispanos
Inscribirse


We also take the opportunity to remind stakeholders of the remaining webinars to be held in March:
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
30 Mar
09:00 EDT
Results Management under the 2021 International Standard for Results ManagementSameh Elray,
Manager, WADA Africa Office (Moderator)

Tharinda Puth, Manager, Legal Affairs, WADA
African Series

For ADOs and members of Disciplinary/ Appeal Panels from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible.
30 Mar
13:00 EDT
Anti-Doping Education: How athletes can contribute to clean sportKady Kanouté, Chair of WADA’s Education Committee and member of WADA’s Athlete Committee
 
Amanda Hudson, Director, Education, WADA
 
Kangeun Lee, Senior Manager, Digital Learning and Education, WADA
 
Ben Sandford, Chair of WADA’s Athlete Committee (Moderator)
Athlete Series

For Athletes
Register here
31 Mar
9:00 EDT
Athlete Curriculum and Workbook: Support tools for the development and implementation of education programsTony Cunningham, Senior Manager, Education, WADA (Moderator)

Ariadna Camargo, Coordinator, Education, WADA

Eva Erfle, Education Consultant, WADA
CISP Series

For ADOs
Register here

Please first create an ADEL account before registering via the link above.

To register, please simply view the registration instructions in the ‘To register’ sections of the above table.

Please note that on an ongoing basis, WADA will communicate its evolving live webinar schedule and prompt stakeholders to register and participate.

Should you have any questions regarding the above, please contact Ms. Selva Balasingam, WADA Communications Coordinator, at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency

29/03/21 – WADA PROVIDES BRANDED VISUAL MATERIAL FOR USE BY STAKEHOLDERS FOR PLAY TRUE DAY 2021

Montreal, 26 March 2021

Dear Colleagues,

Further to the World Anti-Doping Agency’s (WADA’s) media release of 9 March 2021, WADA wishes to remind stakeholders that Play True Day 2021 will be celebrated on 9 April 2021.
Since 2014, in April of every year, WADA and the anti-doping community worldwide have celebrated Play True Day — a day that is dedicated to Clean Sport and is intended to raise awareness among athletes, the sporting public and others about the importance of protecting Clean Sport.

This year’s theme is “What does Play True mean to you?”. Therefore, we invite athletes, National and Regional Anti-Doping Organizations, Sports Federations, Governments, Major Event Organizers and other anti-doping stakeholders from around the world to join the Agency’s social media campaign on 9 April 2021.

Like previous years, to engage as many stakeholders as possible, WADA has created a number of branded visuals (available in English, French and Spanish) for participants to incorporate and share their own Play True Day 2021 photos and videos. These include:

  • Branded frames that can be layered onto photo or video messages;
  • A Play True Pledge that can be either printed and personalized or personalized digitally for various social media platforms; and

Various GIFs that will be created for the day to be used on Instagram.

[Click here for examples and detailed instructions on how to use the above visuals]

Participants are also encouraged to:

  • innovate by creating personalized What does Play True mean to you? visuals based on their specific country, language and/or sport;
  • use hashtags #PlayTrue and #PlayTrueDay both in the lead-up to and on the day to extend the reach and impact of the campaign on social media; and
  • follow the campaign in real time via our dedicated Play True Day social media wall on WADA’s website.

Should you have any queries or if you would like to inform WADA of your planned Play True Day social media efforts, please contact Patrick Handfield, Digital Communications Consultant/Webmaster at: patrick.handfield@wada-ama.org.

Finally, as an anti-doping community stakeholder, we would kindly ask you to ensure that this message is conveyed on to the relevant persons within your organization so they too can participate in the campaign.

Thank you and we look forward to you joining in the celebration of Play True Day 2021.

Best regards,

World Anti-Doping Agency


25/03/21 – WADA TO VIRTUALLY HOST THERAPEUTIC USE EXEMPTION SYMPOSIUM IN APRIL

Montreal, 24 March 2021

Dear Colleagues,
 
As you may recall, on 9 December 2020, the World Anti-Doping Agency (WADA) announced that, due to the COVID-19 pandemic, the Agency was postponing its ‘in person’ Therapeutic Use Exemption (TUE) Symposium, which was to be held from 22-23 April 2021 in Incheon, South Korea. At the time, the Agency also asked stakeholders to save new dates for the Symposium in their calendars of 21-22 April 2022 in Incheon.
 
WADA still hopes to welcome stakeholders in person for its TUE Symposium in Incheon next year. In the meantime, however, we are pleased to announce that the Agency will virtually host a TUE Symposium, via two, two-hour sessions, on 22 and 23 April 2021.
 
The primary objective of the virtual TUE Symposium is to further harmonize the approach to TUEs, which ensure that athletes with legitimate medical conditions may participate in sport despite their need for a prohibited substance or method. As you can see from the Program, the virtual TUE Symposium will discuss elements of the 2021 International Standard for Therapeutic Use Exemptions that entered into effect on 1 January 2021; and, include interactive discussions on medical cases; medico-legal issues; retroactive TUEs; and the challenges regarding global harmonization of practices. There will also be dedicated question-and-answer sessions.
 
Stakeholders are encouraged to attend both days of the virtual TUE Symposium and are invited to register:

  • here for part 1 of the Program on 22 April from 00:00 to 02:10 (EDT).
  • here for part 2 of the Program on 23 April from 00:00 to 02:10 (EDT).

Should you have any questions regarding the virtual TUE Symposium, please contact WADA’s Medical Unit at medical@wada-ama.org.

We look forward to seeing you virtually in April and to meeting you in person in 2022.

Best regards,

World Anti-Doping Agency


16/03/21 –WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR MARCH

Montreal, 12 March 2021

The World Anti-Doping Agency (WADA) is pleased to publish the Agency’s ‘live’ webinar schedule for March, which encompasses all webinars being offered, in particular:

Unless otherwise noted, the webinars are being hosted in English only.
 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceTo register
25 Mar
09:00 EST

Anti-doping regional workshop for National Anti-Doping Organizations (NADOs) and Law Enforcement
Mathieu Holz, Senior Investigator, Intelligence and Investigations, WADA
 
Sébastien Gaillard,
Criminal Intelligence Officer, INTERPOL General Secretariat
N/A

For anti-doping experts from NADOs and Law Enforcement from European Nordic/Baltic countries
Registration via invitation only
30 Mar
09:00 EST
Results Management under the 2021 International Standard for Results Management (ISRM)Tharinda Puth, Manager, Legal Affairs, WADA
 
Sameh Elray,

Manager, WADA Africa Office (Moderator)
African Series

For NADOs and members of Disciplinary/ Appeal Panels from African countries
To register, please send your information (name, country, job title) to sameh.elray@wada-ama.org as soon as possible
30 Mar
13:00 EST
Anti-Doping Education: How athletes can contribute to clean sportKady Kanouté, Chair of WADA’s Education Committee and member of WADA’s Athlete Committee
 
Amanda Hudson, Director, Education, WADA
 
Kangeun Lee, Senior Manager, Digital Learning and Education, WADA
 
Ben Sandford, Chair of WADA’s Athlete Committee (Moderator)
Athlete Series

For Athletes
Register here
31 Mar
9:00 EST
Athlete Curriculum and Education Plan Workbook: 2021 International Standard for Education (ISE) support tools for Anti-Doping Organizations (ADOs)Tony Cunningham, Senior Manager, Education, WADA (Moderator)

Ariadna Camargo, Coordinator, Education, WADA

Eva Erfle, Education Consultant, WADA
CISP Series

For ADOs
Register here

Please first create an ADEL account before registering via the link above.

To register, please simply view the registration instructions in the ‘To register’ sections of the above table.

Please note that on an ongoing basis, WADA will communicate its evolving live webinar schedule and prompt stakeholders to register and participate.

Should you have any questions regarding the above, please contact Ms. Selva Balasingam, WADA Communications Coordinator, at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


11/03/21 – WADA LAUNCHES STAKEHOLDER CONSULTATION REGARDING TECHNICAL DOCUMENT ON MINIMUM REQUIRED PERFORMANCE LEVELS FOR DETECTION AND IDENTIFICATION OF NON-THRESHOLD SUBSTANCES BY CHROMATOGRAPHIC — MASS SPECTROMETRIC ANALYTICAL METHODS

Montreal, 10 March 2021

Dear Colleagues,

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process to revise the Technical Document (TD) on Minimum Required Performance Levels (MRPLs) for Detection and Identification of Non-Threshold Substances by Chromatographic — Mass Spectrometric Analytical Methods (TD2021MRPL). Stakeholders are invited to review the TD2021MRPL and provide comments by 31 March 2021, using WADA’s online consultation platform, WADAConnect.

This new version of the TDMRPL – which is set to replace the TD2019MRPL that is currently in force – includes the revision of MRPLs for several Non-Threshold Substances. In addition, the TD2021MRPL establishes Minimum Reporting Levels (MRLs) for certain classes and examples of Non-Threshold Substances. In particular, attention is brought to the MRLs for some substances (namely clenbuterol, ractopamine, zeranol, and zilpaterol) that may be used as growth promoters for livestock in some countries and therefore may be associated with adverse analytical findings resulting from the consumption of contaminated meat; as well as, for certain diuretics (namely acetazolamide, bumetanide, furosemide, hydrochlorothiazide, torasemide, and triamterene) that may be found as contaminants in some pharmaceutical products. Importantly, this new version of the TDMRPL introduces the requirement for adjustment of concentrations of Non-Threshold Substances with an MRL when the specific gravity of the sample is higher than (>) 1.018.

WADA’s TDs provide specific technical requirements to Anti-Doping Organizations and WADA-accredited laboratories. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code, TDs are occasionally developed to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

For any questions related to the above, we invite you to contact science@wada-ama.org.

We thank you in advance for your feedback.

Best regards,

World Anti-Doping Agency


11/03/21 – WADA INVITES STAKEHOLDERS TO “SAVE THE DATE” FOR PLAY TRUE DAY 2021

PLAY TRUE DAY 2021 WILL TAKE PLACE ON 9 APRIL

Montreal, 9 March 2021

Dear Colleagues,
 
The World Anti-Doping Agency (WADA) invites stakeholders to “save the date” on 9 April to celebrate Play True Day 2021.

Since 2014, in April of every year, the World Anti-Doping Agency (WADA) and the anti-doping community worldwide have celebrated ‘Play True Day’ — a day that is dedicated to Clean Sport and is intended to raise awareness among athletes, the sporting public and others about the importance of protecting Clean Sport.
 
The inspiration for Play True Day stems from a WADA-hosted Education Conference in 2013, which was attended by 17 South American countries. While the celebration started as a small South American initiative, last year, the Agency’s digital and social media campaign reached over 50 million people worldwide with numerous individuals and organizations taking part from around the globe.

This year’s theme is “What does Play True mean to you?”. Therefore, we invite athletes, National and Regional Anti-Doping Organizations, Sports Federations, Governments, Major Event Organizers and other anti-doping stakeholders from around the world to join the Agency’s social media campaign on 9 April 2021 and let us know.

Similar to previous years, WADA will be providing branded ‘Play True Day’ visuals that can be used by stakeholders as part of their social media campaigns. However, participants are also encouraged to:

  • innovate by creating personalized what does Play True mean to you? visuals based on their specific country, language and/or sport;
  • use hashtags #PlayTrue and #PlayTrueDay both in the lead-up to and on the day in order to extend the reach and impact of the campaign on social media; and
  • follow the campaign in real time via our dedicated Play True Day social media wall on WADA’s website.

Should you have any queries or if you would like to inform WADA of your planned Play True Day social media efforts, please contact Patrick Handfield, Digital Communications Consultant/Webmaster at: patrick.handfield@wada-ama.org.

Finally, as an anti-doping community stakeholder, we would kindly ask you to ensure that this message is conveyed on to the relevant persons within your organization that would like to participate in the campaign.

Thank you and best regards,

World Anti-Doping Agency


04/02/21 – WADA LAUNCHES STAKEHOLDER CONSULTATION REGARDING NEW TECHNICAL DOCUMENT ON DRIED BLOOD SPOTS FOR DOPING CONTROL

Montreal, 3 March 2021

Dear Colleagues,

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process for the new Technical Document (TD) on Dried Blood Spots (DBS) for Doping Control (TD2021DBS), which is set to come into force on 1 September 2021. All stakeholders are invited to review the TD2021DBS and make recommendations by 31 March 2021, using WADA’s online consultation platform, WADAConnect

The TD2021DBS aims to harmonize DBS testing by providing specific requirements and procedures for DBS sample collection, transport, analysis and storage. For more information on the TD2021DBS, please refer to the Frequently Asked Questions document in WADAConnect.

The application of DBS in the anti-doping context was developed as part of a collaborative effort between WADA and anti-doping stakeholders around the world, including the International Olympic Committee, the China Anti-Doping Agency, the International Testing Agency and the United States Anti-Doping Agency, with additional financial support from Anti-Doping Switzerland, Sport Integrity Australia and the Japan Anti-Doping Agency.

WADA’s TDs provide specific technical requirements to Anti-Doping Organizations and WADA-accredited laboratories. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code, TDs are occasionally developed to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

For any questions related to the above, we invite you to contact dbs@wada-ama.org.

We thank you in advance for your feedback.

Best regards,

World Anti-Doping Agency


23/02/21 – UPDATE ON WADA’S APPROACH TO MONITORING CODE COMPLIANCE BY SIGNATORIES

Montreal, 22 February 2021

Dear Colleagues,

[World Anti-Doping Code Signatories]

We are writing to provide you with an important update on the World Anti-Doping Agency’s (WADA’s) monitoring of World Anti-Doping Code (Code) Signatories’ compliance following the latest meeting of WADA’s independent Compliance Review Committee (CRC), which was held virtually on 17 and 18 February 2021.

The update to WADA’s approach to monitoring compliance followed the Committee’s review of the impact of the ongoing COVID-19 pandemic on Signatories’ anti-doping program activity worldwide. WADA Management presented data on testing activity since the previous meeting of the CRC in October 2020, as well as corrective actions taken by Signatories that received a Corrective Action Report (CAR), or that are already in a compliance procedure*.

The CRC members were encouraged to hear that many Anti-Doping Organizations (ADOs) had increased their activities despite the continuing pandemic. This is particularly satisfactory in the case of those ADOs that received a CAR following the CRC decision in October 2020 to reinstate deadlines for CARs. However, concerns were raised regarding a number of Signatories that did not progress the implementation of corrective actions to the extent expected, despite ongoing support from WADA. Some of these corrective actions were raised as early as 2019.

Therefore, in seeking a balance between the effective protection of clean sport and the impact of the pandemic on the operations of many ADOs worldwide, the CRC took the following decisions in its staggered approach to resuming full compliance procedures:

  1. With immediate effect, and based on its Policy on the Initial Application of the International Standard for Code Compliance by Signatories (ISCCS), WADA will resume compliance procedures for Signatories that have not completed corrective actions by the deadline set in their CAR. A standard compliance procedure provides a Signatory with an additional three months to complete outstanding corrective actions.
     
  2. WADA will maintain the current freezing of deadlines for those Signatories that are already in a compliance procedure, including those who have already been referred to the CRC but not to the WADA Executive Committee. In practical terms, this means that no Signatory will be recommended for non-compliance by the CRC and referred to the WADA Executive Committee before the CRC amends and announces any change to this decision. 
     
  3. WADA will maintain its current approach for cases that may arise where serious non-conformities are not resolved by a Signatory that is in a position to do so. In such cases, a decision can be made to apply the “fast track” compliance procedure outlined in Article 9.5 of the ISCCS.

The CRC will review the decisions taken above alongside the continuing impact of the COVID-19 pandemic at its next meeting on 14-15 April 2021, ahead of the next meeting of WADA’s Executive Committee on 20 May 2021.

We thank you very much for your continued commitment to doping-free sport and remain available to assist all Code Signatories to meet their compliance obligations. Should you have any questions regarding this communication, or Code compliance in general, we invite you to contact us at compliance@wada-ama.org.

Sincerely,
 
World Anti-Doping Agency


*A compliance procedure is opened by WADA’s internal Compliance Taskforce when a Signatory does not resolve a non-conformity contained in a CAR by a given deadline. As a result, the Signatory is generally given a further three months to resolve the outstanding non-conformity to the satisfaction of WADA prior to it being referred to the CRC.


20/02/21 – WADA INVESTIGATORS STRENGTHEN COOPERATION WITH EUROPOL

Montreal, 18 February 2021 – The World Anti-Doping Agency’s (WADA’s) growing reputation for successful collaboration with law enforcement agencies was further enhanced today with the signing of a memorandum of understanding (MOU) with the European Union Agency for Law Enforcement (Europol), which formally establishes and facilitates a mutual framework for cooperation between the two agencies in the area of sports doping.

With intelligence and investigations increasingly becoming key tools in the protection of clean sport around the world, this MOU will enhance the cooperative relationship between WADA’s independent Intelligence and Investigations Department and Europol with the aim of combatting the illegal production and distribution of doping substances within the European Union. Activities will include the exchange of intelligence and practical support, as well as coordination on evidence-gathering and investigations of mutual concern. The MOU is similar to that which has been in place between WADA and INTERPOL since 2009.

WADA President Witold Bańka, who signed the MOU on behalf of WADA, said: “Intelligence and investigations has been an area in which WADA has made great progress since gaining the authority to conduct investigations under the 2015 World Anti-Doping Code. As demonstrated by recent high-profile cases, such as those involving the International Biathlon Union, Operation Aderlass, the International Weightlifting Federation and the Europol-coordinated Operation VIRIBUS, the sharing of information between law enforcement agencies and anti-doping organizations can be crucial in exposing wrong-doing that would not have been detected through testing or other analytical methods.

“Law enforcement and other government agencies possess the power to attack the source and supply of illegal substances, which sport does not have, as well as the power to search and detain those suspected of crimes. Equally, WADA receives information and develops expertise that can be useful to the police in their criminal investigations. Through partnerships such as this one, we are ensuring that cooperation between these two groups continues to strengthen for the good of clean sport. WADA is very grateful to the European Union for its ongoing enthusiasm and willingness to join forces with WADA in this way.”

Signing on behalf of Europol, its Executive Director, Catherine De Bolle, said: “To scale up the global fight against the production and trafficking of doping substances and its use to corrupt fair sports competitions, Europol is strengthening its cooperation with the major player in the fight against doping in sports worldwide. The new agreement will focus on exchanging knowledge and expertise, capacity building, and further collaboration between Europol and the World Anti-Doping Agency.”

This MOU is the latest in a series of bilateral collaborative exercises between WADA and other agencies with the objective of maintaining a level playing field for athletes. Last year, WADA signed an MOU with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), which broadened the scope of information shared about marketed products as well as biomedical products still in the early stages of research and development, with the aim of quickly implementing detection methods for new performance-enhancing substances.

In recent years, WADA has signed other MOUs and partnership agreements with organizations working towards a range of complementary objectives, including in education, scientific research, medicine, the support of whistleblowers, the fight against international drug trafficking, capacity building and regional development, in particular.

Click here for a video statement from WADA President Witold Bańka.


16/02/21 – WADA LAUNCHES 2021 ATHLETE-LED WEBINAR SERIES FOR ATHLETES

Montreal, 15 February 2021

The World Anti-Doping Agency (WADA) is pleased to launch its 2021 series of athlete-led webinars for athletes, which is an initiative started last year by WADA’s Athlete Committee that enables interactive engagement by the Agency with athletes worldwide. 
 
WADA invites athletes and others to register for the first webinar of the series, titled 2021 COVID-19 and Clean Sport Update, which will be held on 25 February from 13-14:00 EST; and, will focus on the impact of COVID-19 on athletes and the anti-doping system.
 
During this webinar, WADA Athlete Committee Chair Ben Sandford and the following athlete and expert panelists will discuss the ongoing effect that the COVID-19 pandemic is having on anti-doping for athletes; including, an open Q&A regarding its impacts on testing, the role of vaccines and the way forward.

  • Dr. Olivier Rabin, Senior Executive Director, Sciences and International Partnerships, WADA
  • James Sclater, Director of Anti-Doping, International Paralympic Committee
  • Dr. Lenka Wech, Olympian in rowing and member of WADA’s Health, Medical and Research Committee

Over the last year, WADA and its Athlete Committee have provided information for athletes and others on the matter of COVID-19; in particular, regarding the protection of athlete health and how clean sport can persevere during these challenging times.

“As the situation continues to evolve with COVID-19, WADA is committed to update athletes on the effect that the pandemic is having on anti-doping and answer questions they may have on vaccines,” said WADA Athlete Committee Chair, Ben Sandford. “We want to provide athletes with up-to-date information; and, we want to be able to hear and address their concerns. Similar to last year, we hope that this series of webinars will be an effective platform to exchange with athletes and understand how we can best support them and engage them in further strengthening the global anti-doping system.”

Anti-Doping Organizations worldwide are encouraged to relay this announcement on to their athletes; and, to encourage them to register.

WADA will publish a complete 2021 webinar series in the coming weeks that will include other webinars for this athlete-led series; as well as webinars that will be part of the Agency’s Code Implementation Support Program (CISP); and, others as deemed relevant.

Should you have any questions or comments on the above-referenced webinar, please contact Stacy Spletzer-Jegen, WADA’s Senior Manager, Athlete Relations & Communications, at: stacy.spletzer@wada-ama.org


09/02/21 – WADA RELEASES UPDATED GUIDELINES TO COMPLEMENT THE 2021 INTERNATIONAL STANDARD FOR TESTING AND INVESTIGATIONS

Montreal, 9 February 2021

Dear colleagues,

Today, the World Anti-Doping Agency (WADA) publishes updated Guidelines to support Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Testing and Investigations (ISTI), which came into force on 1 January 2021.

The below guidelines are the first two in a set of four guidelines that will be published over the coming weeks:

  1. Guidelines for Sample Collection Personnel; and
  2. Guidelines for Sample Collection (previously titled, Urine Sample Collection Guidelines and Blood Sample Collection Guidelines).

The guidelines have been updated not only to be in line with the 2021 ISTI requirements but also to offer more practical examples for ADOs implementing a sample collection personnel program and/or sample collection procedures.

The guidelines can be found on WADA’s website and on its Anti-Doping Education and Learning platform (ADEL), as part of the Code Implementation Support Program (CISP). The guidelines are accompanied by a suite of operational templates which are also available on ADEL.

While the guidelines are initially being released in English, the official French versions will follow in the coming weeks along with the remaining two ISTI guidelines, namely:

  1. Guidelines for Implementing an Effective Testing Program; and
  2. Guidelines for Gathering Information and Sharing Intelligence.

WADA guidelines provide Code Signatories with recommended practices for several aspects of anti-doping programs. While they are not mandatory, they offer technical guidance to ADOs in the implementation of their anti-doping programs. As with all guidelines under the World Anti-Doping Program, these documents are subject to ongoing review.

Should you have any questions regarding the guidelines related to the 2021 ISTI, or wish to provide feedback, please contact WADA’s Standards and Harmonization Department at: SandH@wada-ama.org

Best regards,

World Anti-Doping Agency


05/02/21 – WADA LAUNCHES NEW E-LEARNING COURSE FOR ATHLETES AND COACHES HEADING TO TOKYO 2020 PARALYMPIC GAMES

Montreal, 5 February 2021 – With just under seven months to go until the start of the postponed Tokyo 2020 Paralympic Games, the World Anti-Doping Agency (WADA) is pleased to launch a new education course on its Anti-Doping Education and Learning platform (ADEL), specifically designed for athletes and coaches aiming to attend the Tokyo 2020 Paralympic Games.

The new course, entitled ADEL for Tokyo 2020 Paralympics, was developed by WADA in collaboration with the International Paralympic Committee (IPC). This collaboration was established as part of WADA’s ongoing work to support the implementation of the International Standard for Education (ISE), which promotes the principle that athletes and their Athlete Support Personnel (ASP) should be educated prior to arriving at a Major Games or event. The course has been designed to ensure that athletes and coaches can be informed in advance about the anti-doping program in place at the Tokyo 2020 Paralympic Games; and, how it will cater to the specific needs of Paralympic athletes.

Those taking the new course will gain an understanding of the Tokyo 2020 Paralympic Games’ anti-doping rules, procedures and requirements – including how to check medications and apply for a Therapeutic Use Exemption (TUE), how to provide Whereabouts information, and explanations of the athletes’ rights and responsibilities during the testing process. The course will also allow athletes, coaches, guides and pilots (for visually impaired athletes) to identify key information, such as important dates that they need to be aware of and which organization has jurisdiction over them during the Games.

WADA Director of Education, Amanda Hudson, said: “WADA is pleased to have worked in collaboration with our partners at the IPC to develop this new addition to our education solutions that is specifically catered to Paralympic athletes and their coaches. The International Standard for Education that entered into force in January promotes the principle that those hoping to compete and participate at major events, including the Paralympic Games, should be educated prior to the event. ‘ADEL for Tokyo 2020 Paralympics’ will enable various Anti-Doping Organizations and National Paralympic Committees to prepare their national teams, specifically the Paralympic athletes and their vital support personnel, on the anti-doping program that will be in place at the Games.”

James Sclater, Anti-Doping Director at the IPC, added: “It is important for the Para athlete community to better understand their rights and obligations. This new ‘ADEL for Tokyo 2020 Paralympics’ course will help ensure that athletes and coaches are armed with the right knowledge ahead of the Tokyo 2020 Paralympic Games.”

“Athletes and coaches should be viewing anti-doping as an integral part of their Tokyo 2020 training regime. It’s vitally important that athletes take the time to understand the rules – we don’t want anyone’s Games experience and years of training going to waste because of an unintentional anti-doping violation that could have been avoided. Likewise, for coaching and support personnel, if they use this course to get even the most basic understanding of the anti-doping rules, then they will be in a stronger position to support their athletes in Tokyo.”

Chelsey Gotell, Chairperson of the IPC Athletes’ Council and Member of WADA’s Athlete Committee, said: “Being an elite athlete involves so much more than being great on the field of play, there’s also an obligation to understand your role within the anti-doping system. Ultimately, it’s every athlete’s responsibility to be fully aware of the timelines, processes and their rights and obligations to abide by the rules.

“Since Rio 2016, there’s been a lot of work between the Paralympic movement and WADA to create more awareness and synergies between the two organizations. The ‘ADEL for Tokyo 2020 Paralympics’ course is a great example of the progress being made in aligning the unique requirements of Para athletes when it comes to anti-doping. I’m fascinated to see what our athletes make of it.” 

Completion of this course – which includes a certificate for those who achieve a score of 80% or higher – is highly recommended. WADA and the IPC strongly encourage all National Paralympic Committees to work in close collaboration with their National or Regional Anti-Doping Organizations to ensure that athletes, coaches and other ASP are properly educated in advance of the Games – a principle that the new ISE reinforces.

The course, which is currently available in English, French and Spanish, has also been adapted slightly to ensure that visually impaired athletes can make their way through the course with their screen readers.

In a similar collaborative effort, we once again highlight the ‘ADEL for Tokyo 2020 Olympics’ course, a collaboration between WADA, the International Olympic Committee and the International Testing Agency. Both courses demonstrate all organizations’ commitment to educate and support athletes, their coaches, and other ASP in the build-up to the 2020 Olympic and Paralympic Games.

Should you have questions regarding either course, please contact WADA’s Education Department at ADEL@wada-ama.org


05/02/21 – WADA PUBLISHES Q&A DOCUMENT TO EXPLAIN THE CAS DECISION REGARDING THE NON-COMPLIANCE OF THE RUSSIAN ANTI-DOPING AGENCY

Montreal, 4 February 2021 – Following the publication of the Court of Arbitration for Sport’s (CAS’s) 186-page full reasoned decision regarding its 17 December 2020 ruling in favor of WADA to declare the Russian Anti-Doping Agency (RUSADA) non-compliant with the World Anti-Doping Code for a period of two years, WADA has developed a question and answer document to assist with stakeholder understanding of the matter.

This is in response to a number of queries received from Anti-Doping Organizations, athletes, members of the media and other stakeholders seeking clarity on some of the award’s finer points and their implications. The Q&A document is in addition to the Agency’s publication of a legal note on 14 January 2021, which outlines the background that led to the CAS proceedings, provides a summary of the parties’ key arguments, and summarizes the decision.


03/02/21 – WADA PROGRAM DEVELOPMENT AND NADO/RADO RELATIONS – BUILDING THE PILLARS FOR A STRONG GLOBAL SYSTEM

In this latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency team and its partners, we look at how anti-doping capacity is being built around the world by fostering strong partnerships with National and Regional Anti-Doping Organizations. Previous ‘Spotlight’ features are available on WADA’s website.

Prior to 1999, the world of anti-doping in sport was in disarray. Rules were not being applied consistently and there were vast differences depending on what sport you played or where in the world you lived. This meant that an athlete could be found guilty of doping in one sport or country, yet still be free to participate elsewhere. That is why the World Anti-Doping Agency (WADA) was founded 21 years ago. It is a remarkable – even unique – partnership between the Sports Movement and Governments who saw the damage that was being done to sports and society, and resolved to fix it by introducing a fair, consistent and globally applied system. And thus, the World Anti-Doping Program was born.

Underpinned by the legal framework of the World Anti-Doping Code (Code) and International Standards, the aim of the Program is to harmonize previously random and uncoordinated efforts into one cohesive set of rules that are applied equally for the protection of all athletes across all borders, sports and disciplines. To this end, the Code and Standards define the rules, and the roles and responsibilities of stakeholders in relation to various anti-doping areas. These include testing, intelligence and investigations, prohibited substances and methods, Therapeutic Use Exemptions (TUEs), compliance, data privacy, and as of 1 January 2021, education, and results management.

That is the policy, that is the theory. In the real world, success in this area depends on providing quality oversight, advice and support to the various National and Regional Anti-Doping Organizations (NADOs and RADOs) all over the world. That is where WADA’s Program Development and NADO/RADO Relations Department (PDNRR) comes in. It is one of WADA’s core activities to establish and maintain effective and collaborative relations with NADOs and RADOs and to implement development and capacity-building programs for those that require support.

The overall strategy related to these core activities is the responsibility of PDNRR, developed and implemented in close cooperation with WADA’s four Regional Offices (ROs).

WADA Director of PDNRR, Tom May, said: “The anti-doping environment is becoming increasingly complex and fast moving. It requires a lot of knowledge and resources. The legitimacy of the anti-doping system and the athletes’ perception of it are often influenced by the quality of an anti-doping program. This is why our work in this area is so important.”

Growing Impact

In July 2020, WADA published its Five-Year Strategic Plan which, under the theme ‘Leading Anti-Doping in a New Era’, lays the foundation for WADA’s strategic activity for 2020-2024 focusing on six strategic priorities around leadership, growing impact, putting athletes at the center, collaboration and unity, visibility and high performance. With a particular focus on ‘growing impact’, last month, PDNRR finalized its new NADO and RADO Program Strategies which will direct activities in this area into the future.

Mr. May added: “For many years, WADA has provided daily assistance to NADOs and RADOs through all activity areas. This year, WADA has developed robust and proactive NADO and RADO Program Strategies that ensure our NADO/RADO relations and development activities are planned and delivered in an effective and coordinated way.”

The essence of the Program is around development and sustainability. Strengthening the global network of NADOs and RADOs is all about facilitating, assisting and supporting them based on their individual needs. To thrive, they must start off on a firm footing with sound structures founded on principles of good governance and with the engagement of athletes. From there, capacity building can be achieved, strong and compliant anti-doping rules can be enforced, and mutually beneficial collaborations can be set up between the organizations and the relevant governments, National Olympic Committees (NOCs), WADA-accredited laboratories and other stakeholders.

It is the vision of the NADO Program Strategy – and a requirement of the revised Code that came into force on 1 January 2021 – that NADOs are all able to implement Code compliant anti-doping programs with full operational independence. To that end, on 9 November 2020, WADA published its guide to strengthening NADOs’ independence, offering support to NADOs in this important area.

The RADO Program was launched in 2004 to strengthen the protection of clean sport by developing innovative anti-doping strategies for those countries that needed them most. RADOs support financially stretched and understaffed NADOs and NOCs that act as NADOs with funding, training and ongoing anti-doping assistance. The Program currently assists 15 RADOs and 131 countries across the world. At all times, WADA tries to maximize the use of resources assigned to the RADO Program taking into consideration the specific needs of RADO member countries.

Mr. May said: “The RADO Program has made significant progress in building capacity, quality and expertise around the world and it has proved to be very useful to many RADO member countries over the years. However, more work needs to be undertaken in order to continue developing effective anti-doping programs that are compliant with the Code. Therefore, it is important that its strategy is evaluated and updated regularly.

“One of the most important aspects of our work in NADO/RADO relations is the bilateral cooperation that goes on between NADOs. Also, many RADOs benefit from a geographical proximity to a more experienced NADO, which can mentor others within that region by providing expertise and certain resources to help strengthen the overall system on the principle that a victory for one is a victory for all. We are grateful to all of our partners in the NADO and RADO community for their commitment to help.”

There are many great examples all over the world of cooperation between these key stakeholders in clean sport. They include:

NADO to NADO

On 12 May 2020 WADA announced the successful completion of the three-year partnership agreement between the South African Institute for Drug-Free Sport (SAIDS) and the Ethiopian National Anti-Doping Organization (ETH-NADO). This partnership, which was facilitated and monitored by WADA, is a great example of how a more experienced NADO (in this case SAIDS) can provide support, guidance and expertise to a developing NADO in building anti-doping capacity. SAIDS continues to assist other developing NADOs in Africa, including Egypt and Nigeria, while ETH-NADO is now committed to using its enhanced expertise in supporting other NADOs in their development.

RADO to MEMBERS

The Central Asia RADO (RADOCA), based on Almaty, Kazakhstan, has been supporting its eight member countries in developing anti-doping capacity since its establishment in 2006. Over the past two years alone, the RADO, led by its Director Dr. Venera Abdulla and Chair Dr. Maira Bakasheva, have worked with the authorities in Kyrgyzstan, Turkmenistan and Uzbekistan to establish their own NADOs and build capacity and expertise to implement anti-doping programs compliant with the Code. While Uzbekistan is also benefiting from a partnership with the Korea Anti-Doping Agency, the cooperation and support it receives from the RADO is critical to its development.

NADO to RADO

Showing real leadership, United Kingdom Anti-Doping (UKAD) has been supporting the development of RADOs globally for several years. In conjunction with its own international strategy, and in addition to its NADO development activities, UKAD has conducted trainings for RADOs on a variety of topics, including education, test planning, TUEs and results management. These trainings have benefited eight different RADOs with more than 70 RADO member countries. More recently, UKAD developed and conducted a train-the-trainer course for sample collection personnel in Kenya (where both the Africa Zone V RADO and the Anti-Doping Agency of Kenya benefited) and is continuing to work with WADA for both RADO and NADO development.

UKAD CEO Nicole Sapstead said: “To protect UK athletes’ right to compete in clean sport, wherever they are in the world, UKAD’s international team work alongside key stakeholders to help improve anti-doping standards globally. Working with Anti-Doping Organizations in priority countries, we support them on many areas of anti-doping and we also coordinate our work with the UK Government to align our projects with broader development and sustainability goals. Despite the challenges faced due to COVID-19, it has been satisfying that we have been able to continue this work remotely throughout 2020.”

Crucially, all these important cooperation initiatives happen in conjunction with WADA’s ROs to ensure they are carried out according to national and regional needs as well as in line with the Code, International Standards and the World Anti-Doping Program.

After 21 years, WADA’s tried and trusted approach of collaboration and support, underpinned by a strong legal framework, continues to grow and yield results to the benefit of athletes everywhere.


03/02/21 – WADA DOES NOT APPEAL CAS DECISION REGARDING RUSSIAN ANTI-DOPING AGENCY TO SWISS FEDERAL TRIBUNAL

Montreal, 2 February 2021 – Following the passing of the deadline to appeal the December 2020 decision of the Court of Arbitration for Sport (CAS) in the case between the World Anti-Doping Agency (WADA) and the Russian Anti-Doping Agency (RUSADA), which ruled in favor of WADA and declared RUSADA non-compliant with the World Anti-Doping Code, WADA confirms that it did not appeal the CAS decision to the Swiss Federal Tribunal.

WADA was disappointed that the CAS Panel, based on its own assessment of proportionality, decided not to impose all the consequences that WADA sought (and not for the full four-year period). However, the grounds of appeal to the Swiss Federal Tribunal are limited to procedural matters such as jurisdiction, the composition of the Panel and the right to be heard. The Swiss Federal Tribunal does not conduct a review of the merits and would therefore not interfere with the Panel’s assessment of the proportionality of the consequences. As a result, and following unanimous advice from in-house and external legal counsels, WADA strongly believes an appeal would have served no useful purpose and decided to refrain from doing so. 


31/01/21 – WADA RELEASES NEW AND UPDATED GUIDELINES TO COMPLEMENT THE 2021 INTERNATIONAL STANDARD FOR LABORATORIES

Montreal, 29 January 2021

Dear colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the following new and updated Laboratory Guidelines to support laboratories and Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Laboratories (ISL), which came into force on 1 January 2021.

New

Updated

Under the ISL, Laboratory Guidelines are issued to provide guidance to WADA-accredited laboratories, WADA-approved laboratories for the Athlete Biological Passport; and, other stakeholders on specific technical or procedural issues. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code (Code), the Guidelines undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results.

While implementation of the Guidelines is not mandatory, all accredited and approved laboratories are encouraged to follow, to the fullest extent possible, the recommendations of best practice that they outline.

Should you have any questions regarding the Laboratory Guidelines, or wish to provide feedback, please contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


28/01/21 WADA WELCOMES REPORT ON INVESTIGATION INTO INTERNATIONAL BIATHLON UNION

Montreal, 28 January 2021 – The World Anti-Doping Agency (WADA) welcomes the report published earlier today from the External Review Commission of the International Biathlon Union (IBU) in relation to an investigation into alleged corruption within the IBU. This investigation was initiated by WADA’s independent Intelligence and Investigations Department in November 2016.

WADA President Witold Bańka said: “Information collected by WADA’s independent Intelligence and Investigations Department gave this investigation its initial impetus and our investigators have remained in close communication with law enforcement authorities in Austria and Norway, as well as the IBU External Review Commission. We are pleased that our work helped the Commission’s investigation and we remain ready to assist law enforcement and the IBU in any way we can for the remainder of this case.

“This is another success for WADA’s intelligence and investigation team and its policy of collaboration with law enforcement and other stakeholders that are committed to doping-free sport. It shows once again that WADA will act without fear to do what is right for clean sport. The allegations featured in this report are abhorrent to all who care about sport integrity. However, it is to the credit of the IBU that in the wake of this scandal, it has taken significant steps to enhance the integrity of its anti-doping program.”

Given that the law enforcement element of this operation is ongoing, WADA cannot comment on the details of the investigation at this time.


28/01/21 WADA WELCOMES ADDITIONAL FINANCIAL COMMITMENTS FROM GOVERNMENTS OF CYPRUS, FRANCE, GREECE AND POLAND

Montreal, 27 January 2021 – The World Anti-Doping Agency (WADA) welcomes additional financial commitments totaling close to USD 200,000 from the Governments of Cyprus, France, Greece and Poland, which will be dedicated to the Agency’s scientific research and intelligence and investigations (I&I) activities.

These commitments are additional to the Governments’ annual contributions to WADA’s regular budget, which are matched by the International Olympic Committee (IOC) on behalf of the Sports Movement, and are part of an initiative announced in November 2019 by IOC President Thomas Bach to further strengthen WADA’s scientific research and I&I activities. Under this initiative, additional contributions provided by Governments are matched by the IOC, which means that these latest commitments will yield almost USD 400,000 extra for the global anti-doping system, bringing the total pledged to date under this particular initiative to almost USD 5.58 million.

Specifically, the Government of France has pledged to contribute an additional USD 60,000, while WADA has already received USD 108,000 from the Polish Government, USD 24,300 from Greece and USD 3,201 from Cyprus.

WADA President Witold Bańka said: “Whenever WADA receives additional contributions from governments, it is hugely appreciated and the Agency is grateful to the Governments of Cyprus, France, Greece and Poland for this strong show of support for our mission to protect clean sport. These additional resources will be used to enhance our work in the area of scientific research, as well as supporting WADA’s independent Intelligence and Investigations Department, and represent an encouraging vote of confidence in our work.

“It is worth remembering, also, that every dollar contributed in this way by governments is doubled thanks to the generous initiative put in place by the IOC. Since it was announced in November 2019, several nations have seized this opportunity to grow anti-doping capacity in these two important areas, which are bringing about considerable success. I appeal to other governments to join forces and take advantage of this opportunity.”

In December 2020, WADA announced details of other additional contributions received from China (almost USD 1 million), with more pledged from the governments of Egypt (USD 100,000), India (USD 1 million) and Saudi Arabia (USD 500,000), all of which will be matched by the IOC.


22/01/21 WADA OFFERS NEW EDUCATION RESOURCES FOR ATHLETES AND ATHLETE SUPPORT PERSONNEL

Montreal, 21 January 2021

Dear Colleagues,

As part of the World Anti-Doping Agency’s (WADA’s) commitment to education and the development of balanced anti-doping programs worldwide, the Agency wishes to highlight three new education resources for athletes and athlete support personnel (ASP) that are available on its new and improved Anti-Doping Education and Learning Platform (ADEL), which was launched on 6 January 2021.

The Athlete Guide to the 2021 Code and the ASP Guide to the 2021 Code provide information on the significant changes within the new World Anti-Doping Code (Code) that entered into effect on 1 January 2021. The Guides also contain information regarding roles and responsibilities and the types of Anti-Doping Rule Violations under the Code. Both Guides are currently available in English, French, Spanish and Slovenian, with more languages to be released in the coming months.

The Athletes and ASP Guide to the 2021 Prohibited List, explains the main changes to the List of Prohibited Substances and Methods (List) that entered into effect on 1 January 2021. It also provides an early notification of the change in status of Glucocorticoids that will come into effect on 1 January 2022, as approved by WADA’s Executive Committee in September 2020. This Guide is currently available in English, with French and Spanish to be published shortly and other languages to be released in the coming months.

Each of the above resources is available on WADA’s ADEL Platform and can be viewed digitally or downloaded as a PDF.

About WADA’s new ADEL Platform

WADA’s new ADEL Platform provides education and learning opportunities for the anti-doping community worldwide – including athletes, coaches, parents, medical professionals and more. Anti-doping practitioners can also find learning opportunities to help them carry out their roles, and resources to support development of their anti-doping programs as part of the Code Implementation Support Program (CISP).

WADA invites all Anti-Doping Organizations to visit the new ADEL Platform and to encourage National Federations, athletes and ASP under their jurisdiction to do so as well. We also invite stakeholders to consult the ADEL Roadmap, which is updated on a monthly basis, to keep track of new courses and resources, along with information on their available languages, formats and timelines for release.

Lastly, we wish to highlight that some of our previously published resources, such as the ‘At a Glance Series’, are currently being updated in line with the 2021 Code and will be available on ADEL once finalized. We are prioritizing digital versions at this time which can be viewed on the ADEL Platform or via the ADEL by WADA Mobile App.

Should you have any questions regarding the ADEL Platform or any of the above-mentioned Guides – including how to make a request to translate our education resources – please visit the ADEL Helpdesk.

Best regards,

World Anti-Doping Agency


12/01/21 WADA PUBLISHES GUIDANCE NOTE FOR ANTI-DOPING ORGANIZATIONS REGARDING SUBSTANCES OF ABUSE UNDER 2021 WORLD ANTI-DOPING CODE

Montreal, 11 January 2021

Dear colleagues,
 
Today, the World Anti-Doping Agency (WADA) publishes a Guidance Note regarding Substances of Abuse under the revised 2021 World Anti-Doping Code (the Code), which entered into effect on 1 January 2021.
 
Pursuant to Article 4.2.3 of the Code, some substances on the 2021 List of Prohibited Substances and Prohibited Methods (2021 Prohibited List) have been identified as Substances of Abuse “because they are frequently abused in society outside the context of sport”.
 
Under Article 10.2.4.1 of the Code, regarding these substances, “if the Athlete can establish that any ingestion or Use occurred Out-of-Competition and was unrelated to sport performance, then the period of Ineligibility shall be three months Ineligibility. In addition, the period of Ineligibility calculated under this Article 10.2.4.1 may be reduced to one month if the Athlete or other Person satisfactorily completes a Substance of Abuse treatment program approved by the Anti-Doping Organization with Results Management responsibility.”
 
WADA’s Prohibited List Expert Advisory Group (ListEG) has identified the following substances as Substances of Abuse in the 2021 Prohibited List.

  • Cocaine (S.6a – Non-specified Stimulants);
  • Methylenedioxymethamphetamine (MDMA / “ecstasy”) (S.6b – Specified Stimulants);
  • Diamorphine (Heroin) (S.7 – Narcotics); and
  • Tetrahydrocannabinol (THC) (S.8 – Cannabinoids).

The Guidance Note offers direction to Anti-Doping Organizations regarding application of Code Article 4.2.3.

Should you have any questions, or wish to provide feedback, please contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


12/01/2021 TRIBUTES POUR IN FOR RETIRING WADA BOARD MEMBER AND FOUNDING PRESIDENT RICHARD POUND

Montreal, 8 January 2021 – On 31 December 2020, the World Anti-Doping Agency’s (WADA’s) Founding President and longstanding advocate for clean sport, Richard Pound, came to the end of his final term on WADA’s Foundation Board (Board), having served the Agency with distinction in various capacities since its inception in 1999.

The positive contribution made by Mr. Pound to the world of sport in general and anti-doping in particular cannot be overstated. A lawyer by profession, he was instrumental in the establishment of WADA nearly 22 years ago, serving for almost nine years as the Agency’s first President. In that time, and against the odds, he oversaw the drafting and implementation of the World Anti-Doping Code (Code) which, for the first time, managed to harmonize the rules across sports and nations of the world. In what was a stellar athletic and sports administration career, that remains perhaps one of his greatest achievements.

A swimmer, who represented his native Canada at the 1960 Olympic Games in Rome, Italy, and won four medals at the 1962 Commonwealth Games in Perth, Australia, Mr. Pound applied the same commitment and will to win when it came to protecting clean sport. With integrity, honesty and an unparalleled knowledge of the subject, Mr. Pound navigated this complex and often difficult world, putting WADA on a firm footing in the early years and helping to strengthen the global anti-doping system thereafter.

Even after concluding his term as President at the end of 2007, Mr. Pound, who is today the longest-standing active member of the International Olympic Committee (IOC), remained closely involved in WADA, continuing to serve on the Board and then, in 2015, leading a ground-breaking investigation that uncovered the details of an institutionalized doping scheme within Russian athletics, and led to the Russian Anti-Doping Agency being declared non-compliant with the Code.

On the occasion of his retirement from WADA’s Board, a number of leaders from the worlds of sport, government and science have paid tribute to Mr. Pound and reflected on the significant contribution he has made.

WADA President, Witold Bańka, said: “For 21 years, the name Dick Pound has been synonymous with WADA and the campaign to protect clean sport. A trailblazer who knew the importance of bringing sports and governments together, Dick has worked tirelessly to establish that collaboration and build the harmonized, robust and fair anti-doping system we have today. Everyone who loves sport and who cherishes the values of fair play, owes a lot to Dick and what he has achieved. His knowledge, experience and leadership have been crucial to WADA’s success over two decades and we wish him well.”

Prime Minister of Canada, Justin Trudeau, said: “On behalf of all Canadians, I would like to thank and congratulate Dick Pound for his many years of service with the World Anti-Doping Agency. As the first President, Dick was instrumental in the creation of the Agency. Thanks to his past athletic background, his years of working with various Olympic sports organizations and his credibility, he was able to bring his experience and knowledge to the Agency and in the global fight against doping in sport. He also helped make our country a leader in this fight, including by establishing the headquarters in Montreal. Dick, thank you again. I wish you the best for the future.”

IOC President, Thomas Bach, said: “Richard Pound has made a great contribution for the protection of clean athletes by fighting vigorously against doping. I could experience this first-hand in my early days as an IOC member when we were working together on the then Olympic Movement Anti-Doping Code, the forerunner of the World Anti-Doping Code. There, I could appreciate his strong commitment to the integrity of sports and competitions and to the Olympic Values. This clear orientation has been and still is the guiding thread in all the positions he held, in particular as Founding President of WADA. The entire Olympic Movement owes him our gratitude for his outstanding contribution to the credibility of sport.”

Three-time Olympian and Chair of WADA’s Athlete Committee, Ben Sandford, said: “On behalf of the WADA Athlete Committee and athletes around the world, I’d like to thank Richard for the incredible contribution he has made to clean sport. His vision and leadership have been instrumental in shaping the World Anti-Doping Program and WADA into what they are today. He has helped to make sport fairer and helped us all to continue to believe in the magic of sport. We will forever be grateful for everything he has done.”

WADA Director General, Olivier Niggli, said: “Dick Pound was the right person, in the right place at the right time. Having him as President at the beginning of WADA’s existence really established the Agency and gave it the credibility that it needed and deserved. He was a pioneer. Starting from scratch, he had to dig the trenches while also managing to move things forward. He led the successful project to harmonize the anti-doping rules across all sports and all countries – I don’t think people realize what a singular achievement that was. I’m not sure that such a successful collaboration exists in any other field and Dick’s role in that was crucial. He was the life and breath of WADA in those early years. As President, he extolled all the virtues of WADA, such as integrity, transparency and independence, and the world of sport owes him an enormous debt of gratitude.”

Chairman of the Institute of National Anti-Doping Organisations, Michael Ask, said: “Mr. Pound is definitely the founding father of modern anti-doping. If it wasn’t for his foresight and political savvy, we would not have had a WADA and we would never have had a uniform set of rules as we have today with the World Anti-Doping Code. These have undoubtedly been the most important steps forward in the fight for clean sport. One has never been in doubt about Mr. Pound’s moral compass. He has always acted as a free agent expressing his opinion clearly without fear or favor. Whether you agree or disagree with his views, Mr. Pound always says what he means and means what he says. For that reason, Mr. Pound will always have my deepest respect.” 

Olympic silver medal-winning rower and President of the Canadian Olympic Committee, Tricia Smith, said: “Richard’s leadership in the establishment of WADA was truly groundbreaking. It is difficult to think of anyone who could have led the organization in those early years as well as he did, bringing the sport system together. Never one to shy away from a challenge, no matter how daunting it seemed, Richard is fearless in the pursuit of that in which he believes. We are fortunate that one of the things he believes in is sport.”

Secretary of State for Amateur Sports in the Government of Canada from 1999-2001 and Mayor of Montreal from 2013-17, the Honorable Denis Coderre, said: “Dick Pound is a true gentleman and a great leader. With him, what you see is what you get. I had the opportunity to work with Richard when I was appointed to the Prime Minister’s cabinet in 1999 so we were together at the forefront when WADA was established. I was always impressed by his dedication to and passion for sport. He was a true leader, totally devoted to the athletes and a champion of the true values of Olympism. Ethics in sports were always a priority for him. To be part of WADA’s foundation is one thing, but to ensure its sustainability is another, and this was possible because of his skillful chairmanship. I always appreciated his ability to get things done at the Board level. His style was a mixture of composure, humor, decency and class, always focusing on results, fairness and a sense of justice. He was never afraid to take the heat for the sake of accountability or to go after the cheaters no matter who they were or where they came from. I want to take this opportunity to pay tribute to a great Canadian. Thank you, Richard, for your contribution, thank you for your friendship, your righteousness and moral stand. It was a privilege, honor, and pleasure to work with you and be at your side. Montreal, Canada and the global sports community salute you.”

Director of the WADA-accredited Laboratory at the INRS Armand-Frappier Santé Biotechnologie Research Centre, Montreal, Canada and former President of the World Association of AntiDoping Scientists, Christiane Ayotte, O.C., Ph. D., said: “Richard assumed the first and crucial presidency of WADA with intelligence and passion. Always goal-oriented, he skillfully obtained approval for important decisions at the meetings he led. He understood that the Agency needed to be known and supported publicly beyond political and sporting circles. Thus, with political correctness put to one side, he became a fearsome spokesman to the media, who were eager for his catchy quotes and, in the process, he made WADA indispensable and always relevant. During his presidency, Richard was able to bring together divergent interests and opinions of the various anti-doping stakeholders, delivering the strong public support the Agency received.”


12/01/21WADA LAUNCHES NEW AND IMPROVED
ANTI-DOPING EDUCATION AND LEARNING PLATFORM (ADEL)

Montreal, 6 January 2021 – Today, the World Anti-Doping Agency (WADA) launched its Anti-Doping Education and Learning platform (ADEL), which is a new and improved version of the current Anti-Doping e-Learning platform (ADeL) that was launched in January 2018.
 
Via the new ADEL platform, WADA will provide education and learning opportunities for the anti-doping community worldwide; including: athletes, coaches, parents, medical professionals and more. Additionally, on ADEL, anti-doping practitioners will be able to find learning opportunities to help them carry out their roles; and, resources to support development of their anti-doping programs.
 
WADA Director General, Olivier Niggli, said: “WADA recognizes the power of education to its mission for doping-free sport. The launch of the new and improved ADEL is an important milestone. It demonstrates the Agency’s commitment to education and our intention to support the development of balanced anti-doping programs that include education as a core function by Anti-Doping Organizations. ADEL directly supports the objectives of the new International Standard for Education (ISE), which took effect on 1 January 2021 and is a very significant advancement in anti-doping education policy. We are very proud of these accomplishments. They are the result of a collaborative effort that we have led with stakeholders over the past few years.”
 
The ADEL platform will have a modernized look and feel; and, will feature a wider range of educational courses and resources for more target audiences as identified in the World Anti-Doping Code (Code) and the ISE. ADEL will also provide new opportunities for the anti-doping community to access technical help on a range of topics.
 
WADA Education Director, Amanda Hudson, said: “Online education is one way to reach target audiences, particularly during the COVID-19 pandemic. The new ADEL will support the needs of the anti-doping community by providing education solutions for those responsible for the development of education programs, as well as learning opportunities and technical resources for Anti-Doping Organizations to benefit from. WADA aims for ADEL to become the ‘go to’ place for Anti-Doping Organizations to access resources to support the development of their anti-doping programs and the solutions they need to enable them to educate their communities.”
 
ADEL now includes new education programs for international- and national-level athletes; athletes who are part of a Registered Testing Pool; high performance coaches; and, parents of elite athletes, which complement the Tokyo 2020 Olympics course for athletes and coaches; ADEL for Medical Professionals (MPs); and ADEL for MPs at Major Games. The platform also includes previously published resources; such as, the Athlete and Athlete Support Personnel Guides to the Significant Changes in the 2021 Code; the Athlete and Athlete Support Personnel Guide to the 2021 List, as well as, all Code Implementation Support Program (CISP) resources, including the recently published Guidelines for Education, Therapeutic Use Exemptions and Results Management. WADA aims to publish all courses and resources in English and French, with Spanish to follow; and more courses and resources will be developed in 2021.
 
The new ADEL features

  • The platform and the education content will be fully responsive to allow users to learn via a desktop, laptop, tablet or mobile phone.
  • Learning can happen on the go with the option to complete the courses offline via the ‘ADEL by WADA’ mobile app.
  • Personalized learning plans per role and/or stage of development.
  • Gamification concept, including digital badges and points to collect as users learn.
  • Centralized ADEL Academy for all education offerings.
  • Community learning by exchanging questions and answers with people working in anti-doping.
  • Simple reporting dashboard and customized reports function for Anti-Doping Organization administrators.
  • A dedicated ADEL Helpdesk page with articles to help users solve common issues as well as a dedicated place for Anti-Doping Organizations to request translations of resources.

To access the new ADEL:

To join the new ADEL webinar to learn more about the new platform:

  • Date: 21 January at 09:00 (EST).
  • How to participate: Once you have registered on ADEL, you can register for the webinar via the platform.

For more information, please visit the:

ADEL helpdesk


12/01/21 NEW YEAR MESSAGE TO STAKEHOLDERS FROM WADA PRESIDENT AND DIRECTOR GENERAL

Montreal, 7 January 2021

Dear Colleagues,

On behalf of the World Anti-Doping Agency (WADA), we wish you and yours a happy, healthy and successful New Year. We hope that you enjoyed a restful holiday season and that you join us in greeting 2021 with renewed energy.

While closing the book on 2020, we wish first of all to recognize the efforts of the global anti-doping community that pulled together to ensure the integrity of the global anti-doping system in light of the COVID-19 pandemic. Clearly, when we embarked on 2020, we had no idea of the journey that lay ahead. The pandemic challenged the anti-doping community, like society in general, to quickly put measures in place to minimize its impact; and, we did so together.

For WADA’s part, this translated mainly into producing guidance materials for athletes and Anti-Doping Organizations to ensure that testing would continue in a structured and safe way, but also that Anti-Doping Organizations would continue to use all available tools to maintain the integrity of the system when testing may be temporarily diminished. These tools include in particular education for athletes and others; the Athlete Biological Passport, which assesses the evolution of athletes’ biological profiles; intelligence received through whistleblowers, which can lead to target-testing or to launching investigations; and, sample storage for future re-analysis as science advances and detection techniques are refined.

We will continue to work with the global anti-doping community this year to ensure that any anti-doping gaps can be identified and addressed. And we will continue to use the challenges raised by the COVID-19 pandemic to further stimulate innovation to make anti-doping stronger. This is why WADA is collaborating with stakeholders to explore new sample collection and analytical techniques such as dried blood spot analysis and artificial intelligence. This collaboration continues to give us confidence that, with vaccines now being deployed worldwide, anti-doping will emerge from this pandemic more resilient.

2021 World Anti-Doping Code and International Standards

Another significant effort made by the anti-doping community over the last year has been the revision by World Anti-Doping Code (Code) Signatories of their anti-doping rules and preparations for implementation of the 2021 Code, International Standards and Athletes’ Anti-Doping Rights Act. These key documents were approved in November 2019 during the World Conference on Doping in Sport following a two-year stakeholder consultation process and entered into force on 1 January 2021.

Over the past year, WADA has supported Signatories in aligning their rules with the revised Code and has provided robust educational and informational support via our Code Implementation Support Program so that they could hit the ground running in January.

We are grateful to all our stakeholders that have contributed to this strengthened World Anti-Doping Program. We are confident that, by reinforcing our efforts as a united anti-doping community, this new Program will help us drive further progress for athletes and sport worldwide.

RUSADA Non-Compliance

Once again, we closed out the year with a major outcome related to the compliance of the Russian Anti-Doping Agency (RUSADA) – this time, with the 17 December decision by the Court of Arbitration for Sport (CAS) to declare RUSADA non-compliant with the Code for a period of two years and impose a number of significant consequences. While this decision confirms in large part the recommendation made in November 2019 by WADA’s independent Compliance Review Committee, which was unanimously accepted by the Agency’s Executive Committee (ExCo) on 9 December 2019, WADA remains disappointed that the recommendation was not upheld in its entirety. We now expect the full reasoned decision to be published by CAS shortly as per the requirements of the International Standard for Code Compliance by Signatories (ISCCS).

In looking at this case, it is important to keep in mind that the CAS decision related specifically to the manipulation of Moscow laboratory data by the Russian authorities while the data were being forensically copied by WADA’s Intelligence & Investigations Department in January 2019 as part of Operation LIMS. This manipulation was in clear contravention of critical criteria set by the ExCo when RUSADA was reinstated as compliant, under strict conditions, in September 2018. The CAS decision did not relate to the broader Russian Doping Crisis dating back to 2014. This is a key point given that the ISCCS – along with a number of amendments to the Code focusing on Signatories’ compliance – came into force on 1 April 2018 and cannot be applied retroactively. Prior to 1 April 2018, WADA did not have the proper legal basis to pursue this matter.

While the Russian Doping Crisis has been very destabilizing for athletes, their entourage, WADA and the anti-doping system, we firmly believe that WADA has adapted and shaped its strategy in such a way that the Agency and the global anti-doping system have grown stronger, and continue to transform from this major disruption. This is evidenced by developments such as the Agency having strengthened its intelligence and investigations (I&I) capability, including with the launch of a very successful Speak Up! whistleblower program; and, having expanded its compliance monitoring program, including through introduction of the ISCCS, which was upheld by the recent CAS decision.

WADA Governance Reforms

In parallel with these developments, we continue to progress with our wide-ranging governance reforms, which were approved by WADA’s Foundation Board (Board) in November 2018 and are being introduced according to the agreed schedule. Of the 70 reform recommendations made by a WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In particular, WADA now has an independent President and Vice-President; there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except for the independent Compliance Review Committee as it relates to NADOs); and, there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees. There is now also a Nominations Committee to ensure that the right people in terms of skills and independence serve in senior governance roles within WADA.

These reforms will continue in 2021. A few weeks ago, in December 2020, the Board appointed two additional independent members to the ExCo. With the addition of these two members, the ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. In addition, in November 2020, the ExCo created a new Working Group on the Review of WADA Governance Reforms. An essential part of the work of this Group will be to monitor the effect of the ongoing governance reforms and propose additional reforms going forward. This will involve in particular a wide-ranging consultation with stakeholders in the coming months.

But we will not stop here. While more than one third of our current ExCo and Board members are active and former international-level athletes, work is underway to further enhance athlete representation within WADA. Discussions are also ongoing regarding the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure.

We are determined to ensure that WADA’s governance model continues to evolve with best practice over time.

Working Together for Clean Sport

Moving forward, much of our work will be guided by our 2020-2024 Strategic Plan. This Plan, which reflects the feedback of key stakeholders within the anti-doping ecosystem, acknowledges that WADA is completely different to what it was a few years ago. It also reflects a consensus that WADA must go further to build bridges and unite efforts to protect athletes and the integrity of sports globally.

Guided by the Strategic Plan, which has been defined with athletes at the center, WADA is and will be looking for every opportunity to meaningfully engage with athletes to enhance the global anti-doping system. We support our Athlete Committee –which is chaired by three-time Olympian in skeleton, Ben Sandford of New Zealand — in carrying out its mandate to provide athlete perspectives to WADA on all relevant anti-doping matters. The Athlete Committee will continue its work in 2021 to come up with reform proposals so that they can become a truly representative body. We both and senior WADA staff will continue to meet with individual athletes and groups that represent different sports, regions of the world and perspectives. The numerous meetings held in 2020 with athletes and athlete groups; as well as, with athletes that sit on the WADA Board, ExCo, Athlete Committee and expert committees; were very constructive, and the general feedback from these discussions was very supportive of WADA’s work and new Strategic Plan.  

In the meantime, our 140+ talented and committed team members worldwide will continue to engage and collaborate with stakeholders and to work tirelessly to protect the integrity of sport. We will continue to further develop key anti-doping areas – from education, science, and innovations in our Anti-Doping Administration & Management System (ADAMS), to I&I and compliance monitoring. We will be sure to mobilize the very best contributions from the anti-doping community and to inspire ourselves from successes in other fields and areas of business.

We are committed to engaging all stakeholders in further developing anti-doping; to enhancing anti-doping capacity and community worldwide; and to securing the additional funding that is required to further enable doping-free sport. We believe that with the support of the anti-doping community, we will achieve more progress together in 2021 and beyond.

Once again, we thank you for your commitment to clean sport and wish you all a healthy and happy New Year.


Sincerely,


05/01/21 WADA REMINDS STAKEHOLDERS THAT
THE 2021 WORLD ANTI-DOPING CODE, INTERNATIONAL STANDARDS AND ATHLETES’ ANTI-DOPING RIGHTS ACT ARE NOW IN FORCE

Montreal, 1 January 2021 – The World Anti-Doping Agency reminds stakeholders that, effective today, the 2021 World Anti-Doping Code (Code); the following International Standards (Standards); and, the Athletes’ Anti-Doping Rights Act (Act) have entered into force. The documents, which were subject to a two-year stakeholder consultation process, were approved on 7 November 2019 during the Agency’s World Conference on Doping in Sport that was held in Katowice, Poland. 

  1. International Standard for Code Compliance by Signatories (ISCCS)
  2. International Standard for Education (ISE) (New)
  3. International Standard for Laboratories (ISL)
  4. International Standard for the Protection of Privacy and Personal Information (ISPPPI)
  5. International Standard for Results Management (ISRM) (New)
  6. International Standard for Testing and Investigations (ISTI)
  7. International Standard for Therapeutic Use Exemptions (ISTUE)

As it relates to the International Standard for the List of Prohibited Substances and Methods (Prohibited List), it is reviewed annually via a separate stakeholder consultation process; and, was published separately earlier today.
 
The 2021 Code, which follows on from previous versions that entered into effect in 2004, 2009 and 2015, includes a number of important changes to global anti-doping policies, rules and regulations within Anti-Doping Organizations (ADOs) around the world. It works in conjunction with the eight Standards that foster consistency among ADOs in technical areas. The Athletes’ Anti-Doping Rights Act, which was developed by WADA’s Athlete Committee in consultation with thousands of athletes and stakeholders worldwide, is based on the 2021 Code and Standards and aims to ensure that athlete rights within anti-doping are clearly set out, accessible, and universally applicable.
 
WADA Director General, Olivier Niggli said: “WADA is grateful to its stakeholders worldwide, which contributed significantly to this strengthened World Anti-Doping Program that takes effect today. Beyond harmonizing and coordinating anti-doping programs worldwide, its purpose is to protect athletes’ fundamental right to participate in doping-free sport and to promote health, fairness and equality for athletes worldwide. I am convinced that, by reinforcing our efforts as a united anti-doping community, this new Program will help us drive further progress for athletes and sport worldwide.”
 
Code Implementation Support Program
 
WADA also wishes to draw your attention to the Agency’s Code Implementation Support Program (CISP), which was launched on 4 May 2020 and provides resources to prepare Code Signatories and other stakeholders for implementation of the new Code and Standards. 
 
Obtaining printed copies of the Code
 
In keeping with WADA’s sustainability efforts, in recent years the Agency has minimized print in favor of making its publications available digitally. However, given the importance of the Code, which will live for a number of years and be used on a daily basis by the Agency’s stakeholders:

  • At the end of November, WADA mailed a limited quantity of printed English or French copies to Code Signatories;
  • The Agency has made English and French print-ready versions available on our website (as linked above) for stakeholders to print locally; and
  • We are putting a mechanism in place for stakeholders and others that may wish to purchase printed copies in English and/or French; regarding which, we will provide more information on our website in the coming days.

Should you have questions or feedback regarding the Code, the Standards and/or the Act, please contact code@wada-ama.org; or, questions or feedback related to CISP, please contact 2021CISP@wada-ama.org.


05/01/21 WADA 2021 LIST OF PROHIBITED SUBSTANCES AND METHODS NOW IN FORCE

Agency calls on athletes and all stakeholders to note List modifications concerning substances and methods

Montreal, 1 January 2021 – The World Anti-Doping Agency (WADA) reminds athletes and all other stakeholders that its 2021 List of Prohibited Substances and Methods (List) enters into force today (1 January). The 2021 List, which has been redesigned in order to improve navigation and usability for athletes and their support personnel, was approved by WADA’s Executive Committee (ExCo) during its meeting on 14-15 September 2020 and was first published on 30 September 2020.

The List, which is one of the eight International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code), designates what substances and methods are prohibited both in- and out-of-competition, and which substances are banned in particular sports.

WADA Director General Olivier Niggli said: “WADA kindly ask athletes, their entourage and all other stakeholders to review the List carefully and to take particular note of this year’s modifications to avoid inadvertent use of substances and methods that are prohibited in sport for 2021.”

The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive consultation process that includes WADA’s List Expert Group gathering information, circulating a draft List among stakeholders, taking their submissions into consideration and revising the draft, followed by review by the Agency’s Health, Medical and Research (HMR) Committee.

The HMR Committee then makes its recommendation to the WADA Executive Committee, which approves the List during its September meeting.

For a substance or method to be added to the List, it must be determined that it meets two of the following three criteria:

  1. It has the potential to enhance or enhances sport performance
  2. It represents an actual or potential health risk to the athletes
  3. It violates the spirit of sport

It should be noted that for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they may be accommodated if they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE Program is a rigorous and necessary part of elite sport which has overwhelming acceptance from athletes, physicians and anti-doping stakeholders.

To view the changes made in the  2021 Prohibited List as compared to the 2020 version, please see the 2021 Summary of Modifications and Explanatory Notes.

Languages and Formats

The 2021 Prohibited List; the 2021 Summary of Modifications and Explanatory Notes; and the  2021 Monitoring Program are available for download on WADA’s website in multiple languages.

Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest to info@wada-ama.org. WADA will then provide the necessary files and, once the translation is finalized, will make the List available on the Agency’s website.

The List’s mobile-friendly digital edition can be accessed here.


05/01/21 WADA STATEMENT FOLLOWING SWISS FEDERAL TRIBUNAL DECISION TO UPHOLD SUN YANG’S APPLICATION FOR REVISION OF CAS AWARD

Montreal, 23 December 2020 – The World Anti-Doping Agency (WADA) has been informed of the decision of the Swiss Federal Tribunal to uphold the revision application filed by Chinese swimmer Sun Yang and to set aside the 20 February 2020 award of a Court of Arbitration for Sport (CAS) Panel. The case is in relation to WADA’s successful appeal against the original Fédération Internationale de Natation (FINA) disciplinary panel decision following an incident that led to a doping control involving Sun Yang not being completed as planned.

The Swiss Federal Tribunal’s decision upholds a challenge against the Chair of the CAS Panel and makes no comment on the substance of this case.

In the CAS award, WADA clearly prevailed on the substance of the case as it was able to show that there were a number of aspects of the original FINA decision that were incorrect under the World Anti-Doping Code and the related International Standard for Testing and Investigations. WADA will take steps to present its case robustly again when the matter returns to the CAS Panel, which will be chaired by a different president.

At this stage, WADA has not received the Tribunal’s full reasoned decision and therefore cannot comment further.


05/01/21 WADA RELEASES LABORATORY TECHNICAL LETTERS FOR 2021

Montreal, 22 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the following Technical Letters (TLs) for 2021 and the Summary of Modifications which were approved by WADA’s Executive Committee, via circulatory vote, on 21 December 2020.

This particular review of WADA’s TLs was triggered by the need to bring the below TLs in line with the 2021 World Anti-Doping Code (Code) and the 2021 International Standard for Laboratories (ISL) which both come into force on 1 January 2021.

Under the ISL, WADA’s TLs provide specific instructions to the WADA-accredited Laboratories, WADA-approved Laboratories and other stakeholders regarding the analysis, interpretation and reporting of results for particular Prohibited Substance(s) and/or Prohibited Method(s), or the application of specific laboratory procedures. As part of WADA’s mandate to enhance anti-doping activities under the Code, TLs undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

2021 TECHNICAL LETTERS

1. TL01 – Meclofenoxate
In this new version of the TL, an explanatory comment regarding the pharmacokinetics of CPAHs herbicides was included in the introduction, and reporting levels of meclofenoxate and 4-CPA are now provided in the section related to Analysis and Reporting Requirements. Additional guidance for the “B” Confirmation Procedure was included. Terms and definitions have been updated where relevant.

2. TL02 – Mebeverine Metabolism
In this new version of the TL, two mebeverine-specific Metabolites have been specified (mebeverine acid and desmethyl mebeverine acid), replacing the p-methoxy-ethylamphetamine, p-OH-ethylamphetamine and p-methoxy-amphetamine metabolites, which have been removed from the Reporting Requirements. Terms and definitions have been updated where relevant.

3. TL03 – Zilpaterol
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

4. TL04 – Zeranol
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

5. TL05 – Oxilofrine
In this new version of the TL, additional analysis and requirements were included to address whether the oxilofrine finding is consistent with the metabolization of ephedrine. Therefore, a specific minimum reporting level has been established for oxilofrine when detected in the presence of ephedrine. Terms and definitions have been updated where relevant.

6. TL06 – Possible Metabolism of Proguanil into Chlorazanil 
In this new version of the TL, articles have been reorganized to facilitate interpretation. The “Scientific Background” information has been removed, and the relevant information moved into the Introduction article. A scientific publication regarding the formation of the diuretic chlorazanil from the antimalarial drug proguanil has been included as a reference. Other terms and definitions have been updated where relevant.

7. TL07 – Andarine – Flutamide
In this new version of the TL, the Analysis and Reporting requirements have been updated to clarify the specific case for which an Adverse Analytical Finding (AAF) for andarine shall be reported. In addition, a comment specifying that the Laboratories shall not report an AAF for andarine based only on the presence of O-dephenylandarine has been included. Terms and definitions have been updated where relevant.

8. TL08 – Use of Internal Standards
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

9. TL09 – Oxethazaine
In this new version of the TL, articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

10. TL10 – In situ Formation of Exogenous Compounds
In this new version of the TL, the requirements regarding prednisolone and prednisone analysis have been removed. Terms and definitions have been updated where relevant.

11. TL11 – Oxymorphone
In this new version of the TL, the Reporting Requirements now include the mandatory analysis of methylnatrexone by LC-MS before reporting an AAF for oxymorphone. Terms and definitions have been updated where relevant.

12. TL12 – Enobosarm
In this new version of the TL, the TL name has been updated from “TL12 – Ostarine” to “TL12 – Enobosarm” to be aligned with the Selective Androgen Receptor Modulators’ (SARMs) nomenclature used in the Prohibited List. The Analysis and Reporting requirements have been updated to clarify the specific case for which an enobosarm AAF shall be reported. In addition, a comment was included specifying that the Laboratories shall not report an AAF for enobosarm based only on the presence of O-dephenylandarine. Terms and definitions have been updated where relevant.

13. TL13 – Trimetazidine
In this new version of the TL, the Analysis and Reporting Requirements article includes additional guidance that the Laboratories shall consider before reporting an AAF for trimetazidine. Therefore, the instruction to consult the WADA Science Department for trimetazidine suspicious findings has been removed. Terms and definitions have been updated where relevant.

14. TL14 – Difference in “A” and “B” Sample Urine Characteristics
In this new version of the TL, terms and definitions have been updated where relevant.

15. TL15 – Hydromorphone
In this new version of the TL, terms and definitions have been updated where relevant.

16. TL16 – Tretoquinol
In this new version of the TL, the instruction to report an AAF for tretoquinol only if the sample has been collected after 15 January 2019 has been removed. In addition, the instruction to record samples in which the tretoquinol concentration is estimated below 20 ng/mL has been also removed. Terms and definitions have been updated where relevant.

17. TL17 – Detection of Tulobuterol in the Presence of Bupropion
In this new version of the TL, relevant articles have been reorganized to facilitate interpretation. Terms and definitions have been updated where relevant.

18. TL18 – Testolactone
In this new version of the TL, terms and definitions have been updated where relevant.

19. TL19 – Prednisone and Prednisolone
In this new version of the TL, updates were necessary to align the TL with the new TD2021IRMS. The reference to TL10 has been removed from the Introduction and updates have been made on terms and definitions, where relevant, for consistency with the TD2021IRMS.

20. TL20 – Specific Substances with a Steroid Structure
In this new version of the TL, additional substances have been included, which the Laboratories shall consider before reporting a result as an AAF. In addition, since the new TD2021IRMS does not include specific criteria for the GC/C/IRMS analysis of the substances mentioned in this TL, the recommendation to perform GC/C/IRMS analysis has been removed. Terms and definitions have been updated where relevant.

21. TL21 – 6-oxo and Metabolites
In this new version of the TL, terms and definitions have been updated where relevant.

22. TL22 – Ethylmorphine
In this new version of the TL, the WADA Laboratory Expert Group (LabEG) proposed to postpone the effective date of the TL22 until 1 May 2021 due to the lack of commercial sources of the norethylmorphine reference material. Several sources for the reference material have been identified and availability is expected soon. WADA is monitoring these efforts.

DEADLINES

Please note that all WADA-accredited Laboratories are required to implement these TLs in their procedures by the following deadlines:

1 January 2021:

  • TL01 – Meclofenoxate
  • TL03 – Zilpaterol
  • TL04 – Zeranol
  • TL06 – Possible Metabolism of Proguanil into Chlorazanil
  • TL07 – Andarine – Flutamide
  • TL08 – Use of Internal Standards
  • TL09 – Oxethazaine
  • TL10 – In Situ Formation of Exogenous Compounds
  • TL12 – Enobosarm
  • TL13 – Trimetazidine
  • TL14 – Difference in “A” and “B” Sample Urine Characteristics
  • TL15 – Hydromorphone
  • TL16 – Tretroquinol
  • TL17 – Detection of Tulobuterol in the Presence of Bupropion
  • TL18 – Testolactone
  • TL19 – Prednisone and Prednisolone
  • TL20 – Specific Substances with a Steroid Structure
  • TL21 – 6-oxo and metabolites

1 April 2021:

  • TL02 – Mebeverine Metabolism
  • TL05 – Oxilofrine
  • TL11 – Oxymorphone

1 May 2021:

  • TL22 – Ethylmorphine

The above TLs are available and indexed on WADA’s website.

Should you have any questions or comments regarding the 2021 Technical Letters, please feel free to contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


05/01/21 WADA RELEASES LABORATORY TECHNICAL DOCUMENTS FOR 2021

Montreal, 22 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the following Technical Documents (TDs) for 2021 and Summaries of Modifications which were approved by WADA’s Executive Committee, via circulatory vote, on 21 December 2020.

This particular review of WADA’s TDs was triggered by the need to bring the following ones in line with the 2021 World Anti-Doping Code (Code) and the 2021 International Standard for Laboratories (ISL), which both come into force on 1 January 2021.

Under the ISL, WADA’s TDs are issued to provide direction to WADA-accredited Laboratories, WADA-approved Laboratories and other stakeholders on specific technical or procedural issues. As part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code, TDs undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping tests and the reporting of test results. They are refined and revised in consultation with WADA stakeholders.

2021 TECHNICAL DOCUMENTS

1. TD2021BAR – Analytical Requirements for the Hematological Module of the Athlete Biological Passport.

The TD2021BAR replaces the former TD2019BAR. In this revised version of the TD, relevant definitions have been updated and further clarification introduced, where relevant, to facilitate interpretation.

2. TD2021CG/LH – Analysis, Reporting and Management of Urinary human Chorionic Gonadotrophin (hCG) and Luteinizing Hormone (LH) Findings in Male Athletes.

The TD2021CG/LH replaces the former TD2019CG/LH, which has been modified to include the following main changes: the possible use of total hCG assays for the initial testing procedure has been reintroduced to facilitate the analytical strategy; and further clarifications regarding the selection of hCG assays for the initial testing and confirmation procedures, as well as the management of reported hCG results, are now provided. Terms and definitions have been updated where relevant.

3. TD2021DL – Decision Limits for the Confirmatory Quantification of Exogenous Threshold Substances by Chromatography-based Analytical Methods.

The TD2021DL replaces the former TD2019DL Version 2, which has been modified to include the following main changes: sections have been reorganized to facilitate interpretation; the title has been adjusted to better reflect the revised scope of the TD, which has been redirected towards the confirmatory quantification of exogenous threshold substances when using Chromatography-based methods; the previous section on method validation has been removed since it is now well described in other documents; the applicable Decision Limits (DLs) and concentration levels of the exogenous threshold substances shall be reported to three significant figures; the examples in the text were updated accordingly; terms and definitions have been updated where relevant; and finally, a new Annex B was created to detail the values for the specific gravity-adjusted DLs.

4. TD2021EPO – Harmonization of Analysis and Reporting of Erythropoietin (EPO) and other Erythropoietin-Receptor Agonists (ERAs) by Polyacrylamide Gel Electrophoretic (PAGE) Analytical Methods.

The TD2021EPO replaces the former TD2014EPO, which has been modified to include the following main changes: adjustment of the title to reflect the current classification of these erythropoiesis stimulating agents in the 2021 Prohibited List; addition of test sensitivity controls as an additional, optional requirement for initial testing and confirmation procedures; definition of minimum required performance limits (MRPL) for detection of ERAs; mandatory immunopurification of ERAs before PAGE analysis; use of discontinuous transfer buffers for immunoblotting; use of a biotinylated primary anti-EPO antibody; and conditions to report an Atypical Finding for ERAs. Terms and definitions have been updated where relevant.

5. TD2021GH – Human Growth Hormone (hGH) Isoform Differential Immunoassays for Doping Control Analyses.

The TD2021GH replaces the former TD2019GH, which has been modified to include minimal changes that primarily affect its formatting as well as the updating of terms and definitions where relevant.

6. TD2021IDCR – Minimum Criteria for Chromatographic-Mass Spectrometric Confirmation of the Identity of Analytes for Doping Control Purposes.

The TD2021IDCR replaces the former TD2015IDCR, which has been modified to include the following main changes: clarifications have been provided regarding the selection and use of the applied Reference Diagnostic Ion in order to obtain the Retention Time and to calculate the Relative Abundances of the Analyte’s Diagnostic Ions; and the definitions of Reference Diagnostic Ion, Reference Specimen, Retention Time and Relative Retention Time have been included to facilitate interpretation. Other terms and definitions have been updated where relevant.

7. TD2021IRMS – Detection of Synthetic Forms of Prohibited Substances by GC/C/IRMS.

The TD2021IRMS replaces the former TD2019IRMS, which has been modified to include the following main changes: adjustment of the title to better reflect the revised scope of the TD, which has been expanded to include the analysis of other prohibited substances in addition to endogenous anabolic androgenic steroids (EAAS); addition of new target compounds (TC): 6a-hydroxy-androstenedione, epiandrosterone sulfate, prednisone and prednisolone; addition of pregnanetriol (PT) as an endogenous reference compound (ERC); calculation of absolute Δδ13C values; revision of uc_Max requirements; requirement to consider results obtained with two different ERCs for reporting an Adverse Analytical Finding (with an updated Annex A on Selection and Use of ERCs); and review of some interpretation criteria (e.g. for A and Etio) in Annex B. Terms and definitions have been updated where relevant.
 
8. TD2021LCOC – Laboratory Internal Chain of Custody.

The TD2021LCOC replaces the former TD2009LCOC, which has been modified to include the following main change: the TD has been completely reorganized to incorporate specific requirements for the maintenance and recording of chain of custody for sample reception, sample handling, aliquots, storage and sample transfers, including the use of electronic chain of custody systems. Terms and definitions have been updated where relevant.

9. TD2021LDOC – Laboratory Documentation Packages.

The TD2021LDOC replaces the former TD2019LDOC, which has been modified to include the following main changes: requirements for specific methods including Urine ABP, GC/C/IRMS, EPO and Blood ABP have been revised; and each annex has been updated based on the revised versions of the relevant TDs. Comments have been incorporated where relevant to provide further clarification of the requirements. Terms and definitions have been updated where relevant.

10. TD2021NA – Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone.

The TD2021NA replaces the former TD2019NA, which has been modified to include the following main changes: better clarification of the possible endogenous origins of urinary 19-NA; better description of GC/C/IRMS performance characteristics and requirements when applied to 19-NA; instructions on the analysis to be performed when there are indications of 5a-reductase inhibitor activity in the sample; guidance to discriminate between oral consumption and injection of norsteroid preparations based on the pharmacokinetics of 19-NA excretion; and enhanced guidance for results interpretation and reporting in a tabulated form.

11. TD2021EAAS – Measuring and Reporting of Endogenous Anabolic Androgenic Steroid (EAAS) Markers of the Urinary Steroid Profile.

The TD2021EAAS replaces the former TD2018EAAS, which has been modified to include the following main changes: adjustment of the title to better reflect the scope of the TD; reorganization of different sections to facilitate interpretation; definition of reporting limits for non-prohibited substances that may alter the steroid profile; revision of the modalities of confirmation procedure requests (CPR); and steroid profile reporting requirements for “A” and “B” samples. Terms and definitions have been updated where relevant.

12. TD2021APMU – Athlete Passport Management Unit (APMU) Requirements and Procedures.

The TD2021APMU replaces the former TD2019APMU, which has been modified to include the following main changes: modifications have been introduced regarding the review of ATPF-CPR notifications for samples in which factors impacting the steroid profile have been reported; the management of SSP-CPR notifications has been transferred to the APMU, including revised criteria for triggering SSP-CPR notifications; steps to identify urine exchange (tampering) have been included; and the section dedicated to the analysis of steroid esters has been shifted from the TDEAAS to this new version of TDAPMU. Terms and definitions have been updated where relevant.
 
DEADLINES

Please note that all WADA-accredited Laboratories, WADA-approved Laboratories (for TD2021BAR, TD2021LDOC (Annex E) and TD2021LCOC) and APMUs (for TD2021APMU) are required to implement these TDs in their procedures by the following deadlines:

1 April 2021:

  • TD2021BAR
  • TD2021CG/LH
  • TD2021DL
  • TD2021GH
  • TD2021IDCR
  • TD2021LCOC
  • TD2021LDOC
  • TD2021NA
  • TD2021EAAS
  • TD2021APMU (for APMUs only)

1 May 2021:

  • TD2021EPO
  • TD2021IRMS

The above TDs are available and indexed on WADA’s website.

Should you have any questions or comments regarding the 2021 Technical Documents, please feel free to contact WADA’s Science Department at: science@wada-ama.org.

Best regards,

World Anti-Doping Agency


21/12/20 WADA RELEASES UPDATED GUIDELINES TO COMPLEMENT THE 2021 INTERNATIONAL STANDARD FOR THERAPEUTIC USE EXEMPTIONS

Montreal, 18 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) releases updated Guidelines for Therapeutic Use Exemptions (TUEs) to support Anti-Doping Organizations (ADOs) and other stakeholders in their implementation and application of the revised International Standard for Therapeutic Use Exemptions (ISTUE), which comes into force on 1 January 2021.

The new ISTUE Guidelines provide detailed information and examples for athletes, ADOs, physicians and Athlete Support Personnel to guide them when a TUE may be required to use a Prohibited Substance or Method due to an illness or a medical condition. These Guidelines have been updated in accordance with the 2021 World Anti-Doping Code (Code) and ISTUE. While the Guidelines are initially being published in English, the official French version will be published in early 2021.

The Guidelines can be found on WADA’s website and on the Agency’s Anti-Doping eLearning Platform (ADEL), as part of the Code Implementation Support Program (CISP), which provides additional resources to support the implementation of the ISTUE, as well as the revised Code and other International Standards that enter into force on 1 January 2021.

WADA guidelines provide Code Signatories with recommended practices for several aspects of anti-doping programs. While these guidelines are not mandatory, they offer technical guidance to ADOs in the implementation of their anti-doping programs. As with all guidelines under the World Anti-Doping Program, they are subject to ongoing review.

Should you have any questions regarding the Guidelines for Therapeutic Use Exemptions, or wish to provide feedback, please contact WADA’s Medical Unit at: medical@wada-ama.org.

Best regards,

World Anti-Doping Agency


21/12/20 WADA PUBLISHES 2019 TESTING
FIGURES REPORT

Report Highlights

  • A 5.5% increase in the overall number of samples analyzed: 263,519 in 2018 to 278,047 in 2019.
     
  • A slight decrease in the total percentage of Adverse Analytical Findings (AAFs): 1.05% in 2018 (2,774 AAFs from 263,519 samples) to 0.97% in 2019 (2,702 AAFs from 278,047 samples).
     
  • About 60% of WADA-accredited Laboratories saw an increase in the total number of samples recorded.
     
  • An almost similar total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.3% in 2018 (24,495 of 263,519) and 9.1% in 2019 (25,339 of 278,047).
     
  • An increase of 16% in the number of ABP blood samples tested: 31,265 in 2018 to 36,401 in 2019.
  • An increase in AAFs reported for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs).
     

Montreal, 18 December 2020 – The World Anti-Doping Agency (WADA) today published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.

This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).

WADA Director General Olivier Niggli said: “WADA’s Annual Testing Figures Report is a key tool for information sharing between Anti-Doping Organizations. It provides the anti-doping community with a wealth of data allowing them to assess their anti-doping strategies and identify potential patterns of doping or areas of improvement.

“The 2019 Report, which encompasses all doping control samples analyzed and reported by WADA-accredited and -approved Laboratories around the world in 2019, also contains enhanced data on gender and Regional Anti-Doping Organization testing following stakeholder questions on these areas. Anti-Doping Organizations will be able to use this comprehensive Report, and the valuable intelligence contained within it, to adapt their anti-doping programs and ensure that their programs are as intelligent as possible and rooted in solid data.”

To help with the interpretation of the 2019 Report, we provide a comprehensive Question and Answer document. Of particular importance, please note that:

  • One single result does not necessarily correspond to one athlete. Results may correspond to multiple findings regarding the same athlete or measurements performed on the same athlete, such as in the case of longitudinal studies of testosterone.
     
  • The number of AAFs in the Report may not correspond with the number of Anti-Doping Rule Violations (ADRVs) reported by Anti-Doping Organizations (ADOs). This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs), and longitudinal studies which can result in no case to answer or no sanction.
  • As usual, this Report does not illustrate statistics on ADRVs, which are reported via a separate ADRV Report – the 2018 version of which was released earlier in December 2020. The ADRV Report reveals analytical and non-analytical cases and the outcomes of results management, which is a process that can take a long time given that it may include investigations, appeals and other processes
     

17/12/20 WADA STATEMENT ON COURT OF ARBITRATION DECISION TO DECLARE RUSSIAN ANTI-DOPING AGENCY AS NON-COMPLIANT

Montreal, 17 December 2020 

The World Anti-Doping Agency (WADA) acknowledges the ruling today by the Court of Arbitration for Sport (CAS) to declare the Russian Anti-Doping Agency (RUSADA) non-compliant with the World Anti-Doping Code (Code) for a period of two years and to impose significant consequences. This decision confirms in large part the recommendation made in November 2019 by WADA’s independent Compliance Review Committee (CRC), which was unanimously accepted by the Agency’s Executive Committee (ExCo) on 9 December 2019.

Today’s CAS ruling is a clear endorsement of WADA’s assertion that data from the Moscow Laboratory were intentionally altered prior to and while they were being forensically copied by WADA Intelligence and Investigations (I&I) in January 2019 as part of Operation LIMS, in contravention of critical criteria set by the ExCo when RUSADA was reinstated as compliant, under strict conditions, in September 2018.

WADA President Witold Bańka said: “WADA is pleased to have won this landmark case. We left no stone unturned in investigating this very complex matter and in presenting our case before CAS. The Panel has clearly upheld our findings that the Russian authorities brazenly and illegally manipulated the Moscow Laboratory data in an effort to cover up an institutionalized doping scheme. In the face of continual resistance and denial from Russia, we clearly proved our case, in accordance with due process. In that regard, this ruling is an important moment for clean sport and athletes all over the world.

“We are, however, disappointed that the CAS Panel did not endorse each and every one of our recommended consequences for the four-year period we requested. We believe they were proportionate and reasonable, but ultimately WADA is not the judge but the prosecutor and we must respect the decision of the Panel. These are still the strongest set of consequences ever imposed on any country for doping-related offences and the award clearly endorses the resolute, process-driven approach taken by WADA in dealing effectively with this case. Russia will not be permitted to participate in, bid for or host any covered event, including two editions of the Olympic and Paralympic Games and many other major events, for the next two years. The Russian flag will not fly nor its anthem played. This sends a clear message that institutionalized cheating and concerted efforts to subvert the global anti-doping system will not be tolerated.

“The egregious manipulation by the Russian authorities of data retrieved by WADA Intelligence and Investigations from the Moscow Laboratory was the latest in a long list of offences and it has led today to significant consequences for the authorities. Russian authorities were afforded every opportunity to get their house in order and re-join the global anti-doping community for the good of their athletes and the integrity of sport, but they chose instead to continue on their path of deception and denial.”

WADA Director General Olivier Niggli said: “Today, the global anti-doping program is much stronger than it was at the time of the Sochi Olympic and Paralympic Games in 2014, and with the revised World Anti-Doping Code that comes into force on 1 January 2021, the program will be even stronger. The CAS ruling was made possible by the enhancements that have been put in place by WADA since the end of 2014 when the Russian doping program was first exposed. In particular, WADA’s acquisition of investigative powers in 2015 and the growth of our independent Intelligence and Investigations Department have proven to be a game-changer, while the International Standard for Compliance by Signatories (ISCCS) that entered into effect in April 2018 has stood up to this rigorous test. This CAS decision in such a high-profile and complex case demonstrates that the legal framework underpinning anti-doping works and works well.

“WADA’s determination to act resolutely and lawfully in the face of the Russian doping crisis was the correct approach. The diligence of our investigators, the vision of the independent Compliance Review Committee and our ability to take action via the Compliance Standard have enabled WADA to make the right decisions at every stage.

“WADA can now focus its energy on ensuring that those athletes, who were identified as potentially violating the rules as part of our wide-ranging Operation LIMS investigation, are brought to justice. WADA will continue to follow up with the International Federations to which we provided evidence packages in April 2020 as part of Operation LIMS to ensure those cases are dealt with swiftly and appropriately. If they are not, we will continue to exercise our independent right of appeal to CAS.

“It is also crucial that a credible, operationally independent and efficient anti-doping system prevails in Russia for the good of all athletes. To that end, we welcome the CAS Panel’s confirmation that a condition of RUSADA’s reinstatement once the two-year period has elapsed will be that WADA remains satisfied that RUSADA’s operational independence is being respected and there is no improper outside interference.”

As per Article 10.4.1 of the ISCCS, WADA expects the full reasoned decision will be publicly reported by CAS next week.


15/12/20 WADA ISSUES CALL FOR PROPOSALS FOR 2021 SCIENTIFIC RESEARCH GRANTS

Montreal, 15 December 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to issue a Call for Proposals for 2021 Scientific Research Grants.

Science is key to driving advances in anti-doping. Innovative research helps the anti-doping community identify new trends in doping, new drugs, new delivery mechanisms and new methods of detection.   

Since 2001, WADA has committed more than US$ 83 million to helping researchers around the world develop breakthroughs in anti-doping science. These grants are critical because they increase the volume of research dedicated to developing new and improved detection methods for performance-enhancing substances and methods as well as attract high level researchers to this cause.

Scientists interested in submitting research projects are invited to submit their applications via the Agency’s WADAGrants platform by 1 March 2021 (24:00 GMT).

Learn more about the 2021 Scientific Research Grants Program and the application process.

Obtenga más información sobre la Convocatoria de subvenciones de investigación 2021 y el procedimiento de solicitud.

Best regards,

World Anti-Doping Agency


08/12/20 WADA PUBLISHES UPDATED THERAPEUTIC USE EXEMPTION APPLICATION FORM IN SUPPORT OF THE
2021 INTERNATIONAL STANDARD FOR
THERAPEUTIC USE EXEMPTIONS

Montreal, 8 December 2020

Dear Colleagues,

Today, the World Anti-Doping Agency (WADA) publishes an updated template of the Therapeutic Use Exemption (TUE) Application Form to support Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Therapeutic Use Exemptions (ISTUE), which comes into force on 1 January 2021. The French and Spanish versions will be published on WADA’s website in the coming weeks. 

The updated TUE Application Form has been improved to assist athletes and their physicians with the TUE application process – including detailing the diagnoses and reasons behind the request for a TUE.

The Form may be modified by ADOs to include additional requests for information; however, no sections or items may be removed, including the new TUE Privacy notice. Similarly, ADOs may translate the Form into other languages; although, the existing English or French text must be retained. 

Should you have any questions regarding the Form, please feel free to contact WADA’s Medical Department at: medical@wada-ama.org.

Best regards,

World Anti-Doping Agency


04/12/20 WADA’s 2019 TESTING FIGURES REPORT: FOR AFO REVIEW

Montreal, 4 December 2020

Dear Colleagues,

Article 14.5 of the World Anti-Doping Code (Code) stipulates that the World Anti-Doping Agency (WADA) shall act as a central clearinghouse for Doping Control Testing data and results. Accordingly, on an annual basis, the Agency publishes reports which consolidate data that have been reported by WADA-accredited laboratories via the Agency’s Anti-Doping Administration and Management System (ADAMS).

Today, we are pleased to provide WADA’s 2019 Testing Figures Report which is broken down into the following four sub-reports. They represent analysis conducted by the WADA-accredited laboratories in 2019, in- and out-of-competition, for urine, blood, and the Athlete Biological Passport (ABP).

The sub-reports are:

  1. Laboratory report
  2. Sport report
  3. Testing Authority report
  4. ABP (blood analysis)

WADA is providing you, Anti-Doping Organizations (ADOs), with these reports in advance of their public distribution, inviting you to review your respective testing data and verify the data via ADAMS. We would ask you to provide comments no later than 14 December 2020 via WADAConnect, the Agency’s online consultation platform. Easy to use, WADAConnect will prompt you to create a user account and input your comments.

[For further information related to WADAConnect, please refer to the simple user guide.]

Furthermore, and in order to facilitate this process, the Agency would encourage you to refer to the Reporting Guide to Monitor Testing, which will guide you in compiling and verifying your respective results in ADAMS, including the Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) related to samples from your testing programs.

Should you have any questions regarding the Testing Figures Report, please contact statistics@wada-ama.org.

We thank you for your cooperation and remain available to respond to any questions that you may have in this regard.

Best regards,

World Anti-Doping Agency


03/12/20 WADA EXECUTIVE COMMITTEE WELCOMES TWO ADDITIONAL INDEPENDENT MEMBERS

Montreal, 3 December 2020 – During a two-week circulatory vote that followed its 12 November virtual meeting, the Foundation Board (Board) of the World Anti-Doping Agency (WADA) confirmed the recommendations of both the Agency’s Nominations Committee and Executive Committee (ExCo) and appointed Gabriella Battaini-Dragoni and Patricia Sangenis as two additional independent members of the ExCo.
 
Originally from Italy, Ms. Battaina-Dragoni is the current Deputy Secretary General of the Council of Europe (COE), and will retire from this position in the coming weeks. From 2011-12, she was COE’s Director General of Programs and was Director General of Education, Culture and Heritage, Youth and Sport from 2004-11. A strong proponent of ethics in sports, she played a leading role in the planning and promotion of a number of COE’s sports integrity initiatives that sit alongside its longstanding Anti-Doping Convention. She is currently representing the COE on WADA’s Board – a seat she will relinquish due to her appointment to the ExCo.
 
Dr. Sangenis is a reputed sports physician from Argentina. For more than 20 years, she helped to deliver medical services and doping control for various sporting events, including at the Olympic and Paralympic Games, and she is a former member of the International Olympic Committee Medical and Scientific Commission. Through her work as a practitioner and academic, she has been a strong advocate for sport and physical activity, especially among women and girls, with the aim of achieving equal opportunities, not only in terms of participation, but also as it relates to health, leadership and other areas.
 
The additional independent members’ terms will commence on 1 March 2021. From that date, therefore, WADA’s ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. Currently, one third of the members of both WADA’s ExCo and Board are active or former international-level athletes.
 
As such, the full ExCo will consist next year of:

  1. Witold Bańka (Independent Chair, WADA President)
  2. Yang Yang (Independent Vice-Chair, WADA Vice-President)
  3. Patricia Sangenis (Independent)
  4. Gabriella Battaini-Dragoni (Independent)
  5. Ugur Erderner (International Olympic Committee)
  6. Jiri Kejval (Association of National Olympic Committees)
  7. Ingmar de Vos (Association of Summer Olympic International Federations)
  8. Nenad Lalovic (Global Association of International Sports Federations)
  9. Danka Bartekova (IOC Athletes Commission)
  10. Amira El Fadil (Public Authorities – Africa)
  11. Andrea Sotomayor (Public Authorities – Americas)
  12. Tanose Taido (Public Authorities – Asia)
  13. Dan Kersch (Public Authorities – Europe)
  14. Grant Robertson (Public Authorities – Oceania)

This change is the latest in a wide-ranging series of governance reforms implemented by WADA since November 2018 to ensure the Agency’s governance remains fit for purpose and can adapt to future challenges. Of the 70 reform recommendations made by the WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In addition to the four independent ExCo members, there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except, as it relates to NADOs, for the independent Compliance Review Committee), and there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees.
 
In addition, work continues on additional athlete representation within WADA’s governance, as well as the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure. A draft of the Code of Ethics has been developed with the objective of it being approved by the Board in May 2021.
 
On 11 November 2020, the ExCo approved the composition of a new Working Group on the Review of WADA Governance Reforms to monitor the effect of the ongoing reforms and propose additional reforms going forward following a broad stakeholder consultation. This Group includes five governance experts and one expert athlete (nominated by WADA’s Athlete Committee), with the possibility of expanding the Group to include another expert athlete.
 
WADA President Witold Bańka said: “The significant progress WADA has made on governance reform continues and I would like to welcome Dr. Sangenis and Ms. Battaini-Dragoni as strong, independent voices on the ExCo. WADA’s governance reform is expanding. With the establishment of the new Working Group, the governance model will be further strengthened on an ongoing basis. It is vital that WADA is not static and that our governance continues to evolve in line with international best practice.”
 
2021 Budget
 
As part of its circulatory vote, the Board also approved the 2021 WADA budget, which was endorsed by the Agency’s Finance and Administration Committee at its meeting in August and recommended by the ExCo on 11 November. The agreed budget is USD 43,371,517, representing an 8% increase as compared to 2020, which was accepted by the Board in May 2018 as part of a four-year series of annual increases from 2019-22. 
 
WADA Investigations Policy
 
Lastly, the Board approved amendments to the WADA Investigation Policy, as recommended by the ExCo at its November meeting. The amendments refer primarily to the timing of publication of WADA’s investigative findings and the need for transparency to help lift the veil on doping schemes while also protecting the identity of whistleblowers and not compromising any ongoing results management processes or law enforcement activities.


02/12/20 WADA WELCOMES ADDITIONAL CONTRIBUTIONS FROM GOVERNMENTS OF CHINA, EGYPT, INDIA AND SAUDI ARABIA

Montreal, 2 December 2020 – The World Anti-Doping Agency (WADA) today welcomes additional contributions totaling close to USD2.6 million from the Governments of China, Egypt, India and Saudi Arabia, which will be dedicated to the Agency’s scientific research and intelligence and investigations (I&I) activities.

The contributions are additional to the Governments’ annual contributions to WADA’s regular budget, which are matched by the International Olympic Committee (IOC) on behalf of the Sports Movement, and are part of an initiative announced in November 2019 by IOC President Thomas Bach to further strengthen WADA’s scientific research and I&I programs. Under this initiative, additional contributions provided by Governments are matched by the IOC, which means that these contributions will yield almost USD5.2 million extra for the global anti-doping system.

WADA President Witold Bańka said: “This is a massive boost for WADA and for Clean Sport. The Agency is grateful to the Governments of China, Egypt, India and Saudi Arabia for supporting the protection of sport in this way. These generous contributions can be seen as a strong commitment from these nations and will be put to good use enhancing scientific research, as well as the work of WADA’s independent Intelligence and Investigations Department. Both areas have delivered significant achievements in recent years and these additional resources will contribute greatly towards WADA’s mission for doping-free sport.

“Thanks are of course also due to the IOC for launching this initiative and generously matching these amounts, ensuring that every dollar invested by Governments brings two dollars into the system. This collaborative initiative is proving to be very successful and demonstrates the strength of the partnership between the Sports Movement and Public Authorities when it comes to anti-doping. I encourage other Governments to take advantage of this opportunity that the IOC has offered.”

Specifically, the Government of India has pledged an additional USD1 million, Saudi Arabia USD500,000 and Egypt USD100,000, while WADA has already received the USD992,694 pledged by the Chinese Government. China, Saudi Arabia and Egypt have previously made similar additional contributions and, in the past four years, outside of this particular initiative, WADA has also received additional contributions from the Governments of Australia, Azerbaijan, Brazil, Denmark, France, Japan, Kuwait, Poland and the USA, as well as three different levels of Government in Canada, the City of Lausanne and the Canton de Vaud in Switzerland.


17/11/20 WADA STATEMENT ON U.S. SENATE’S PASSING OF THE RODCHENKOV ANTI-DOPING ACT

Montreal, 17 November 2020 – The World Anti-Doping Agency (WADA) maintains its concern following yesterday’s decision by the United States (U.S.) Senate to pass the Rodchenkov Anti-Doping Act of 2019 (Rodchenkov Act).

WADA supports Governments who use their legislative powers to protect athletes in the fight against doping in sport. However, while recognizing positive elements of this legislation, WADA and other stakeholders continue to believe that some very important elements of the Act will have unintended consequences and will disrupt the global legal anti-doping framework recognized to date by 190 nations, including the U.S., through the UNESCO International Convention Against Doping in Sport. WADA and many other organizations representing governments and sports around the world, including from within the Council of Europe, the International Olympic Committee and a number of Anti-Doping Organizations, have expressed concerns around the issue of extraterritoriality in the Act as it will undermine the fight against doping worldwide.

No nation has ever before asserted criminal jurisdiction over doping offences that occurred outside its national borders – and for good reason. It is likely to lead to overlapping laws in different jurisdictions that will compromise having a single set of anti-doping rules for all sports and all Anti-Doping Organizations under the World Anti-Doping Code (Code). This will have negative consequences as harmonization of the rules is at the very core of the global anti-doping system.

WADA remains concerned that by unilaterally exerting U.S. criminal jurisdiction over all global doping activity, the Act will likely undermine clean sport by jeopardizing critical partnerships and cooperation between nations. Further, the Act could impede the capacity to benefit from whistleblowers by exposing them to possible prosecution and preventing ‘substantial assistance’ deals in line with the provisions of the Code.

This Act may lead to other nations adopting similar legislation, thereby subjecting U.S. citizens and sport bodies to similar extraterritorial jurisdictions and criminal sanctions, many of which may be political in nature or imposed to discriminate against specific nationalities. This will be detrimental to anti-doping efforts everywhere, including in the U.S.

WADA President Witold Bańka said: “We join other stakeholders around the globe in asking why this U.S. legislation, which purports to protect athletes and claims jurisdiction overseas, specifically excludes the hugely popular and influential professional and college leagues. Nearly half a million athletes compete in U.S. college sports, and thousands more in the professional leagues. These leagues were originally included in the Act but were subsequently removed without explanation. Why are those who surround the athletes in these associations and leagues now exempt from the scope of this legislation? If it is not good enough for American sports, why is it being imposed on the rest of the world?

“While the Act was passed without consultation with international anti-doping partners, WADA will seek to work with U.S. authorities on implementing this legislation to ensure that the global anti-doping system, which has evolved for 20 years in close collaboration with the U.S., is not upended, that WADA’s mandated investigative capacity is not diminished, and that the negative impact of this Act is minimized.”


16/11/20 WADA PUBLISHES ADO SURVEY OUTCOMES
CONCERNING IMPACT OF COVID-19 ON
ANTI-DOPING PROGRAMS WORLDWIDE

Montreal, 16 November 2020

Dear colleagues,

The World Anti-Doping Agency (WADA) is pleased to share the outcomes of a surveythat the Agency issued on 2 September 2020 to Anti-Doping Organizations (ADOs) worldwide for completion by 18 September 2020. The survey, which was aimed at assessing the impact that COVID-19 was having on anti-doping programs worldwide, is part of a broader review to also determine what lessons can be learned from the situation; gather feedback on the COVID-19 Guidance for Resuming Testing document issued by WADA on 6 May 2020; and, determine the impact that COVID-19 was having on sample collection, shipment and the sample analytical process.

The survey was issued to 247 ADOs and nearly half of them responded. Of the respondents:

  • 75% were National Anti-Doping Organizations (NADOs);
  • 10% were International Federations (IFs); and
  • 15% were ‘Other’ (e.g., Regional Anti-Doping Organizations).

WADA is extremely grateful to all who took the time to complete the survey. As you will see from the survey results, responses showed that the guidance documents that WADA developed and shared with ADOs in the early stages of the pandemic were very useful. The feedback received is assisting WADA in determining the improvements that can be made to these documents; as well as, the global anti-doping system; in particular, how we can continue to adapt and be better prepared should similar public health crises arise in the future.

In short, the survey provided feedback on a number of key areas that have or are in the process of being addressed including:

  • That information and guidance documents be updated as promptly as possible. WADA is working with key stakeholders to update guidance documents for ADOs. In particular, the Strategic Testing Expert Group is in the process of updating the COVID-19 Guidance for Resuming Testing document, which WADA intends to publish late November 2020 in the dedicated COVID-19 section of WADA’s website. This will provide further assistance to ADOs as they continue to test/resume testing during the pandemic including guidance on in-competition testing, blood testing, storage of samples, and B sample analysis — all with the continued focus on the health and safety of athletes and sample collection personnel.
     
  • Requests for flexibility around compliance matters. The independent Compliance Review Committee (CRC) announced flexibility around compliance matters due to the exceptional nature of the situation. This was communicated to Code Signatories after each of the meetings of the CRC since March 2020 and will be further reviewed during the next CRC meeting in early 2021.
     
  • That there be priority testing. WADA is working with the anti-doping community to ensure that the priority for testing is on athletes that are due to compete in upcoming major events, including: the Olympic and Paralympic Games in Tokyo, World Championships and other major events.
     
  • That there be ongoing support for the 2021 World Anti-Doping Code (Code) implementation. WADA will continue to support ADOs with their implementation of the 2021 Code and International Standards via its Code Implementation Support Program (CISP) that includes numerous live webinars, guideline documents and other supporting documentation (e.g., factsheets, checklists, templates, etc.) – all that are available on WADA’s Anti-Doping e-Learning platform (ADeL). In addition, we encourage all ADOs to continue engaging with the relevant WADA Departments as well as the WADA Regional Offices for direct assistance and support.

Should you have any questions, please feel free to contact us at SandH@wada-ama.org.

Thank you again to all that participated in the survey — best regards,

World Anti-Doping Agency


13/11/20 2018 ADRVs REPORT ‘PRE-RELEASE’ CONSULTATION

Montreal, 13 November 2020

Dear Colleagues,

In accordance with Articles 14.4 and 14.5 of the World Anti-Doping Code (Code), WADA, acting as a central clearinghouse for doping control testing results, annually publishes statistical reports summarizing the information that it receives from Anti-Doping Organizations (ADOs).

Today, we are pleased to provide ADOs with a ‘pre-release’ of the 2018 Anti-Doping Rule Violations (ADRVs) Report, which is presented in the following four sections, and includes analytical ADRVs as a result of Adverse Analytical Findings (AAFs) reported by the WADA-accredited laboratories and non-analytical ADRVs reported to WADA by ADOs:

  • Section 1: Outcomes of 2018 AAFs by Sport Category
  • Section 2: Outcomes of 2018 AAFs by Testing Authority Category
  • Section 3: Report of 2018 Non-Analytical ADRVs
  • Section 4: Report of 2018 Total Analytical and Non-Analytical ADRVs

WADA provides the Report to you in advance of public distribution so that you can review and/or comment on the data of your respective ADO before it is published. Accordingly, should you wish to comment, kindly do so no later than 23 November 2020 via WADAConnect, the Agency’s online consultation platform. Easy to use, WADAConnect will prompt you to create a user account and input your comments. For further information related to WADAConnect, please refer to the simple user guide.

Should you have any other questions or comments concerning the 2018 ADRVs Report, we invite you to contact statistics@wada-ama.org.

Best regards,

World Anti-Doping Agency


12/11/20 WADA EXECUTIVE COMMITTEE AND FOUNDATION BOARD EXPAND UPON AGENCY’S GOVERNANCE REFORMS

Montreal, 12 November 2020 – The World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) and Foundation Board (Board) met virtually yesterday (11 November) and today (12 November), respectively.The 38-member Board is WADA’s highest policy-making body. It delegates the management and running of the Agency to the 12-member ExCo. Accordingly, the ExCo takes decisions of its own and makes recommendations to the Board for decisions concerning the performance of certain activities and the administration of assets.
 
Given the virtual nature of this week’s meetings due to COVID-19, decisions stemming from the Board meeting, which was open to the media and observers as per WADA’s Statutes, will be made via a two-week circulatory voting process. This will ensure the integrity of the voting process and mitigate any difficulties that may arise from holding a virtual meeting with such a large group of participants. WADA will then publicly communicate the decisions once they are confirmed. The major decisions taken by the ExCo are outlined below.
 
A Tribute to John Fahey
 
The Board meeting opened with a moment of silence in memory of former WADA President John Fahey, who passed away on 12 September in Australia at the age of 75. Mr. Fahey, who was admired and respected across the worlds of sport and politics, served with distinction as WADA President from 2008-13.
 
Advancing and Expanding Governance Reform
 
The ExCo and Board received a progress report on the implementation and timing of WADA’s wide-ranging governance reforms, which were approved by the Board in November 2018 and are being introduced according to the agreed schedule. Of the 70 reform recommendations made by the WADA Governance Reforms Working Group in November 2018, all have now been actioned to some degree – the vast majority having been fully implemented. In particular, WADA now has an independent President and Vice-President, there is at least one athlete and one representative of National Anti-Doping Organizations (NADOs) on each Standing Committee (except for the independent Compliance Review Committee as it relates to NADOs), and there is a limit of three terms of three years each for members of the ExCo, Board and Standing Committees.
 
Yesterday, the ExCo:

  • Endorsed the recommendation made by the Agency’s Nominations Committee for the appointment of two additional independent members of the ExCo (for consideration by the Board via circulatory vote) and recommended to the Board to approve this proposal. With the addition of these two members, going forward the ExCo will be composed of four independent members (including the President and the Vice-President), five representatives of Governments and five of the Sport Movement, with active or former athletes represented in each of these categories. Currently, one third of the members of both WADA’s ExCo and Board are active or former international-level athletes;
  • Streamlined the governance of the Agency’s Expert Advisory Groups and Working Groups; and
  • Approved the composition of a new Working Group on the Review of WADA Governance Reforms to ensure that the Agency continues to evolve in line with international best practice. This Group includes five governance experts (two proposed by Governments, two by the Sport Movement, and one independent Chair) and one expert athlete (nominated by WADA’s Athlete Committee), with the possibility of expanding the Group to include another expert athlete. Beginning its work immediately, it will be responsible for monitoring the effect of the ongoing reforms and for proposing additional governance reforms going forward. An essential part of the work of the Group will be to consult all stakeholders, including athletes and NADOs, using a wide-ranging consultation process in the same spirit as the one used for past World Anti-Doping Code reviews. The members of the Group are:
     
    • Prof. Ulrich Haas (Independent Chair, Germany)
    • Maria Clarke (New Zealand)
    • Adam Pengilly (Athlete, UK)
    • Romano Subiotto (Italy/UK)
    • An Vermeersch (Belgium)
    • Michael Vesper (Germany)

In addition, work continues on additional athlete representation within WADA’s governance (as outlined below), as well as the introduction of a WADA Code of Ethics and formation of an Independent Ethics Board or similar structure. A draft of the Code of Ethics has been developed with the objective of an approval during the Foundation Board in May 2021.
 
WADA President Witold Bańka said: “WADA continues to progress with its wide-ranging governance reforms to remain fit for purpose and to be able to adapt to challenges that lie ahead. I was pleased that during these last two days, the ExCo and Board recognized the progress that has been made to date while remaining focused on the next steps. A large number of members from both the Sports Movement and Governments around the world voiced their appreciation for how these significant reforms were being implemented. In particular, they welcomed the addition of independent members to the Executive Committee and the formation of the new Working Group on the Review of WADA Governance Reforms that will ensure that we keep up this momentum of change.”
 
2021 Standing Committees
 
Following a rigorous process of nomination and consideration, the ExCo approved a number of new or renewed members of each of the five Standing Committees for 2021, with the exception of the Public Authority representative on the Compliance Review Committee that will be recommended for approval in December 2020. More than half (27 out of 53) of the appointed members are women, and 33 countries from the five continents are represented on the 2021 Committees. The full list of the 2021 Standing Committee members will be published shortly.
 
Athlete Representation
 
Both the ExCo and Board were updated on the work of all Standing Committees. In particular, the Athlete Committee Chair, Ben Sandford, outlined the work of the Athlete Representation Working Group – a subset of the Athlete Committee – that is reviewing the current governance of the Athlete Committee and looking at ways to further enhance athlete representation at WADA. Ben Sandford also updated the ExCo on the current work conducted on the concept of an ombudsperson(s) resource for anti-doping.
 
President Bańka updated the ExCo and Board on his initiative to meet regularly with athlete groups, in line with WADA’s new Five-Year Strategic Plan that places athlete engagement at the heart of the organization’s activities. Since launching the initiative, and despite the restrictions imposed by the COVID-19 pandemic, Mr. Bańka has managed to hold productive virtual meetings with hundreds of athletes from various athlete commissions and groups worldwide. He said that a key outcome of the exercise will be to help establish how to ensure athlete perspectives can best be represented within WADA.
 
COVID-19
 
WADA Management updated the ExCo and Board regarding COVID-19’s impact on the global anti-doping system. Members were presented with a summary of the results of a WADA survey of Anti-Doping Organizations that sought information on the impact of the pandemic and feedback on the usefulness of WADA’s guidance documents, which are publicly available on a dedicated section of the WADA website. This survey will be made public in the coming days.
 
WADA Director General Olivier Niggli said: “It is encouraging to see how committed the anti-doping community is to maintaining the integrity of the global anti-doping system in the face of COVID-19. While public health remains everybody’s number-one priority and testing is only one of multiple anti-doping tools, the number of tests has continued to raise during the last months, and the level of out-of-competition testing in September was at about 80% of the figures of September 2019. WADA will continue to work with Anti-Doping Organizations worldwide and provide any support they may need to help them return to full power in all of their anti-doping activities.”
 
International Weightlifting Federation (IWF)
 
The Director of WADA’s Intelligence and Investigations (I&I) Department, Gunter Younger, reported to the Board in relation to his team’s ongoing investigation into the IWF and the sport of weightlifting, which has been running since August 2017. The investigation includes a probe of a high-ranking member of the IWF (Operation Outreach), Romanian weightlifters and others (Operation Heir), allegations of improper practices by some national weightlifting federations (Operation Extra) and a ground-breaking investigation into the global practice of urine substitution by weightlifters and the use of doppelgängers (Operation Arrow). Provisional outcomes of this significant investigation were published last month.
 
The positive outcomes from this investigation were only possible due to a combination of brave whistleblowers bringing evidence to WADA via the ‘Speak Up!’ program and the diligence and skill of investigators.
 
2021 Budget
 
The ExCo recommended that the Board adopt the 2021 WADA budget endorsed by the Agency’s Finance Committee at its meeting in August. The proposed budget, which is USD 43,371,517, represents an 8% increase as compared to 2020, as accepted by the Board in May 2018 as part of a four-year series of annual increases from 2019-22. The Board will consider the recommendation via circulatory vote.
 
Asia Public Authorities representative and President of the Saudi Arabian Anti-Doping Committee, Mohammed Saleh Al Konbaz, informed the meeting that the Saudi Government intended to make an additional contribution to WADA of USD500,000 as part of an initiative put in place last year by IOC President Thomas Bach to boost funding for the Agency’s science and investigations budgets. Additional contributions provided by Governments under this scheme are matched by the IOC, which means that Mr. Al Konbaz’s announcement represents USD1 million that will be added to the global protection of clean sport.
 
Board decisions will be announced once the two-week circulatory voting period has elapsed. In the meantime, WADA will publish more detailed information on the decisions taken by the ExCo in the coming days.


9/11/20 WADA PUBLISHES GUIDE TO STRENGTHENING NATIONAL ANTI-DOPING ORGANIZATIONS’ OPERATIONAL INDEPENDENCE

Montreal, 9 November 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) has published a Guide for the Operational Independence of National Anti-Doping Organizations (NADOs) that will support them in strengthening and reinforcing their operational independence as required by the revised World Anti-Doping Code (Code) that was approved in November 2019 and comes into force on 1 January 2021.

Following an exhaustive consultation process, Article 20.5.1 of the 2021 Code will ensure that NADOs are independent from sport and government in their operational decisions and activities by prohibiting any operational involvement by anyone who is at the same time involved in the management or operations of any International Federation, National Federation, Major Event Organization, National Olympic Committee, National Paralympic Committee, or Government department with responsibility for sport or anti-doping.

WADA Director General Olivier Niggli said: “Operational independence is crucial for NADOs as they seek to deliver anti-doping programs without undue influence from governments or sports. Bringing this requirement under the terms of the World Anti-Doping Code makes this independence a condition of their ongoing compliance. Just as WADA is operationally independent from both those stakeholders, so must be Anti-Doping Organizations at the national level, in accordance with international best practice. I would like to thank NADOs for their overwhelming support on this issue and, through this Guide, we are delighted to be able to support them as they deliver on the strengthened provision.”

WADA Director, Program Development and NADO/RADO Relations, Tom May said: “The majority of NADOs operate independently from Governments and sport. However, in a situation where a NADO’s operational independence is not evident or is being threatened, we now have the tools to follow up and ensure this independence is protected. This Guide provides clear direction regarding these requirements to the anti-doping community and we look forward to working with NADOs on implementing these principles.”

Responding to a number of requests from NADOs, this Guide outlines the regulatory and practical measures that should be in place to ensure they can comply with the 2021 Code when it comes into force. The Guide is made up of two parts. Part one sets out mandatory provisions that are found in the Code and that will be monitored by WADA for the purposes of compliance. Part two sets out recommended aspects that NADOs are encouraged to adopt as best practice, providing examples of how these measures can best be implemented.

During the drafting process, the Guide was shared with WADA’s NADO Advisory Group, representatives of the Monitoring Group of the Anti-Doping Convention of the Council of Europe, as well as three Regional Anti-Doping Organizations for review. Feedback received was incorporated into the final version of the document, which was presented to the independent Compliance Review Committee (CRC) at its meeting in early October. The CRC welcomed the development of the Guide and supported WADA’s efforts in clarifying the requirements of NADO operational independence to its stakeholders.

In addition to this Guide, WADA will provide assistance and develop practical tools to support NADOs in enhancing their operational independence. This includes a comprehensive webinar on the topic, which is scheduled for December.

For further information on the Guide, please contact WADA at WADAProgramDevelopment@wada-ama.org.

Best regards,

World Anti-Doping Agency


7/11/20 JOINT STATEMENT FROM WADA AND THE U.S. OFFICE OF NATIONAL DRUG CONTROL POLICY

Montreal, 7 November 2020 – Yesterday, the World Anti-Doping Agency (WADA) President, Witold Bańka, and the Director of the White House Office of National Drug Control Policy (ONDCP) in the United States (and an Americas public authority representative on WADA’s Foundation Board), the Honorable James W. Carroll, held a virtual meeting to discuss matters of interest to the two organizations with the goal of better working together for the good of athletes and the global anti-doping system.
 
In what was a very positive meeting, the two organizations agreed that the U.S. Government was vital for the protection of clean sport around the world, and that they would pursue strong and open bilateral communication going forward.
 
Mr. Banka and Mr. Carroll were united in the view that this was an important meeting, where WADA and the ONDCP were able to discuss a number of areas of mutual concern in an open and honest way. Mr. Carroll reaffirmed the U.S. Government’s commitment to work with WADA, from within WADA. They both agreed that the partnership between WADA and the U.S. Government was vitally important for the protection of clean sport around the world. As such, they committed to strengthening this partnership going forward and saw this meeting as an important step along a renewed path of dialogue and collaboration.
 
The main topics covered in the meeting included:

  • The ongoing reforms to WADA’s governance, including U.S. Government and athlete representation within WADA’s committee structures;
  • How the two organizations can work together to strengthen and harmonize the anti-doping system in the U.S.; and
  • The impact of COVID-19 on the global anti-doping system.

6/11/20 WADA STRATEGIC TESTING EXPERT GROUP EVALUATES IMPACT OF COVID-19

Montreal, 6 November 2020

Dear Colleagues,

During four virtual meetings in October 2020, the World Anti-Doping Agency’s (WADA’s) newly established Strategic Testing Expert Group focused its discussions on the impact that COVID-19 has had on global testing programs and evaluated how the anti-doping community can continually improve the ways in which it plans, collects and analyzes doping control samples to maximize detection efficiency and deterrence.

The Expert Group discussed the impact that COVID-19 has had on athletes; global anti-doping testing programs (in particular, by reviewing 2020 testing statistics); and, WADA-accredited laboratories. During these meetings, five National Anti-Doping Organizations (from China, Denmark, the Netherlands, Norway and the United States) presented the alternative sample collection strategies that they had developed and piloted during the pandemic, which enabled the collection of samples to continue during these difficult times.

In the interest of providing greater insight to stakeholders regarding the matters covered during these meetings, we are pleased to share a Summary of Outcomes.

The Expert Group also discussed the feedback received from stakeholders via WADA’s ‘Survey on the Impact of COVID-19 on ADOs’, which the Agency carried out in September. As a result of the feedback received, which will be published in full in the coming days, the May 2020 ‘COVID-19 Guidance for Resuming Testing’ will be revised and replaced by a ‘Guidance for Testing During COVID-19’ document in late November 2020. More details on this work are contained within the Summary of Outcomes document.

Should you have any questions regarding the work of the Expert Group and the outcomes of its discussions, we invite you to contact WADA at SandH@wada-ama.org

Best regards,

World Anti-Doping Agency


5/11/20 WADA AWAITS RESULT OF CAS HEARING WITH RUSSIAN ANTI-DOPING AGENCY

Montreal, 5 November 2020 – The four-day arbitration procedure between the World Anti-Doping Agency (WADA) and the Russian Anti-Doping Agency (RUSADA) before the Court of Arbitration for Sport (CAS) concluded today in Lausanne, Switzerland.

WADA President Witold Bańka said: “WADA is satisfied with how we presented our case and we now look forward to receiving the decision of the Panel. As at every other stage, we are following due process in relation to RUSADA’s compliance procedure as we continue to deal effectively with this complex matter.”

The hearing related to the unanimous WADA Executive Committee (ExCo) decision of 9 December 2019, to endorse the recommendation made by the independent Compliance Review Committee that RUSADA be declared non-compliant with the World Anti-Doping Code for a period of four years, with a range of consequences attached. This followed the results of an investigation that alleged data from the Moscow Laboratory was intentionally altered prior to and while it was being forensically copied by WADA in January 2019, in contravention of RUSADA’s reinstatement conditions, approved by the ExCo in September 2018.

Due to COVID-19 restrictions in place around the world, the hearing took place in a mixed format with arbitrators, parties, legal representatives and witnesses attending either in person or virtually, via a video link. WADA had requested that the hearing be held in public but for that to happen all parties were required to be in agreement and that was not the case.

The procedure was conducted by a CAS Arbitral Panel composed of Judge Mark Williams (Australia, President), Prof. Luigi Fumagalli (Italy) and Dr. Hamid Gharavi (France / Iran). As confirmed by CAS, the Panel will announce its decision at a later date and, until that time, WADA will make no further comment.


3/11/20 WADA POSTPONES 2021 ANNUAL SYMPOSIUM DUE TO ONGOING UNCERTAINTY LINKED TO COVID-19

Montreal, 3 November 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) regrets to announce that, due to ongoing uncertainty linked to COVID-19, the Agency is postponing its 2021 Annual Symposium that was to be held on 17-18 March 2021 in Lausanne, Switzerland. WADA would kindly ask stakeholders to take note that the Agency has tentatively booked the SwissTech Convention Center in Lausanne for an in-person or hybrid (in-person and virtual) Symposium on 19-20 October 2021.

WADA’s Annual Symposium, which is traditionally the biggest gathering on the anti-doping calendar, is designed for anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations; representatives from Athlete Commissions, Governments, WADA-accredited laboratories and Athlete Passport Management Units; as well as, other stakeholders such as service providers, researchers and the media – all that are integral to clean sport.

WADA Director General Olivier Niggli said: “WADA is disappointed that its Annual Symposium has been disrupted once again by COVID-19. Given the importance for WADA and the anti-doping community to come together in person, especially following such a long period of social distancing, we hoped to be able to offer a Symposium with in-person and virtual participation in March next year. However, with the current health situation around the world, and the restrictions imposed in Switzerland on gatherings, we were simply not confident that we would be able to offer a program and networking experience that participants value and are accustomed to.

“Therefore, similar to what WADA did this year after the 2020 edition was cancelled due to COVID-19, we will ensure that key issues that would have been covered will be presented and discussed via alternative means, including webinars.”

In the meantime, WADA has tentatively booked dates for an in-person or hybrid Symposium on 19-20 October 2021. We therefore kindly ask our stakeholders to save these dates and we will keep you regularly informed of our plans next year.

Should you have any questions regarding the Symposium, please contact WADA’s Events Manager, Ms. Anais Lefevre, at anais.lefevre@wada-ama.org.

We hope to be able to see you in person again soon.

Best regards,

World Anti-Doping Agency


2/11/20 SÃO TOMÉ AND PRÍNCIPE BECOMES 190TH COUNTRY TO RATIFY UNESCO ANTI-DOPING CONVENTION

Montreal, 2 November 2020 – The World Anti-Doping Agency (WADA) is pleased to announce that the African nation of São Tomé and Príncipe has become the 190th State Party to ratify the UNESCO International Convention against Doping in Sport (UNESCO Convention). This leaves just five countries worldwide that have yet to complete their ratification of the UNESCO Convention.

WADA President Witold Bańka said: “It is always a moment of celebration for WADA and clean sport when another nation signs up as a State Party to the UNESCO Convention. It demonstrates to us and the rest of the world that São Tomé and Príncipe is serious about its commitment to anti-doping.

“The aim of the UNESCO Convention is to bring nations together, united in the common mission of protecting sport. It has assisted WADA in its efforts to bring consistency and harmonization to anti-doping policy around the globe. Almost all Governments of the world have now pledged their support to clean sport and it is vitally important that they implement it effectively in their respective countries for the good of athletes everywhere.

“São Tomé and Príncipe is the second African country to ratify the UNESCO Convention within the past 12 months, which shows an increasing level of dedication to clean sport in the region. We sincerely hope that the outstanding nations from Africa and other regions will follow in due course.”

The Convention, which was adopted on 19 October 2005, is the practical instrument by which governments formalize their commitment to the fight against doping. It allows governments to align their domestic policies with the World Anti-Doping Code, thus harmonizing the rules governing anti-doping in sport and public legislation. Under UNESCO standards, the Convention has set records in terms of the speed with which it was prepared, adopted and ratified.

See the complete list of countries that have ratified the UNESCO Convention.


30/10/20 WADA PREPARED FOR CAS HEARING WITH RUSSIAN ANTI-DOPING AGENCY

Montreal, 30 October 2020 – The World Anti-Doping Agency’s (WADA’s) arbitration procedure with the Russian Anti-Doping Agency (RUSADA) will be heard before the Court of Arbitration for Sport (CAS) from 2-5 November in Lausanne, Switzerland.

WADA President Witold Bańka said: “WADA has left no stone unturned in preparation for this hearing and we are looking forward to having the opportunity to present our case clearly and fairly to the Panel. I remain convinced that the WADA Executive Committee made the right recommendation in this case last December. As at every other stage, we are following due process in relation to RUSADA’s compliance procedure as we continue to deal effectively with this complex matter.”

The hearing relates to the unanimous WADA Executive Committee (ExCo) decision of 9 December 2019, to endorse the recommendation made by the independent Compliance Review Committee that RUSADA be declared non-compliant with the World Anti-Doping Code for a period of four years, with a range of consequences attached. This followed the results of an investigation that alleged data from the Moscow Laboratory was intentionally altered prior to and while it was being forensically copied by WADA in January 2019, in contravention of RUSADA’s reinstatement conditions, approved by the ExCo in September 2018.

Due to COVID-19 restrictions in place around the world, the hearing will take place in a mixed format with parties, legal representatives and witnesses attending either in person or virtually, via a video link. WADA had requested that the hearing be held in public but for that to happen all parties were required to be in agreement and that was not the case.

WADA will not be holding any media briefing or conference prior to the arbitral award being announced by CAS.


23/10/20 WADA PUBLISHES REVISED POLICY FOR THE ACCEPTANCE OF NEW WORLD ANTI-DOPING CODE SIGNATORIES

Montreal, 23 October 2020 – Today, the World Anti-Doping Agency (WADA) publishes its revised Policy for the Acceptance of New World Anti-Doping Code Signatories (Signatory Policy), which was approved by the Agency’s Executive Committee (ExCo) during its meeting of 14-15 September 2020.

The revised Signatory Policy, which will come into force on 1 January 2021, has been reviewed to ensure that it aligns with the 2021 World Anti-Doping Code (Code). It is intended to enable organizations that are committed to protecting clean athletes to become Code Signatories. The Policy relates specifically to Code Article 23.1, which outlines the entities that may become Signatories to the Code.

It was determined that the current Signatory Policy – which has been in effect since November 2017 – needed to be reviewed and updated. Therefore, in May 2019, it was agreed that a working group, composed of WADA stakeholder representatives of the Sports Movement and Public Authorities, be established to consider the matter and develop proposed revisions to the Policy. The revisions that were included within the revised Policy reflect the consensus reached by the group. They aim at finding the right balance between protecting the pyramidal model of sport and allowing WADA to accept, as Code Signatories, organizations that are of sufficient relevance in the world of sport; and, are committed to protecting clean athletes, regardless of their status within the Sports Movement.

In summary, the revised Signatory Policy establishes a process whereby an applicant will be assessed in a collaborative manner between WADA Management and a newly created “Signatory Expert Group”, convened as required. As outlined in the Terms of Reference, such a Group would be comprised of one representative from the Sports Movement and one from the Public Authorities; as well as an independent Chair proposed by WADA Management to be approved by the WADA ExCo.

Once WADA Management and the Signatory Expert Group (or, in case of disagreement, the WADA ExCo) determine that the criteria of assessment are met, WADA Management will review the anti-doping program of the applicant through a Code Compliance Questionnaire and review its anti-doping rules. If the applicant’s anti-doping program has no critical non-conformities with the Code and the International Standards or all of its critical non-conformities are corrected within the relevant deadline(s), the applicant shall be accepted as a Signatory by WADA Management.


22/10/20 WADA DEVELOPS NEW METHOD OF IDENTIFYING SAMPLE TAMPERING AS PART OF WEIGHTLIFTING INVESTIGATION

Montreal, 22 October 2020 – The World Anti-Doping Agency (WADA) has developed a new method of detecting the prohibited practice of urine substitution at the point of collection and the use of sample surrogates or ‘doppelgängers’, following a ground-breaking investigation into the sport of weightlifting.
 
After more than three years examining the activities of the International Weightlifting Federation (IWF) and the sport as a whole, WADA’s independent Intelligence and Investigations (I&I) Department today publishes the provisional findings of what is still an ongoing investigation.
 
Launched in August 2017, WADA I&I’s investigation into weightlifting has four pillars, namely:

  1. Operation Outreach, looking into claims that a high-ranking member of the IWF was paid to promote Russian interests and to protect Russian athletes from detection;
  2. Operation Heir, investigating allegations of an organized doping and protection scheme operating within Romanian weightlifting;
  3. Operation Extra, dealing with the complex process of collection, collation and assessment of all weightlifting intelligence received by WADA I&I; and
  4. Operation Arrow, a covert investigation into the practice of urine substitution at the point of collection.

This investigation has focused not just on athletes but also on others who might have been involved in facilitating this deception, including doping control officers, coaches, other athlete support personnel and officials. In 2019, WADA I&I successfully sought the support of multiple law enforcement agencies to investigate some of the allegations mentioned in the report. These law enforcement agencies approved today’s publication of this provisional report.

As it relates to Operation Arrow, the new methodology to refine the identification of potential substitute urine was developed by WADA I&I with assistance in part from confidential sources and analysis experts. This methodology has so far allowed investigators to identify, through DNA profile analysis, cases of suspected urine substitution involving 18 weightlifters from six countries. These cases will be presented to the International Testing Agency (ITA), to which the IWF has now delegated the conduct of its anti-doping program, for results management. WADA I&I found evidence of ‘doppelgängers’ being used to impersonate athletes during the sample collection process, ensuring clean urine was fraudulently provided.

WADA President Witold Bańka said: “WADA is appalled by what its Intelligence and Investigations Department has uncovered in this investigation. For too long, clean weightlifters have had to deal with an entrenched culture of doping in their sport, where the promotion of fear ensured that the truth remained hidden and that those who wanted to do the right thing were isolated. Once again this has shown the importance of whistleblower information and the positive difference that can be made when people with information have the courage to come forward. Intelligence from well-placed confidential sources, coupled with the diligent work of WADA Intelligence and Investigations, is delivering significant results across a host of investigations.

“WADA will continue to do all it can to help provide clean weightlifters with a safe and healthy environment for their sport. To do that more effectively in general, I believe this report shows clearly that it is time to start a discussion as to whether WADA should be granted additional powers of investigation, including unfettered access to all relevant internal documents and servers within the organization under investigation.”

WADA Director of I&I, Gunter Younger said: “In all we do, WADA Intelligence and Investigations seeks justice for athletes and for clean sport. The investigation into weightlifting has been complex, difficult and time-consuming with many obstacles placed in our way. The fear and silence that pervades this sport has been a significant impediment. Therefore, it has been very encouraging to receive such a large volume of intelligence as we did via WADA’s confidential whistleblower platform, ‘Speak up!’ The success of this investigation is down in large part to the bravery of those whistleblowers.

“We also commit to identifying other new investigative methods for our partners in the fight against doping. We want to detect doping wherever and however it occurs. The methodology applied as part of Operation Arrow in identifying cases of urine substitution can easily be applied to sports other than weightlifting. We will share the learnings and methodologies with Anti-Doping Organizations, laboratories and Athlete Passport Management Units to ensure a global and united effort to address urine substitution.”

Intelligence gathering within the sport of weightlifting continues. Following the McLaren IWF Investigation, which provided additional information to WADA I&I, WADA I&I is working closely with the ITA to ensure that all relevant intelligence is being thoroughly pursued (in addition to the 18 specific cases highlighted above). While the ITA is the IWF’s delegated independent investigative authority, as a Signatory to the World Anti-Doping Code, the IWF remains ultimately responsible and is subject to WADA I&I’s follow-up procedures, including through the Agency’s Compliance Monitoring Program*.

A further report will be published in due course, upon the completion of all outstanding law enforcement and I&I investigations. 


*In addition, as announced on 15 June 2020, WADA continues to be in close contact with the ITA to monitor the management of pending weightlifting cases following the information obtained by the McLaren IWF Investigation.


17/09/20 WADA TO HOST SIX ADDITIONAL ‘LIVE’ WEBINARS IN OCTOBER

Montreal, 17 September 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) publishes today the Agency’s ‘live’ webinar schedule for October, which encompasses webinars being offered as part of the following previously announced series:

  • A series that is part of WADA’s 2021 Code Implementation Support Program (CISP), which was launched on 4 May; and
  • A series that is athlete-led for athletes, which was announced by WADA on 11 June

The webinars are being hosted in English: 

Date/TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
2 Oct
9:00 EDT
The Athletes’ Anti-Doping Rights ActBen Sandford, Chair, WADA Athlete CommitteeAthlete Series

For Athletes
Register here
8 Oct
9:00 EDT
The Revised Social Science Research Grant ProgramTony Cunningham, Senior Manager, Education, WADA

Ani Meliksetyan, Coordinator, Policy and Research, Education, WADA
For Social Science ResearchersRegister here
14 Oct
 
09:00 EDT
The International Standard for Code Compliance by Signatories & the Future of WADA’s Compliance Monitoring ProgramKevin Haynes, Deputy Director (Audits & Monitoring Program), Standards & Harmonization, WADA

Tim Ricketts, Director, Standards & Harmonization, WADA

Ruta Smaiziene, Manager, Code Compliance, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA (Moderator)
CISP Series

For Anti-Doping Organizations (ADOs)
Register here
21 Oct
10:00 EDT

Preparing for a WADA Audit: How to Respond to International Standard for Protection of Privacy and Personal Information (ISPPPI) Questions
Karine Henrie, Senior Manager, Standards and Harmonization, WADA

Marissa Sunio, Manager, Legal Affairs, WADA

Frédérique Horwood, Lead Counsel, Privacy and Data Governance, WADA (Moderator)
CISP Series

For ADOs
Register here
28 Oct
10:00 EDT
The Training, Accreditation and Re-Accreditation of Sample Collection PersonnelKarine Henrie, Senior Manager, Standards and Harmonization, WADA

Emma Price, Head of Testing, UK Anti-Doping
CISP Series

For ADOs
Register here
29 Oct
07:00 EDT
2021 Prohibited List and beyondDr. Audrey Kinahan, Chair, WADA List Expert Group

Dr. Olivier Rabin, Senior Executive Director, Sciences and International Partnerships, WADA
CISP Series

For All stakeholders
Register here

We also take the opportunity below to remind stakeholders of the remaining webinars to be held in September:

Date / TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
28 Sept
09:00 EDT

Key changes to the International Standard for Therapeutic Use Exemptions (ISTUE) 2021: Presentation of cases
 
Dr. Alan Vernec, Medical Director, WADA

Sam Pool, 2021 Code Implementation Project Manager, UK Anti-Doping
CISP Series

For TUE Physicians

Register here
29 Sept
8:00 EDT

International Standard for Laboratories (ISL) 2021 (Version 11): Impact for Laboratories
Dr. Osquel Barroso, Senior Deputy Director, Laboratories, WADA

Adam Klevinas, Lawyer, Klevinas Sports Legal Solutions

Dr. Katja Mjøsund, Member, WADA TUE Expert Group; Chair, FINCIS TUE Committee
 
CISP Series

For Laboratories

Register here

To register for any or all of the above webinars, please simply view the registration instructions in the ‘Registration Link’ sections of the above tables.

Every mid-month, WADA communicates its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, please contact WADA at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


15/09/20 WADA EXECUTIVE COMMITTEE PAVES
THE WAY FOR FURTHER WADA GOVERNANCE REFORMS

Montreal, 15 September 2020 – The World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) held its third meeting of the year on 14-15 September, during which it received updates on WADA’s progress on key priorities and took a number of decisions, including approval of the List of Prohibited Substances and Methods (List) for 2021.

WADA is composed of a 38-member Foundation Board (Board), which is the Agency’s highest policy-making body, and the 12-person ExCo, to which the Board delegates the management and running of the Agency. The Board and ExCo are composed equally of representatives from the Sports Movement, including athletes, and Governments.

The ExCo meeting, which was held virtually due to COVID-19, opened with a moment of silence in memory of former WADA President John Fahey, who passed away on 12 September in Australia at the age of 75. Mr. Fahey served with distinction as President from 2008-13 and will be greatly missed by his colleagues and friends at the Agency.

After the meeting, WADA President and Chair of the ExCo Witold Bańka, said: “I am very encouraged by the level of engagement and solidarity that was expressed by Executive Committee members over the past couple of days. Representatives both from Governments and the Sports Movement were united in emphasizing the importance to continue to strengthen WADA and to support it in the delivery of its mission in the service of athletes.

“Members of the Executive Committee clearly reiterated their support for the current model of equal partnership between the Governments and Sports Movement that has proven to be successful since WADA was formed 21 years ago. In addition, members expressed their acceptance of the nature and timing of the governance reforms that are being implemented, as well as the way forward for additional reforms to be made in the future.

“As we continue to strengthen WADA’s governance, the Executive Committee is showing real leadership in ensuring the Agency is equipped to do its job effectively for clean sport around the world.”

Governance Reforms

The ExCo received a progress report on the implementation and timing of WADA’s wide-ranging governance reforms, which were approved by the Board in November 2018 and are being introduced according to the agreed schedule.  

When the reforms were approved in 2018, the Board indicated that there should be an ongoing review process installed by WADA to monitor the effect of the reforms, as well as to propose additional, appropriate reforms going forward. While the implemented reforms and those in progress are bringing far-reaching improvements to WADA’s governance structure, the ExCo has decided to maintain the forward momentum provided by these changes and has agreed to establish an expert Working Group on the Review of WADA Governance Reforms now in order to ensure WADA continues to evolve in line with international best practice.

The ExCo agreed that the group would be composed of one independent expert as chairperson, two experts nominated from each of the Sports Movement and the Governments, and one athlete. The composition of this Working Group will be finalized in November this year. Also in November, the Board, which has ultimate authority on governance matters, is scheduled in particular to appoint two independent ExCo members and discuss the ongoing development of a WADA Code of Ethics. As further reforms unfold, there will be broad consultation to allow all stakeholders to contribute to the shape of WADA’s governance so as to ensure it remains fit for the future.

U.S. ONCDP Report and Rodchenkov Act

The ExCo received an update regarding ongoing discussions between WADA and the U.S. Office of National Drug Control Policy (ONDCP) in relation to the possibility of the ONDCP withdrawing its WADA funding unless the Agency agreed to a number of demands related to WADA governance.

Mr Bańka said: “It is very important that WADA and the U.S. authorities work together to further strengthen anti-doping and again, I state my willingness to be part of constructive discussions in order to ensure collaboration between the U.S. and the global anti-doping community.”

There was overwhelming support among ExCo members to maintain the model of equal partnership between the Sports Movement and Governments and, on that basis, for dialogue between WADA and the U.S to be restored.

The meeting also received an update on the status of the Rodchenkov Anti-Doping Act that is currently before the U.S. Senate for consideration. There remain widely held concerns among other governments, the Sports Movement, and other anti-doping stakeholders over the Act’s extra-territoriality, its negative unintended consequences and the fact that it was amended specifically to exclude the American professional leagues and college sports, which account for more than half a million athletes within the U.S.

COVID-19

The ExCo received an update regarding the state of the global anti-doping program during the ongoing COVID-19 pandemic. As restrictions are being lifted in a growing number of countries around the world, more and more Anti-Doping Organizations (ADOs) are resuming their testing programs, following the guidance provided by WADA and the various government and health authorities.

WADA Director General Olivier Niggli said: “Following the initial global slowdown, anti-doping work has intensified quickly in recent weeks with more than 11,000 samples collected in July and in excess of 13,000 in August. The Anti-Doping Organizations are to be commended for their hard work at this difficult time as they seek to return their global testing programs to full power. As announced on 9 September, we have established a 10-person Strategic Testing Expert Group that is, among other activities, collecting and assessing feedback from ADOs on their testing programs during the COVID-19 pandemic. It is important that we build a global picture so that lessons can be learned from this unprecedented time and the global anti-doping community can respond effectively to similar public health crises should they arise in the future.”

WADA will continue to publish updates regarding its response to COVID-19 as the situation evolves and will formally update the ExCo again at its next meeting in November.

Athletes

While each Standing Committee Chair reported on the progress achieved in their respective areas of work, WADA’s Athlete Committee Chair, Ben Sandford, outlined the work of the Athlete Representation Working Group – a subset of the Athlete Committee – that is looking at ways to further develop athlete representation at WADA, as well as discussions around the concept of an ombudsperson(s) resource for anti-doping and its project that is delivering a series of informational webinars for athletes.

WADA’s President reported on his initiative to meet regularly with athlete groups, in line with WADA’s new five-year Strategic Plan that places athlete engagement at the heart of the organization’s activities. Since launching the initiative and despite the restrictions imposed by the COVID-19 pandemic, Mr. Bańka has managed to hold productive virtual meetings with hundreds of athletes from various athlete commissions worldwide. A key outcome of the exercise will be to establish how to ensure athlete perspectives can best be represented within WADA and how linkages might be improved between these athlete members and their WADA Athlete Committee colleagues, and ultimately all athletes affected by anti-doping.

RUSADA

The meeting received an update on the current situation with the Russian Anti-Doping Agency (RUSADA), including the recent dismissal of its Director General, Yuriy Ganus. While RUSADA’s appeal of WADA’s assertion of non-compliance and related consequences will be heard by the Court of Arbitration for Sport in early November, WADA is communicating with the authorities in Russia to ensure it has all of the information needed to assess the latest situation. WADA continues to monitor closely RUSADA’s programs and activities, including testing, to ensure its operational independence is maintained, and will continue to provide regular updates to the Agency’s independent Compliance Review Committee.

2021 Prohibited List and other International Standards

The ExCo approved the 2021 List, which will be published before 1 October 2020, and which will come into effect on 1 January 2021. Updated annually, the List designates what substances and methods are prohibited both in and out of competition under the World Anti-Doping Code (Code). Following input from the WADA Athlete Committee, the List has undergone a dynamic redesign that has also made it more user-friendly and easier to navigate for athletes.

Beyond approval of the 2021 List, which contains minor changes from the current 2020 List, the ExCo approved the revised International Standard for Laboratories and International Standard for the Protection of Privacy and Personal Information that were subject to public consultation and will also come into force on 1 January 2021.

Research Grants 

The ExCo approved funding recommendations for research proposals for WADA’s 2020 call for scientific research grants. A total of 19 projects were selected for funding amounting to USD 2,585,833. Details of these projects will be published on WADA’s website in the coming months once the individual contracts are signed.

Policy for Acceptance of New Code Signatories

The ExCo approved a revised policy for the acceptance of new Signatories to the Code, which will be applied by WADA as per Article 23.1.3 of the revised Code when it comes into effect on 1 January 2021. The revision is intended to enable more organizations that are committed to protecting clean athletes, regardless of their status within the Sports Movement, to become Signatories.

Social Science Research

The ExCo approved the Social Science Research Strategy 2020-24, which was developed by WADA in collaboration with the Social Science Research Review Panel and overseen by the Education Committee. The strategy widens the scope of WADA’s social science research activities, moving these beyond a grant program and enhancing the benefits that social science research can bring to the efforts of the anti-doping community to protect clean sport.

WADA will publish the new Social Science Research Strategy 2020-24, as well as the other documents approved by the ExCo and mentioned above, in the coming weeks.


09/09/20 NEW WADA STRATEGIC TESTING EXPERT GROUP REVIEWS LESSONS LEARNED FROM COVID-19 PANDEMIC TO BE READY FOR FUTURE SIMILAR CRISES

Montreal, 9 September 2020 – As the World Anti-Doping Agency (WADA) continues to provide leadership to the Clean Sport community during the COVID-19 pandemic, a multi-disciplinary testing expert group has been formed to identify lessons that can be learned from this unprecedented time and ensure the global anti-doping community can respond effectively to potential similar public health crises in the future.
 
Restrictions are being lifted in a growing number of countries around the world and, as a result, Anti-Doping Organizations (ADOs) are resuming their testing programs, following the guidance provided by WADA and the various health authorities. In line with a commitment given on 6 May, WADA has established a 10-person Strategic Testing Expert Group that is, among other activities, collecting and assessing feedback from ADOs on their testing programs during the COVID-19 pandemic.
 
WADA Director General Olivier Niggli said: “WADA and the Clean Sport community’s first priority during the coronavirus pandemic has always been the health and safety of athletes, doping control personnel and the general public. This is reflected in the reduction of testing programs in many parts of the world over the past months. However, now that activities are resuming in a growing number of countries, it is encouraging that anti-doping work has intensified quickly with more than 11,000 samples collected in July. Anti-Doping Organizations are to be congratulated for their efforts as they show their commitment to returning to full power while continuing to follow the advice of health authorities.
 
“To understand the impact of the pandemic on global anti-doping programs, WADA has launched a broad review to identify what lessons can be learned and what improvements can be made to the global anti-doping system should similar public health crises arise in the future. While the situation continues to evolve, we remain ready to assist Anti-Doping Organizations in supporting and monitoring their anti-doping programs.”

As part of the review, last week, WADA sent a survey to ADOs seeking the latest information on their testing programs, in order to build a global picture.
 
The survey is focused on three main areas:

  1. The impact that COVID-19 has had on ADO programs;
  2. ADO views on the COVID-19 Guidance for Resuming Testing document issued by WADA on 6 May, which outlines how the anti-doping community can best operate testing programs in this challenging environment in line with globally recommended health and hygiene procedures and the International Standard for Testing and Investigations; and
  3. The impact that COVID-19 has had on sample shipment and analysis.

The survey outcomes will assist WADA in identifying ways in which the anti-doping community can continue to adapt and be better prepared for similar situations in the future. This may also include developing temporary rules or amendments to the applicable International Standards or the inclusion of specific procedures within an existing WADA Guideline or other guidance document.
 
The Strategic Testing Expert Group is chaired by Matt Fedoruk from the United States Anti-Doping Agency and is made up of anti-doping professionals with a broad range of scientific, medical, legal and other relevant expertise, including an athlete representative.
 
WADA will continue to publish updates regarding its response to COVID-19 as the situation evolves.


04/09/20 WADA CALLS FOR UNITY TO PROTECT
CLEAN ATHLETES

Montreal, 4 September 2020 – Ahead of a meeting of the World Anti-Doping Agency (WADA) Executive Committee on 14-15 September, several representatives of the Governments of the world contacted WADA to express their concerns relative to threats from the United States Government to withdraw funding from the Agency if WADA did not fulfill a number of conditions.

These Governments have identified what they consider to be a weakness in the rules whereby a Government can unilaterally refuse to meet its agreed funding commitments without facing any significant consequences. They feel that what is happening with the U.S. Government could create a negative precedent internationally that could be replicated and would jeopardize the entire global anti-doping system.
 
As a result, these Governments have asked WADA to look at the possibility of amending its rules so that nations which go against the principles of the UNESCO Convention Against Doping in Sport in this way would potentially trigger sanctions under the International Standard for Code Compliance by Signatories.  
 
WADA President Witold Bańka said: “This matter has been raised by some concerned Governments, not by WADA’s leadership, and as is the case with any proposal raised by a stakeholder, WADA has an obligation to consider it carefully. We will examine the rules to see if they need to be strengthened in light of the current situation. As always, due process will be followed and this will be a matter for discussion and consultation.
 
“My focus remains absolutely on the welfare of athletes and, for their sakes, we must continue to protect the anti-doping system that has served clean athletes. Fairness for athletes all over the world remains my number-one priority. I will never let clean athletes become hostages of political games. Under the International Standard for Code Compliance by Signatories there are many possible consequences that do not impact the athletes.
 
“In this critical time for anti-doping, we need unity, not division. I still stand ready to work with the U.S. Government on this and I am hopeful that it will continue to contribute to the global anti-doping program. But what our stakeholders are telling us is that this episode has highlighted the need for more commitment and accountability within the clean sport community. The only way to preserve the global system is for everyone involved to stand united and work together to make it stronger.”

03/09/20 WADA PRESIDENT’S OPEN LETTER
TO ATHLETES

Warsaw, 3 September 2020 

Dear Fellow Athletes,

Just over two years have passed since I announced my decision to run for the presidency of the World Anti-Doping Agency (WADA); and, a little over six months since I took up the position. When I entered the race for this position as a former athlete and lifelong sports person, I was ready to face all odds. From the beginning, given the nature of the business, I knew that it would not be a quiet cruise but rather a boat sailing on the stormy sea. The only thing I hoped for, just as every true athlete does, was the opportunity to take up new challenges; to fulfil my mission in a spirit of  honesty and mutual respect with stakeholders; and, for the Agency and I to be assessed fairly.

Today, I am prepared to reflect on the complex landscape in which WADA and I personally are operating. As I still feel and think like an athlete, I would like to share these thoughts with you, my fellow athletes.

WADA was established in 1999 as a unique platform for cooperation between Governments and the Sports Movement, following the failure of actions taken by each of these parties individually. The forces were united to fight doping, the greatest threat to modern sport, more effectively and persistently. For over 20 years, this organization has matured and assumed new responsibilities, setting new standards for the operations of Anti-Doping Organizations worldwide; and, above all – it has tried to meet the increasing expectations of our stakeholders with limited financial means. Of course, mistakes have not been avoided, but only those who do nothing make no mistakes.

Today, WADA covers many areas, from setting the rules and monitoring compliance; education; and, scientific and social science research; to development of anti-doping programs; building anti-doping capacity around the world; and, carrying out investigations. It can rely on a highly professional and extremely committed staff of international experts and many equally qualified volunteers within its governance structure.

I think that this experiment that started in 1999, which probably not everyone believed in at the time, turned out to be successful. Therefore, as the new president of WADA, who has already had the opportunity to get to know the Agency from the inside but remains objective in his opinions, I am dedicated to further developing this experiment. I believe that only in the spirit of collaboration between Governments and the Sports Movement is it possible to combat doping in sport effectively. This unique construction best serves its most important stakeholder, the athletes around the world.

Today, it is difficult for me to imagine WADA without our public authority stakeholders that engage with their law enforcement agencies and support the fight against doping in their respective countries; just as, I cannot imagine the Agency without the Sports Movement stakeholders ensuring that unified rules are applied across all sports and in all competitions. Is it a perfect construction? I will answer in the words of the eminent British politician, Winston Churchill, who once said of democracy that “…No one pretends that it is perfect or all-wise. Indeed, it has been said that it is the worst form of government except for all those other forms that have been tried from time to time.

Today, WADA is often targeted by political attacks and games. Various arguments are used in these attacks — ranging from how our activities are financed and who can legitimately represent stakeholder interests to allegations of a lack of transparency. I can assure you that I will not allow WADA to get bogged down in these political games; and that, control of WADA is not for sale, no matter what stakeholder we are dealing with.

Some critics of WADA allege a lack of transparency. However, I have the impression that the loudest criticism comes from those who, unfortunately, are not known for being particularly transparent themselves. WADA’s Foundation Board (Board) meetings are open to the media; and, in the future, I want them to be streamed online. Today, on WADA’s website, one can find the Agency’s statutes; the verbatim minutes of WADA’s Board and Executive Committee (ExCo)annual reports; a full list of our annual contributions from governments; our Five-Year Strategic Plan; information on WADA’s governance along with its members/representatives; media releases; and, a wide array of other communications. Every year, WADA responds to thousands of external inquiries from the media, athletes and the general public. Isn’t this transparency?

Could we do more? Of course. However, we also have some limitations. For example, we cannot publish information about pending investigations in order to protect the integrity of the work conducted, as is normal practice in law enforcement, or about developing compliance cases with the World Anti-Doping Code in order to comply with the rules and processes of International Standards. However, I promise you that this information is progressively being made public as soon as it becomes possible without compromising outcomes. This also applies to the Russian Anti-Doping Agency (RUSADA) case, which is currently being reviewed by the Court of Arbitration for Sport (CAS) and for which we asked for a public hearing.

I would expect similar transparency from our critics. For them to be transparent. To publish their governing documents. To tell the world who finances them and who their members are. I am sure that the athlete community would also like to know.

You may think that this letter is a response to criticism. It is not. Criticism is normal to public life; and no organization, especially one as important as WADA, can avoid it. I can assure you that I am not afraid of criticism because every difficult decision gives rise to it and yet, I continue to make such decisions. I do however believe that criticism should be honest and constructive. This is what my sports career has taught me. Constructive criticism can help an athlete to motivate himself or herself and improve his or her performance. Therefore, I can assure you that WADA and I personally take honest criticism very seriously. We value all stakeholder input and feedback; in particular, from you, the athletes.

WADA is an organization that is constantly changing thanks to fruitful collaboration with its stakeholders. In November 2018, WADA’s Board approved governance reforms. As a result, a Nominations Committee was formed to ensure the right people in terms of skills and independence serve in senior governance roles within WADA. A term limit was also introduced for members of the Board, ExCo and all five of our Standing Committees. Only persons who meet the independence criteria may currently apply for the positions of President and Vice President of WADA. As part of the reform, the ExCo will soon be expanded to include two independent members. Moreover, a minimum of one seat for athlete representation has been guaranteed in all Standing Committees; and, one seat for National Anti-Doping Organizations in all Standing Committees except the Athlete Committee and the Compliance Review Committee.

WADA’s Athlete Committee is working on a concept to develop an ombudsperson’s office, which I personally support strongly. Its members are also working on transforming the Committee from an advisory body to a representative body, with the view to a representative of the Committee being appointed to WADA’s ExCo. Already, however, the athletes and former athletes who sit on the most important bodies of WADA, on the ExCo and the Board, constitute over one third of the composition. And this is not the end of the governance reforms.

Meanwhile, I have also read public comments pointing out that we lack “independent” athletes within the governance structure. But what does it mean to “be an independent athlete”? What makes one organization dependent and another independent when both are financed and therefore are dependent on someone? Why are some athletes considered to be better, more worthy, representatives of the athlete community than others? Who wants to create division within our community and for what purpose?

I would like to know the answers to these questions. As a former athlete who has completely resigned from all government functions previously held; and, who has never belonged to a governing body of any sports federation, I consider myself an independent athlete. Moreover, as a person who lost litres of sweat on an athletics track, then served sports in my country as a minister, I always carried the ideals of fair sportsmanship at heart; and therefore, I consider myself a worthy representative of the athlete community at WADA. I also believe that all my colleagues on the ExCo and the Board; who have represented their countries in different sports arenas around the world — sometimes with much more success than I — have the right to consider themselves athlete representatives. And no one, no critic, can take that right away from them. There are no better and worse athletes, more and less worthy to represent us as athlete representatives within WADA.

When I look at the long way that WADA has come over the past two decades, it saddens me that there is a lot of politics at play; battles for positions and influence around the activities of this organization; and, far too little thinking about the values at the core of the Agency’s mission. WADA was created to ensure that all athletes could participate on an equal footing, under fair conditions, without doping, and respecting each other. Today, political disputes obscure this goal.

However, I remember what brought me to WADA, the mission that I wanted and still want to pursue. I firmly believe that we need to put more efforts into further strengthening the global anti-doping system. I do not want athletes to compete with others who are not subject to robust doping control programs just because their countries do not have the resources to put such programs in place. I am talking to many ministers to increase their contribution to the fight against doping in sport, including financial. I have established the Anti-Doping Solidarity Fund, which is intended to raise private funds to strengthen anti-doping capacity in the regions that need such assistance. Soon, WADA will begin its first partnership program with private companies in the field of education. And this is only the beginning. I promise you that I will continue this mission because I believe this is the true purpose of WADA, because I came to WADA not to play political games but to serve you, my fellow athletes.

Concluding my letter, I would like to invite everyone to work hand in hand with me to advance our common mission. For several months now I have been engaging with athletes individually, including via social media; have been holding virtual meetings with athlete committees and groups; and, going forward, have many similar meetings planned. I am doing this because I strongly believe that WADA exists for athletes; that we need you on board; and, that we are accountable to you in carrying out our mission.

Therefore, I strongly encourage you to speak up about Clean Sport. Speak loudly in your countries and in your sports. Criticize us if we deserve it but support our mission.  Please do not be indifferent because, for WADA, you are MOST IMPORTANT. For me, you are MOST IMPORTANT.

Thank you,

Witold Banka
President


24/08/20 WADA REMINDS WORLD ANTI-DOPING CODE SIGNATORIES TO REVISE THEIR ANTI-DOPING RULES FOR 2021

Dear Colleagues,

On 13 December 2019, in connection with the launch of its 2021 Code Implementation Support Program (CISP), the World Anti-Doping Agency (WADA) announced publication, in English, of its 2021 Model Rules for Code Signatories (Model Rules), which are intended to help National Anti-Doping Organizations, International Federations, Major Event Organizations and National Olympic Committees in drafting their new anti-doping rules in line with the 2021 World Anti-Doping Code (Code). These Model Rules have since been made available in French as well.

In order to ensure that anti-doping rules continue to be harmonized worldwide, which is critical to providing athletes with a level playing field, all Code Signatories are required to have drafted and adopted anti-doping rules in line with the 2021 Code by 1 January 2021. Therefore, WADA wishes to remind all Signatories that have not yet done so to take action as soon as possible; and, to send their draft anti-doping rules to compliance@wada-ama.org. Once received, WADA will verify the rules to ensure that they are in line with the 2021 Code; provide feedback if they are not; and ultimately, approve them before the Signatory starts its internal process of adoption of the rules.

We also wish to remind Code Signatories that WADA is required to address cases where Signatories do not have anti-doping rules in line with the 2021 Code by 1 January 2021 as potential instances of non-compliance.

Should you have any questions or require support, please contact us at compliance@wada-ama.org.

Thank you for your cooperation and best regards,

World Anti-Doping Agency


07/08/20 WADA UPDATE ON AGENCY’S COMPLIANCE MONITORING ACTIVITIES IN LIGHT OF COVID-19

Dear Colleagues,
[World Anti-Doping Code Signatories]

We are writing to you to provide you with an update on the World Anti-Doping Agency’s (WADA) monitoring of World Anti-Doping Code (Code) Signatories’ compliance following the latest meeting of WADA’s independent Compliance Review Committee (CRC), held on 4 and 5 August 2020 by conference call.

The Committee focused on the impact of the current COVID-19 pandemic on anti-doping programs worldwide and acknowledged the ongoing complexities affecting Anti-Doping Organizations (ADOs) in this unprecedented and unpredictable situation. 

The CRC members were pleased to hear that many ADOs had resumed their activities. They also expressed the expectation that, as sport activities, including competitions, gradually resume after suspension or restriction, anti-doping activities will be ramped up in parallel. The CRC advised WADA to maintain its compliance monitoring activities in a robust but flexible manner during this time. In the case where serious non-conformities are not resolved by a Signatory who is in a position to do so, WADA has the option to apply the “fast track” compliance procedure as detailed in Article 9.5 of the International Standard for Code Compliance by Signatories (ISCCS).

WADA thus encourages all ADOs to continue to advance their anti-doping programs, to the extent possible, and remains available to assist all Code Signatories.

Regarding the continuation of the temporary measures in effect during this time, the CRC endorsed WADA Management’s proposal to prolong them as part of the Agency’s monitoring of Signatory compliance with the Code. Therefore, there will be no change to the measures that were announced by the CRC in April 2020, which are:

  • the postponement of a number of deadlines (and the consequent freezing of the related enforcement procedures) for ADOs to meet ongoing compliance requirements and complete corrective actions under the ISCCS; and
  • a general degree of adaptability in WADA’s compliance monitoring program during the period. This will include the introduction of “virtual” compliance audits due to travel restrictions limiting the opportunity to conduct in-person audits. These virtual audits, which WADA will start to pilot from September 2020, will involve WADA requesting in advance from the audited ADO a number of documents for review. The virtual audit will then be conducted over a 3- or 4-day period for several hours each day, and WADA will provide any corrective actions identified in a Corrective Action Report (CAR). This is a new WADA initiative to maintain robust monitoring activities during this period. 

The CRC will review these temporary measures and discuss WADA’s longer term plans for Signatory compliance monitoring at its next meeting, scheduled for 6 and 7 October 2020.

We thank you very much for your continued commitment to doping-free sport in these challenging times and invite you to contact us at compliance@wada-ama.org if you have any questions regarding this communication or Code compliance in general.

Sincerely,

World Anti-Doping Agency


23/07/20 WADA LAUNCHES NEW e-LEARNING COURSE FOR ATHLETES AND COACHES HEADING TO TOKYO 2020 GAMES

Montreal, 23 July 2020 – With exactly one year to go until the start of the postponed Tokyo 2020 Olympic Games, the World Anti-Doping Agency (WADA) is pleased to launch a new interactive education course on its Anti-Doping eLearning Platform (ADeL) for athletes and coaches aiming to attend the Tokyo 2020 Olympic Games.

The new course, entitled ‘ADeL for Tokyo 2020 Olympics’, was developed by WADA in collaboration with the International Olympic Committee (IOC) and the International Testing Agency (ITA), and demonstrates the organizations’ commitment to educate and support athletes and their coaches in the build-up to the Games.

Athletes and coaches taking the new course will gain an understanding of the Tokyo 2020 anti-doping rules, procedures and requirements – including how to check medications and apply for a Therapeutic Use Exemption (TUE), how to provide whereabouts information, and explanations of the athletes’ rights and responsibilities during the testing process. The course will also allow athletes and coaches to identify key information, such as important dates that they need to be aware of and which organization has jurisdiction over them during the Games.

WADA Director of Education, Amanda Hudson, said: “With 12 months to go, WADA is pleased to share this new addition to our education solutions that Anti-Doping Organizations can use to educate their athletes and support personnel. ‘ADeL for Tokyo 2020 Olympics’ enables Anti-Doping Organizations to help prepare their national team athletes and coaches on all things anti-doping at the Games. We all want a clean Games and to protect athletes. We therefore encourage Anti-Doping Organizations to utilize this new interactive eLearning course as well as our additional course specifically for medical professionals to educate those heading to Tokyo.

“Athletes and support personnel at the Tokyo 2020 Games next year will participate under the new International Standard for Education (ISE). The Standard promotes the principle that those hoping to compete and participate at major events, such as the Olympic Games, should be educated prior to the event. WADA, along with the IOC and ITA, want to support this principle and ensure that every athlete is given the opportunity to understand the anti-doping program that will be in place for the Games, whether this is their very first Games or if they are seasoned Olympians.”

WADA and the IOC, had previously launched the ‘ADeL for Medical Professionals at Major Games’ course which is a mandatory requirement for all medical professionals attending the Games.

IOC Medical and Scientific Director, Dr Richard Budgett, said: “This course builds on the success of the ‘ADeL for Medical Professionals at Major Games’ course and will be an important part of the preparation for the Games for athletes and their support staff. It complements the pre-Games testing program and reflects the importance of education for the protection of clean athletes.”

During the Games, the ITA will independently manage the anti-doping program on behalf of the IOC. The ITA will therefore coordinate testing activities on-site together with processing of TUEs, Athlete Biological Passport notifications and Results Management. As part of this important program, athletes and Athlete Support Personnel will play a key role in ensuring that the Games are clean – and their work starts now with the release of this new education course that can be completed pre-Games.

ITA Director General, Benjamin Cohen, said: “The ITA is delighted to collaborate with WADA and the IOC in the development of this important education initiative for all athletes and coaches preparing for Tokyo. It will ensure that all team members understand, and know how to comply with, the extensive measures that have been put in place to protect them against doping and to ensure a clean Games.”

Completion of this course – which includes a certificate for those who achieve a score of 80% or higher – is highly recommended. WADA, the IOC and the ITA strongly encourage all National Olympic Committees to work in close collaboration with their National or Regional Anti-Doping Organization and their National Federations to ensure that athletes and coaches are properly educated in advance of the Games – a principle that the International Standard for Education, which comes into force on 1 January 2021, reinforces.


21/07/20 WADA SUSPENDS ACCREDITATION OF NEW DELHI LABORATORY FOR ANOTHER PERIOD OF UP TO SIX MONTHS

Montreal, 21 July 2020 – The World Anti-Doping Agency (WADA) has suspended the accreditation of the National Dope Testing Laboratory (NDTL) in New Delhi, India, for a second period of up to six months.

An original six-month suspension was imposed in August 2019 due to non-conformities with the International Standard for Laboratories (ISL) identified during a WADA site visit, including in relation to the laboratory’s isotope ratio mass spectrometry (GC/C/IRMS) analytical method, as regulated by the relevant WADA Technical Document (TD2016IRMS).

In February 2020, when the six-month suspension period elapsed and some outstanding non-conformities had not been addressed successfully, WADA’s Laboratory Expert Group (LabEG) recommended the initiation of further disciplinary proceedings against the laboratory based on the outstanding non-conformities. These disciplinary proceedings were carried out by an independent Disciplinary Committee that was mandated to make a recommendation to the Chair of the WADA Executive Committee regarding the status of the NDTL’s accreditation, while the laboratory remained suspended. The disciplinary process is now complete and the second six-month suspension began on 17 July 2020.

Pursuant to Article 13.7 of the World Anti-Doping Code, the NDTL may appeal this decision to the Court of Arbitration for Sport within 21 days of receipt of notice.

The suspension prohibits the NDTL from carrying out any anti-doping activities, including all analyses of urine and blood samples. During the period of suspension, if the laboratory satisfies the LabEG in meeting the requirements, it may apply for reinstatement prior to the expiry of the six-month suspension period. Should the laboratory not address the non-conformities by the end of the six-month suspension period, WADA may extend the suspension of the laboratory’s accreditation for up to an additional six months.

In accordance with the ISL, WADA is responsible for accrediting and re-accrediting anti-doping laboratories, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in conjunction with International Organization for Standardization (ISO) assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).


03/07/20 REMINDER: WADA INVITES STAKEHOLDERS TO NOMINATE CANDIDATES FOR 2021 STANDING COMMITTEE MEMBER VACANCIES

Montreal, 3 July 2020 – On 11 May 2020, the World Anti-Doping Agency (WADA) announced that it was seeking nominations for candidates to fill a number of vacant member positions on its five Standing Committees for 2021 as listed below; and, today, we wish to remind you that the deadline for submitting nominations is 25 September 2020.

We would also ask you to take particular note that, since WADA’s May announcement, one member of the Compliance Review Committee (CRC) has indicated that, due to a change in employment, they are unable to continue their term beyond the end of 2020; and therefore, this additional vacancy is now listed in the table below.

The Standing Committees, which report into WADA’s Executive Committee (ExCo), play a key advisory role in policy and priority development for the Agency. The successful candidates will be approved by WADA’s ExCo on 11 November 2020 and take office on 1 January 2021 for three-year terms.

Aside from outlining the vacancies below, WADA is pleased to provide links to the current Terms of Reference (TOR) for each Standing Committee that outline the scope of work and functioning of each Committee.
 

Committees [Terms of Reference (TOR)]Vacant positions
Athlete Committee [TOR)]Two positions
Compliance Review Committee (CRC) [TOR]
 
Three positions:One representing athletes;One independent compliance expert; 

(It should be noted that WADA’s Nominations Committee can also recruit additional candidates for the above CRC positions.)
 One representing Public Authorities (term of two years only, i.e. 2021-2022, to fulfil the remaining years on the current term of the departing member).

(It should be noted that, with regards to this CRC position, the Nominations Committee does not fulfill a role.)
Education Committee [TOR]Four positions
Finance and Administration Committee [TOR]Four positions
Health, Medical and Research Committee [TOR]Four positions

WADA President Witold Bańka said: “WADA encourages its stakeholders to consider their respective regions and organizations and to nominate suitable candidates for the vacant positions on WADA’s 2021 Standing Committees. Having diverse and committed Committee members with the expertise to advise WADA Management and the Executive Committee is crucial to advancing the Agency’s mission as the leader of Clean Sport.”

This call for nominations is in accordance with WADA’s governance reforms that were approved by WADA’s Foundation Board (Board) in November 2018 and formalized by the Board in November 2019; and which, require the Agency, on an annual basis, to announce its call for nominations six months prior to when the decision will be taken by the ExCo.

How to submit nominations

To be considered, all nominations must include the following and be forwarded by Friday, 25 September 2020, to Mr. Olivier Niggli, WADA Director General (c/o marjorie.chinnarassen@wada-ama.org):

  • an updated curriculum vitae, which fully outlines the candidate’s experience and expertise; and
  • a letter of endorsement from one of WADA’s current Board members or a recognized WADA stakeholder group.

Any questions should also be directed to Mr. Niggli, c/o Ms. Chinnarassen.


02/07/20 WADA PUBLISHES ITS FIVE-YEAR STRATEGIC PLAN UNDER THE THEME ‘LEADING ANTI-DOPING IN A NEW ERA’

Montreal, 2 July 2020 – Today, the World Anti-Doping Agency (WADA) publishes its Five-Year Strategic Plan, which lays the foundation for WADA’s strategic activity for 2020-2024 as the Agency is ‘Leading Anti-Doping in a New Era’.
 
The Strategic Plan was agreed by WADA’s Executive Committee (ExCo) when they met virtually on 15 May 2020; and, was subsequently approved unanimously by the Agency’s Foundation Board by circulatory vote.
 
Our journey of reflection and discovery
 
In May 2019, WADA initiated development of the Strategic Plan with a commitment to soliciting feedback from key stakeholders within the anti-doping ecosystem; such as: athletes; representatives of the Sports Movement and Governments of the world; industry influencers; as well as, National Anti-Doping Organizations and WADA-accredited laboratories. The feedback acknowledged how much WADA had achieved over its 20-year history; how the Agency’s growth had helped spur on the global movement for doping-free sport; and, it also identified a number of areas where WADA could improve or focus more.
 
WADA President Witold Banka said: “WADA is now in a completely different place than it was a few years ago thanks to the governance reform that the Agency initiated and to the strengthening of its compliance monitoring activities. While stakeholders recognize these achievements, there is consensus that WADA must go further to build bridges and unite efforts to protect athletes and the integrity of sports globally; and that, the Agency’s resources are not reflecting the magnitude of the challenges that we face.”
 
“The Strategic Priorities laid out in the Strategic Plan have been defined with athletes at the center and will shape the transformational journey that WADA will take over the next five years. Day in, day out, the Agency will continue to collaborate with athletes and all our partners worldwide to strengthen the World Anti-Doping Program. I am very committed to this Plan; most notably, to engaging and empowering athletes in developing Clean Sport; to building anti-doping capacity and community worldwide; and, to securing the additional funding that is required to deliver on Leading Anti-Doping in a New Era. I am confident that, with stakeholder collaboration and unity, we will succeed.”
 
Our Strategic Priorities
 
WADA defined the following Strategic Priorities, which address the key issues and challenges identified via our internal and external consultation: 

  1. Lead: Lead by example by taking bold steps to proactively tackle emerging issues with agility and innovative solutions across all facets of anti-doping.
  2. Grow Impact: Expand the reach and impact of anti-doping programs by enhancing capacity building and knowledge sharing between Anti-Doping Organizations and empowering local program delivery.
  3. Be Athlete-Centered:  Engage and empower athletes to contribute to the development of anti-doping policies, build an easier anti-doping journey for athletes, and increase the contribution that our programs deliver for athletes and their entourage so that they can build healthy and sustainable careers in sport.
  4. Collaborate and Unite:  Engage and collaborate with everyone involved in anti-doping, in particular with the sports movement and public authorities, to increase support, unity and coherence in everyone’s efforts.
  5. Be Visible: Raise awareness and shape a proactive narrative that will demonstrate the positive impact of doping-free sport and WADA’s role.
  6. Perform: Provide greater value to our stakeholders by reducing operational complexities and maximizing impact and cost-effectiveness.

WADA Director General Olivier Niggli said: “Over the years, the WADA team has worked diligently with stakeholders to develop the World Anti-Doping Program. Although doping scandals in recent years have tested the resolve and unity of the anti-doping community, they ultimately served as a catalyst to strengthen the Program. They also demonstrated the persistent challenges of doping in sports worldwide; and, the importance and the need of reinforcing WADA’s leadership and capacity so that it can collaboratively deliver on its global mission for doping-free sport.”
 
“We are now engaging our 140+ talented and committed team members worldwide around the Strategic Plan. We want to be sure to mobilize the very best contributions from all of us in Leading Anti-Doping in a New Era.


30/06/20 WADA INVITES APPLICATIONS FOR RESEARCH PROJECTS ON THE DEVELOPMENT OF DRIED BLOOD SPOT TESTING

Montreal, 30 June 2020 – The World Anti-Doping Agency (WADA) – along with several stakeholders including the China Anti-Doping Agency (CHINADA), the International Olympic Committee (IOC), the International Testing Agency (ITA) and the United States Anti-Doping Agency (USADA) – announces a Request for Applications (RFA) on the development of dried blood spot (DBS) testing.

This RFA is connected to the announcement made by WADA on 3 October 2019, which outlined that the Agency was collaborating with Anti-Doping Organizations from around the world to further the development and implementation of this exciting method for drug testing in sport.
 
In this context, and for the further development of DBS testing, this RFA for targeted research projects identifies the following relevant areas of research in the development of DBS as a new sample type for anti-doping testing:

  1. Discovery and/or validation of new discriminant biomarkers or biomarkers of confounding factors of the haematological module of the Athlete Biological Passport (ABP) in DBS;
  2. Study of the potential advantages of turning to dried plasma spots instead of DBS for testing for prohibited substances; and
  3. Development and validation of a new analytical method for the detection and quantification of human chorionic gonadotrophin (hCG) in DBS.

To submit applications, individuals are asked to create an account on the WADAGrants platform.

Please note that this RFA has different objectives, timelines and eligibility criteria from the RFA released by WADA and the Fonds de recherche du Québec on 17 June 2020 for targeted research projects that aim to develop biomarkers of doping.

The deadline for proposal submission is 31 August 2020 (24:00 GMT).

For further information, please contact WADA’s DBS Project Manager, Léonie Egli at: DBS@wada-ama.org.


23/06/20 SAVE THE DATES FOR WADA’s 2021 ANNUAL SYMPOSIUM AND THERAPEUTIC USE EXEMPTION SYMPOSIUM 

Montreal, 23 June 2020

Dear Colleagues,

While uncertainty continues due to COVID-19, for planning purposes, the World Anti-Doping Agency (WADA) kindly asks its stakeholders to ‘save the date’ for two important WADA events to be held next year:

  1. The 2021 Annual Symposium, which is scheduled to be held on Wednesday, 17 March and Thursday, 18 March 2021 at the SwissTech Convention Center in Lausanne, Switzerland.

    This 16th edition, which will be themed ‘Partnering to Deliver Clean Sport for Athletes in a New Era’ will, once again, be a unique and practical event that offers anti-doping stakeholders the opportunity to interact and learn from one another. The Symposium is designed for anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations; representatives from Athlete Commissions, Governments, WADA-accredited laboratories and Athlete Passport Management Units; as well as, other stakeholders such as service providers, researchers and the media – all that are integral to clean sport.

    In keeping with the theme, we particularly encourage the participation of Anti-Doping Organizations’ athletes and athlete representatives. Given that the International Olympic Committee and the International Paralympic Committee will both be holding major Athlete Forums in 2021 that will feature discussions on anti-doping, WADA has opted not to hold an additional full-day Athlete Session as part of the Symposium in 2021; however, athletes and athlete matters will be front and center in the two-day agenda.

    More details regarding the Annual Symposium, including a draft agenda and logistical information, will be provided when registration opens during the fourth quarter of 2020.
     
  2. The Therapeutic Use Exemption (TUE) Symposium, which is scheduled to be held from Wednesday, 21 April to Friday, 23 April in Incheon, South Korea.

    This fifth edition of WADA’s TUE Symposium will be hosted by the Korea Anti-Doping Agency (KADA); and, will convene physicians and representatives of National Anti-Doping Organizations, International Federations, Major Event Organizations and other international sports organizations from around the globe to discuss medical conditions and the TUE process.

    The primary objective of the Symposium is to harmonize the approach to TUEs, which ensure that athletes with legitimate medical conditions may participate in sport despite their need for a prohibited substance or method. The Symposium will discuss the revised 2021 International Standard for TUEs that will enter into effect on 1 January 2021; and, include interactive discussions on medical cases; medico-legal issues; retroactive TUEs; and, the challenges regarding global harmonization of practices, with the goal of ensuring that fairness is maintained and athletes are afforded similar opportunities, regardless of their sport, geographical location or specific medical issues. 

WADA is committed to ensuring the health and safety of the stakeholder community and the Agency’s staff. Accordingly, the Agency will continue to monitor the evolution of the pandemic; and, base its decisions regarding whether to hold these large-scale gatherings in person or through virtual means on directives issued by public health authorities.

The Agency hopes to have the pleasure of welcoming you in Lausanne and Incheon in 2021.

Best regards,

World Anti-Doping Agency


19/06/20 WADA PUBLISHES ‘LIVE’ WEBINAR SCHEDULE FOR JULY

Montreal, 19 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the Agency’s ‘live’ webinar schedule for July, which encompasses all webinars being offered as part of the following previously announced series. Unless otherwise noted, the webinars are being hosted in English only.

  1. A series that is part of WADA’s 2021 Code Implementation Support Program (CISP), which was launched on 4 May;
  2. A series that is being offered in place of some of the sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19;
  3. A series that is athlete-led for athletes, which was announced by WADA on 11 June;
  4. A series announced on 28 May, which is being offered by the Agency’s Africa Office, to assist anti-doping stakeholders in the region with the development and implementation of robust anti-doping programs; and
  5. A series announced on 19 May, which is being hosted by the Agency’s Latin America Office, to assist Spanish-speaking anti-doping stakeholders around the world with their implementation of the 2021 World Anti-Doping Code.
Date/
Time
Session TitleSpeakers Webinar Series & Target audienceRegistration Link
2 July
10:00 EDT

SESIÓN 6: Casos prácticos (in Spanish)

Session 6: Case workshop
Maria Jose Pesce Cutri, Director, WADA Latin America Office

Tharinda Puth, Manager, Legal Affairs, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA

Juan Lauria, Manager, WADA Latin America Office
Spanish-language Series

NADOs and members of Disciplinary/
Appeal Panels

By invitation only

Please contact WADA’s Latin America Office Coordinator, Edna Serra at edna.serra@wada-ama.org
3 July
09:00 EDT

COVID-19 and Clean Sport
Ben Sandford, Chair, WADA Athlete Committee

Dr. Alan Vernec, Medical Director, WADA

Dr. Andrea Gotzmann, Chairwoman of the Executive Board, National Anti-Doping Agency of Germany

Benjamin Cohen, Director General, International Testing Agency

Tim Ricketts, Director, Standards & Harmonization, WADA

Athlete Series

Athletes

Register here
6 July 2020
09:00 EDT

Anti-Doping Knowledge for Medical Practitioners (in English)

Webinar on anti-doping knowledge and TUEs for Medical Practitioners and Team Doctors
Katia Alloun, Manager, Therapeutic Use Exemptions (TUEs), WADA

Yoko Dozono, Manager, TUEs, WADA

African Series

Medical Practitioners, Team Doctors, TUE Coordinators, RADO Managers

Please contact WADA’s Africa Office Manager, Sameh Elray at sameh.elray@wada-ama.org
7 July 2020
10:00 EDT

Anti-Doping Knowledge for Medical Practitioners (in French)

Webinar on anti-doping knowledge and TUEs for Medical Practitioners and Team Doctors
Katia Alloun, Manager, TUEs, WADA
African Series

Medical Practitioners, Team Doctors, TUE Coordinators, RADO Managers

Please contact WADA’s Africa Office Manager, Sameh Elray at sameh.elray@wada-ama.org
8 July
 
08:30 EDT
Anti-Doping Administration & Management System (ADAMS): WADA’s new Paperless Doping Control System and the Progress of the Next Gen TransformationStuart Kemp, Deputy Chief Operating Officer, WADA Chaya Ndiaye, Senior Manager & ADAMS Team Lead, WADAAnnual Symposium Series

All stakeholders
Register here
9 July
 
09:00 EDT
Athlete Pools and WhereaboutsKevin Haynes, Deputy Director, Standards and Harmonization, WADA

Dan-Thanh Tran, Senior Manager, Ethical Sport Enterprises, Canadian Centre for Ethics in Sport (CCES)
CISP Series

Anti-Doping Organizations (ADOs)
Register here
9 July
10:00 EDT

SESIÓN 7: Casos prácticos (in Spanish)

Session 7: Case workshop
Maria Jose Pesce Cutri, Director, WADA Latin America Office

Tharinda Puth, Manager, Legal Affairs, WADA

Emiliano Simonelli, Chief Compliance Manager, WADA

Juan Lauria, Manager, WADA Latin America Office

Spanish-language Series

NADOs and members of Disciplinary/Appeal Panels

By invitation only

Please contact WADA’s Latin America Office Coordinator, Edna Serra at edna.serra@wada-ama.org
15 July
 
8:00 EDT
Dried Blood Spot (DBS) Testing and AnalysisMarcia MacDonald, Deputy Director, Science & Medicine, WADA; Chair of DBS Steering Committee Jordi Segura, Scientific collaborator of Institut Hospital del Mar d’Investigacions Mèdiques (IMIM); Chair of DBS Analysis & Storage Working Group Qingping Yan, Deputy Director of Operation and Management Dept., CHINADA; Chair of DBS Collection & Transport Working GroupAnnual Symposium Series

ADOs
Register here
15 July
 
10:00 EDT
Introducción al nuevo Estándar Internacional de Educación y su implementación (in Spanish)
 
Webinar on the new International Standard for Education and its Implementation
Ariadna Camargo, Coordinator, Education, WADA

Tony Cunningham, Senior Manager, Education, WADA
Spanish-language Series

ADOs in Latin America
Register here
17 July
 
10:00 EDT
Implementing an Effective Testing ProgramThomas Capdevielle, Head of Testing & Compliance and Deputy Head, Athletics Integrity Unit Matthew Fedoruk, Chief Science Officer, USADA George Tsamis, Senior Manager, Standards and Harmonization, WADACISP Series

ADOs
Register here
23 July
 
8:30 EDT
Cyber Security Essentials for Anti-Doping OrganizationsAndrew Collins, Chief Information Officer, Sport Integrity Australia Jorge Leyva, Chief Executive Officer, Institute of National Anti-Doping Organizations (iNADO) Frédérique Horwood, Lead Counsel, Privacy and Data Governance, WADA (Moderator)CISP Series

ADOs
Register here
29 July
 
9:00 EDT
Key Takeaways of the 2021 International Standard for Results Management (ISRM)Julien Sieveking, Director, Legal Affairs, WADA Ross Wenzel, Attorney-at-law, Kellerhals Carrard; main drafter of the ISRMAnnual Symposium Series

All stakeholders
Register here

We also take the opportunity below to remind stakeholders of the remaining webinar to be held in June from the June ‘live’ webinar schedule that was published on 20 May.

Date / TimeSession TitleSpeakersWebinar Series & Target audienceRegistration Link
22 June
 
09:00 EDT
TUEs: Core Principles and Changes to the 2021 International Standard for TUEsKatia Alloun, Manager, TUEs, WADA
 
David Healy, Manager, TUEs, WADA
 
Alan Vernec, Medical Director, WADA
CISP Series

ADOs
Register here

To register for any or all of the above webinars, please simply click on the Registration Links provided.

Every mid-month, WADA will communicate its live webinar schedule for the following month, prompting stakeholders to register and participate.

Should you have any questions regarding the above, please contact WADA at: selva.balasingam@wada-ama.org.

Best regards,

World Anti-Doping Agency


18/06/20 WADA PUBLISHES FINAL DESIGNED VERSION OF ATHLETES’ ANTI-DOPING RIGHTS ACT

Montreal, 18 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish, in English and French, the final designed version of the Athletes’ Anti-Doping Rights Act (Act), which WADA’s Athlete Committee developed over two and half years in consultation with thousands of athletes and stakeholders worldwide.

The purpose of the Act, which is based on the 2021 World Anti-Doping Code (Code) and its related International Standards that take effect on 1 January 2021, is to ensure that the rights of all athletes worldwide to participate in doping-free sport are clearly set out, accessible, and universally applicable. The document was approved by WADA’s Executive Committee on 7 November 2019 during the World Conference on Doping in Sport in Katowice, Poland.

Developed by athletes, for athletes, the Act provides an outline of rights provided by the 2021 Code and International Standards in terms of equality of opportunity, fair testing programs, medical treatment, justice, accountability, education, data protection and more. It also makes recommendations around athletes’ rights to be part of a system that is free from corruption, that they are appropriately represented in terms of governance and decision-making, and that they have a right to legal aid.

WADA Athlete Committee Chair Ben Sandford said: “We are incredibly grateful to all the athletes and other stakeholders who contributed to developing the Athletes’ Anti-Doping Rights Act. It is vital that athletes and anti-doping organizations know what rights athletes have, how to access them, and where to go for remedy. We hope that the Act will become a valuable resource for athletes and contribute to making sport cleaner and fairer. We call upon the anti-doping community worldwide to support its implementation and its promise.”

WADA President Witold Bańka, who is a former international-level 400m runner, said: “WADA is an athlete-centered organization and everything that we do is to protect athletes’ right to access Clean Sport. I applaud the Athlete Committee’s efforts in developing the Anti-Doping Rights Act, which helps ensure that athletes are aware of their rights and can exercise them, which is vital to the success of Clean Sport.”

This Act is made up of two parts. Part one sets out rights that are found in the Code and International Standards. Part two sets out recommended athlete rights, which are not found in the Code or Standards but are rights that athletes recommend that anti-doping organizations adopt for best practice.

Best regards,

World Anti-Doping Agency


17/06/20 WADA AND FRQ INVITE APPLICATIONS FOR RESEARCH PROJECTS ON THE DEVELOPMENT OF BIOMARKERS

Montreal, 17 June 2020 – The World Anti-Doping Agency (WADA) and the Fonds de recherche du Québec (FRQ) are pleased to announce a special Request for Applications (RFA) for targeted research projects that aim to develop biomarkers of doping. This RFA is connected to the Memorandum of Understanding (MOU) that WADA and the FRQ announced on 16 May 2018 focused on advanced areas of anti-doping scientific research. Under the terms of the MOU, WADA and the FRQ agreed to contribute every year for five years (2018-2022) in order to fund important research projects related to anti-doping.

The development of novel biomarkers of doping is a key priority for anti-doping research. The challenges for the development and implementation of new biomarkers for anti-doping testing not only involve specific analytical approaches and omics technologies, but also require complementary expertise and research approaches that have been advanced in Quebec for the development of clinical biomarkers.

As part of this RFA, WADA and the FRQ aim to promote research on biomarkers of doping that integrates expertise in anti-doping science with Quebec expertise in areas such as biostatistics; bioinformatics; clinical pharmacology; development of diagnostic tests; and, design/analysis of clinical trials. Specifically, applications should aim to develop:

  1. Biomarkers of relevant prohibited substances or methods; or
  2. Biomarkers of known confounding factors encountered in anti-doping testing.

To submit applications, individuals are asked to create an account on the WADAGrants platform. Please note that the research team must contain at least one member based in Quebec. Collaboration between research groups is encouraged, including integration of expertise in both anti-doping science and development of biomarkers for clinical use.

The deadline for proposal submission is 5 October 2020 (24:00 GMT).

For further information, please contact WADA’s Science Department at science@wada-ama.org.


16/06/20 WADA PUBLISHES FINAL VERSIONS OF 2021 WORLD ANTI-DOPING CODE AND INTERNATIONAL STANDARDS IN ENGLISH AND FRENCH

Montreal, 16 June 2020

Dear Colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the final versions of the 2021 World Anti-Doping Code (Code) and International Standards (Standards), which will come into force on 1 January 2021. These final versions include limited changes from those that WADA published on 26 November 2019, which were the versions that were approved by the Agency’s Foundation Board (Board) and Executive Committee (ExCo), respectively, on 7 November 2019, during the Agency’s World Conference on Doping in Sport that was held in Katowice, Poland.

In the interest of full transparency, unless otherwise noted as an exception, the table below provides the following links for the Code and the relevant Standards:

  1. The final 2021 versions (in English and French, WADA’s two official languages).
     
  2. Summary documents (in English only) outlining the limited changes that were made from the 26 November 2019 versions to the final versions being published today.

    It is important to note that none of these limited changes affect in any way the sense, meaning or interpretation of the versions approved in Katowice. Rather, they were required to:
  • adapt and align clauses to changes approved in other clauses;
  • remove inconsistencies;
  • correct references to other Code or International Standards articles; and
  • make grammatical and formatting modifications.  
  1. A redline version outlining all the changes from the current versions in force to the final versions being published today (in English and French).
Final 2021 Versions
 
[In English and French]
Summary documents outlining the limited changes from the 26 November 2019 versions to the final versions published today
 
[In English Only]
Redline version outlining all changes from the current versions in force to the final versions published today
 
[In English and French]
Exceptions
World Anti-Doping CodeLinkLink
International Standard for Code Compliance by Signatories (ISCCS)LinkLink
International Standard for Education (ISE) (New)LinkN/A as is a new Standard
International Standard for Laboratories (ISL)N/A – see exception columnN/AAs communicated in November 2019, the ISL followed a different path than the other Standards.

A revised version 10.0 of the ISL — which was reviewed in order to reflect and incorporate relevant changes and to update the document in line with new technical, scientific and regulatory developments — was approved by the ExCo in May 2019; and, became effective on 1 November 2019. Subsequently, a revised version 11.0 of the ISL was drafted to ensure consistency with the 2021 Code and the other Standards. The amended draft 11.0 was circulated for stakeholder consultation from 10 December 2019 to 4 March 2020. Further to stakeholder feedback, the final draft is being finalized and will be presented for ExCo approval in September 2020.
International Standard for the Protection of Privacy and Personal Information (ISPPPI)N/AN/AOn 2 June 2020, WADA launched a Limited Supplementary Stakeholder Consultation Phase, which closes on 30 June.Stakeholders have until 2 July 2020 to provide feedback; after which, the final version of the ISPPPI will be published.
International Standard for Results Management (ISRM) (New)LinkN/A as is a new Standard
International Standard for Testing and Investigations (ISTI)LinkLink
International Standard for Therapeutic Use Exemptions (ISTUE)LinkLink

International Standard for the List of Prohibited Substances and Methods (Prohibited List)

As it relates to the Prohibited List, it is reviewed annually via a separate stakeholder process, which is underway.

Obtaining printed copies of the Code

In keeping with WADA’s sustainability efforts, in recent years the Agency has minimized print in favor of making its publications available digitally. However, given the importance of the Code, which will live for a number of years and be used on a daily basis by the Agency’s stakeholders, in the coming months, we will be:

  • Mailing out a limited quantity of printed English or French copies to Code Signatories;
  • Making English and French print-ready versions available on our website for stakeholders to print locally; and
  • Putting a mechanism in place for stakeholders and others that may wish to purchase printed copies in English and/or French.

Code Implementation Support Program

In closing, WADA wishes to draw your attention once again to the Agency’s Code Implementation Support Program (CISP), which went live on 4 May 2020. This program was developed to prepare Signatories for implementation of the Code and Standards that come into effect on 1 January 2021. The CISP includes:

  • resources that are available via the Agency’s Anti-Doping eLearning platform (ADeL); and
  • a series of live webinars, hosted by WADA personnel and external experts, to support Code/Standard implementation efforts for targeted audiences and/or regions. The Agency is also hosting live webinars in place of some sessions that would have otherwise been delivered during the Agency’s Annual Symposium, which was due to be held in March 2020 but was cancelled due to COVID-19.

Should you have questions or feedback regarding the Code and Standards, please contact code@wada-ama.org; or, questions or feedback related to the CISP, please contact 2021CISP@wada-ama.org.

Best regards,

World Anti-Doping Agency


15/06/20 WADA UPDATE ON ITS FOLLOW-UP OF McLAREN INVESTIGATION INTO THE INTERNATIONAL WEIGHTLIFTING FEDERATION

Montreal, 15 June 2020 – Following its initial statement on 4 June, the World Anti-Doping Agency (WADA) confirms that on 9 June it received some evidentiary information from the McLaren Independent Investigation Team, which recently completed an investigation into the International Weightlifting Federation (IWF).
 
WADA has since started to analyze the newly received information, which covers the period 2009-2014, to see what further action may be warranted in relation to anti-doping matters highlighted by the investigation. WADA is committed to ensuring that all athletes who are identified as having breached the rules, are brought to justice. The Agency has also made a request to the McLaren Investigation Team to share the remainder of the relevant information as described in Professor McLaren’s report published on 4 June, in particular so it can assess whether anything should be done from a compliance perspective.
 
In addition, WADA’s independent Intelligence & Investigations Department, which has collaborated with the McLaren team throughout, will continue its own ongoing investigation related to the sport of weightlifting.
 
WADA President, Witold Bańka, said: “WADA is appalled by the behavior exposed by the McLaren Investigation Team. The Agency condemns all interference with anti-doping procedures with the utmost vigor. These revelations are incredibly upsetting for clean athletes, for WADA and for all advocates of clean sport.
 
“As is recognized by the McLaren report, I am confident that recent strengthening of global anti-doping rules, and growing powers being afforded to WADA as the global anti-doping regulator, would ensure that, today, this kind of behavior could be dealt with as a matter of anti-doping organization compliance within much shorter timelines. Through the new International Standard for Code Compliance by Signatories, which took effect in April 2018, WADA can now address delayed results management as a matter of compliance.
 
“Cheats must be brought to justice and WADA will continue to ensure all cases are properly followed up by World Anti-Doping Code Signatories. This strengthens my resolve to bolster WADA’s financial capacity so that the Agency has the resources it needs to bring cases to the Court of Arbitration for Sport directly on a regular basis. We want to fully exercise the powers that we now have under anti-doping rules.”
 
Thanks to information obtained by the McLaren investigation team through access to IWF’s servers and other sources of evidence, the Agency wrote to the IWF on 12 June to request immediate action on all cases, with priority being given to those that are close to the statute of limitations. The IWF is the entity responsible to ensure that proper results management is conducted under the World Anti-Doping Code and WADA will monitor that process closely.

11/06/20 WADA LAUNCHES WEBINAR SERIES
FOR ATHLETES

Montreal, 11 June 2020 – Today, the World Anti-Doping Agency (WADA) is pleased to announce the launch of a series of athlete-led webinars to be held over the coming months. This series, which is an initiative of  WADA’s Athlete Committee, is intended to provide a platform for interactive engagement by the Agency with athletes worldwide on anti-doping matters. 
 
The first webinar, titled COVID-19 and Clean Sport, will be held on 3 July at 09:00 EDT; and, will focus on the impact of COVID-19 on athletes and the anti-doping system. The panelists will include the following athletes and experts:

  • Ben Sandford: Chair, WADA Athlete Committee
  • Dr. Alan Vernec: Medical Director, WADA
  • Dr. Andrea Gotzmann, Chairwoman of the Executive Board, National Anti-Doping Agency of Germany
  • Benjamin Cohen: Director General, International Testing Agency
  • Tim Ricketts, Director, Standards & Harmonization, WADA

These panelists will engage participants on the following topics:

  • the current situation in relation to testing;
  • what athletes can expect may be modified with respect to health and safety protections as testing ramps up again; and
  • how Anti-Doping Organizations are innovating and maintaining other elements of their detection and deterrence programs in the face of reduced testing.

Athletes are invited to register for this first webinar, by clicking here. Anti-Doping Organizations worldwide are encouraged to relay this announcement on to their athletes.
 
End May, WADA and its Athlete Committee published a Q&A document for athletes on the matter of COVID-19 to update them about the evolving situation related to the protection of athlete health and how clean sport can persevere during these challenging times. This first webinar will be a continuation of these efforts as WADA and its Athlete Committee strive to ensure that as many athletes as possible are informed about this evolving topic.
 
“Despite the many challenges athletes are facing as a result of COVD-19, we want to provide assurance that anti-doping is not at a standstill,” said WADA Athlete Committee Chair, Ben Sandford. “WADA’s Athlete Committee wants to provide athletes with up-to-date information about the impact that COVID-19 is having on Clean Sport; and, we also need to continue to hear from athletes about what specifically concerns them and how we may be able to address those concerns. Beginning with the topic of COVID-19, we hope that this series of webinars will be an effective platform to share information and hear from athletes about how we can best support them and further improve the global anti-doping system.”

The next webinars in the series for athletes will be announced successively on WADA’s website and via social media.
 
Should you have any questions or comments, please contact Stacy Spletzer-Jegen, WADA’s Senior Manager, Athlete Relations & Communications, at: stacy.spletzer@wada-ama.org.